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Diarrhoea is the one of the leading causes of childhood death globally and in 
South Africa. Plasma sodium and potassium disturbances contribute to this 
diarrhoea mortality, partly mediated by seasonal fluctuations in the 
disturbances. The high prevalence and the potentially serious implications of 
plasma sodium and potassium disturbances raise several issues about their 
prevention, diagnosis and management. 
OB .. IECTIVES 
a) To identify determinants, particularly with seasonal associations, of 
plasma sodium and potassium concentrations in young children 
admitted to hospital with dehydrating diarrhoea. 
b) To assess the diagnostic accuracy and reliability of clinical features 
previously reported to be associated with plasma sodium and 
potassium disturbances in children admitted to a diarrhoea 
Rehydration Unit. 
c) To perform a preliminary assessment of the amount of change in 
clinical management as a result of routine electrolyte testing in 
children with dehydrating diarrhoea. 
METHODS 
Three separate cross-sectional analytical studies - with overlapping data 
collection - were conducted during 15 April 2002 to 14 April 2003 on patients 
l 
between 6 weeks and 2 years of age admitted to the Rehydration Unit at Red 
Cross Children's Hospital, Cape Town. 
RESULTS AND INTERPRETATION 
Study one: Seasonal determinants of plasma sodium and potassium 
concentrations 
Results: Of the 350 patients included in the study, plasma sodium levels 
were available for 348 (99.4%) patients and plasma potassium for 347 
(99.1 %) patients. Determinants with statistically significant negative 
associations (p<0.05) with plasma sodium in multiple linear regression 
analysis were age (-0.29 mmol/l), plasma pH (-22.13 mmol/l), enterotoxigenic 
Escherichia coli infection (-2.13 mmol/l) and enteropathogenic Escherichia 
coli infection (-5.12 mmol/l). Statistically significant positive associations with 
plasma sodium in multiple linear regression analysis were being breast-fed 
(1.91 mmol/l) and living in a brick house (2.66 mmol/l). 
Determinants with statistically significant negative associations with plasma 
potassium in multiple regression linear analysis were duration of diarrhoea 
(-0.02 mmol/l) before admission and Cryptosporidium infection (-0.33 
mmol/l). Statistically significant positive associations (p<0.05) with plasma 
potassium in multiple linear regression analysis were parental education 
(0.04 mmol/l) and plasma pH (1.68 mmol/l). 
Enterotoxigenic Escherichia coli and Cryptosporidium infection had 
significant associations, in the same direction, with both plasma sodium and 
potassium in the bivariate analysis. 
Interpretation: Seasonal fluctuations in plasma sodium and potassium levels 
are at least partly explained by both enterotoxigenic Escherichia coli and 
Cryptosporidium working together, with enterotoxigenic Escherichia coli 
having the larger effect on plasma sodium levels and Cryptosporidium on 
plasma potassium levels. The associations of these enteropathogens with 
the seasonal fluctuations in plasma sodium and potassium levels is a new 
contribution to the current body of research. 
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Study two: Reliability and diagnostic accuracy of clinical signs 
Results: Of the 476 patients enrolled into the study, 475 (99.8%) were 
included in the "final analysis for plasma sodium and 471 (98.9%) for plasma 
potassium. One hundred and eighty-seven patients (39.4%) had plasma 
sodium levels <135 mmol/l and 31 (6.5%) levels >150 mmoi/i. Two hundred 
and thirty-six patients (50.1 %) had plasma potassium levels <3.5 mmoi/i. 
Inter-observer agreement in assessing clinical signs was generally poor. 
Exceptions were abdominal distension (weighted Kappa 0.70; 95% CI 0.49 to 
0.91); ability to sit (weighted Kappa 1.0; 95% CI 1.0 to 1.0); and to stand 
(weighted Kappa 0.72; 95% CI 0.44 to 0.99). Clinicians had no agreement as 
to whether there was a wooden feel to the patients' skin (- 0.02; 95% CI -
1.24 to 1.21). 
None of the signs studied for diagnostic accuracy had clinically meaningful 
associations with any of the plasma sodium and potassium abnormalities. 
Interpretation: This is the first systematic study of the diagnostic accuracy of 
clinical signs of plasma sodium and potassium disturbances in children with 
diarrhoea. The clinical signs assessed were neither useful nor reliable in 
clinical practice, with a consistent pattern of low accuracy across all tests. 
Even though there is uncertainty around the estimates of diagnostic accuracy 
for less prevalent conditions because of low statistical power, the most 
optimistic plausible levels of accuracy are not clinically meaningful, given the 
low prevalence of the target conditions. 
iii 
Study three: Therapeutic impact of routine electrolyte testing in 
management of plasma sodium and potassium disturbances 
Results: Of the 530 patients included in the analysis, plasma sodium levels 
were available for 528 (99.6%) patients and plasma potassium for 525 
(99.1 %) patients. Routine electrolyte testing identified 55 (10.4%) with 
abnormal plasma sodium levels, 18 (3.4%) of which were below 125 mmol/I, 
37 (7.0%) above 150 mmol/l and 23 (4.4%) above 155 mmoi/i. One hundred 
and sixty-six (31.6%) patients had low potassium levels, with 40 (7.6%) 
below 2 mmol/I and 13 (2.5%) below 1.5 mmoi/i. 
The number of patients that needed to be tested for each case that received 
a change in management was high because of the relatively low prevalence 
of some abnormalities. For potassium levels <1.5 mmol/l, the number needed 
to test was between 40 and 44 patients for any management change (95% CI 
ranged from 26 to 99). Even larger numbers (48 patients; 95% CI 30 to 116 
patients) needed to be tested for one management change in hyponatraemia 
(plasma sodium <125 mmol/l). For more prevalent and less severe 
conditions, for example, hypokalaemia (potassium <3 mmo/l), fewer patients 
needed testing (3 to 4) to identify one patient and to change management (5 
to 7 patients). 
Interpretation: This is the first study to report on the therapeutic impact of 
routine electrolyte testing in a low- or middle-income country. Routine testing 
resulted in the detection of plasma sodium and potassium abnormalities. 
However, large numbers of patients needed to be tested for each case of 
management change when abnormalities had a relatively low prevalence. 
The benefits of such testing need to be weighed against the costs of 
performing many tests before one abnormality is identified and treated, taking 
into consideration the presence of other health priorities, financial constraints 
and limited facilities and staffing in most settings were dehydrating diarrhoea 
is more prevalent. 
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A situation where there is close to a near perfect linear relationship among 
some or all of the independent variables in a regression model. This means 
there is some degree of redundancy or overlap among these variables. 
Co-morbidity 
The presence of co-existing or additional diseases with reference to an initial 
diagnosis or with reference to the index condition that is the subject of study. 
Disability-adjusted life years 
A quantitative indicator of burden of disease that reflects the total amount of 
healthy life lost, to all causes, whether from premature mortality or from some 
degree of disability during a period of time. 
Effect modifier 
A factor that modifies the effect of the independent variable on the dependent 
variable. 
False-negative 
A negative test result for the target condition in a person who is actually 
positive. 
False-positive 
A positive test result for the target condition in a person who is actually 
negative. 
Inter-observer variation 
Variations between different observers when reporting on the same 
outcomes at the same time. 
xix 
Kappa score 
A measure of the degree of non-random agreement between observations or 
measures of the same categorical variable. Kappa is always less than or 
equal to one. A value of one implies perfect agreement and values less than 
one imply less than perfect agreement. Kappa can be negative - a sign that 
the two observers agreed less than would be expected just by chance. 
Suggested interpretation of Kappa (Sackett et al., 1991 :30): 
o = no agreement better than chance, 
0- 0.2 = slight agreement, 
0.2 - 0.4 = fair agreement, 
0.4 - 0.6 = moderate agreement, 
0.6 - 0.8 = substantial agreement, 
0.8 - 1.0 = almost perfect agreement. 
Likelihood ratio 
The ratio of the likelihood that a given test result is expected in a patient with 
the target disorder compared to the likelihood that that same result is 
expected in a patient without the target disorder. It is a measure of how much 
a given diagnostic test result (positive or negative) will raise or lower the pre-
test odds of a disorder. 
Number needed to test 
The number of patients who need to be tested to identify one additional 
patient with the target condition. 
Outlier 
An extreme case in one variable, or a combination of variables, which have a 
strong influence on the calculation of summary statistics. 
Post-test probability 
The probability of the target condition being present after the results of the 
diagnostic test are available. 
xx 
Predictive value negative 
The probability that a person does not have the disease given a negative 
test. 
Predictive value positive 
The probability that a person has the disease given a positive test result. 
Pre-test probability 
The probability of the target condition being present before the results of the 
diagnostic test are available 
Reliability 
The extent to which a measure is stable or consistent and produces similar 
results when administered repeatedly. 
Receiver operating characteristic curve 
"A figure depicting the power of a diagnostic test. The receiver operating 
characteristic curve presents the test's true positive rate (sensitivity) on the 
horizontal axis and the false-positive rate (1-specificity) on the vertical axis 
for different cut-points dividing a positive from a negative test. A receiver 
operator curve for a perfect test has an area under the curve = 1.0 while a 
test that performs no better than by chance has an area under the curve of 
only 0.5. These curves help select the best combination of sensitivity and 
specificity with the area under the curve being a summary statistic of overall 
accuracy" (Guyatt & Rennie, 2002:425). 
Selection bias 
The introduction of error due to systematic differences in the characteristics 
of those selected to participate in a study. In sampling bias, which is a type of 
selection bias, error results from failure to ensure that all members of the 
reference population have a known chance of being selected for inclusion in 
the sample. In allocation bias, error results from systematic differences in the 
characteristics of those assigned to treatment versus control groups in a 
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controlled study. Allowing potential participants to self-select for participation 
or for intervention introduces selection bias. 
Sensitivity 
The proportion of truly diseased persons in a screened population who are 
identified as being diseased by the test. It is a measure of the probability of 
correctly diagnosing a condition. 
Specifi'city 
The proportion of truly non-diseased persons who are so identified by the 
screening test. It is a measure of the probability of correctly identifying a non-
diseased person. 
Spectrum bias 
Patients with only particular demographics, co-morbidities and severity of the 
target condition are included in the study sample, resulting in variability in the 
measure of test accuracy. 
Test review bias 
The distortion of the measures of accuracy caused by knowledge of the 
result of the reference standard while interpreting the index test. 
Variance inflation factor 
The impact of colinearity among the independent variables in a regression 
model on the precision of estimation. It expresses the degree to which 
colinearity among the independent variables degrades the precision of an 
estimate. 
Verification bias 
This occurs when a study selectively includes patients based on positive or 
negative results of preliminary testing, or the study test itself. To avoid this, a 
study should include consecutive patients at risk for a particular disease, and 
not only a subset who underwent definitive testing. 
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Weighted Kappa 
When more than two categories are ordered, weighted Kappa takes account 
of the degree of disagreement by giving weights to disagreements according 
to the size of the discrepancy in agreement. Weighted Kappa is usually 
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CHAPTER ONE: INTRODUCTION 
1.1 The magnitude of the problem of diarrhoeal disease 
1.1.1 Globally 
In 1990 an estimated 98% of all deaths globally in children younger than 15 
years of age occurred in developing countries. Thirty-two percent of these 
deaths were in children under 5 years of age (Murray & Lopez, 1997a). One 
of the major contributors to this childhood mortality is diarrhoeal disease, 
despite progress in the understanding of the pathogenesis and management 
of the disease (Thapar & Sanderson, 2004). 
Between 1992 and 2000 in the developing world, 4.9 children per 1000 per 
year died as a result of diarrhoea in the first five years of life. Even though 
there has been a decline in mortality rates over the years, from 13.6 
(between 1955 and 1979) to 5.6 (between 1980 and 1989) per 1000 per 
year, morbidity rates were observed to be greater than in earlier years 
(Kosek et al., 2003). 
The overall burden of disease due to diarrhoea is massive, with an estimated 
loss of 99.6 million disability-adjusted life years (DALYs) annually worldwide 
(Murray & Lopez, 1997b). The median diarrhoea incidence for all children 
under 5 years was 3.2 episodes per child per year (Figure 1.1) (Kosek et al., 
2003). 
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Figure 1.1 Median age-specific incidences for diarrhoeal episodes per 
child per year from three reviews of prospective studies in 
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Mortality data for South Africa are unreliable because of under-registration 
and misclassification (Bradshaw el a/, 2003a), and morbidity data are limited 
(Bradshaw, D. 2004. Personal Communication. 14 May, Medical Research 
Council, Cape Town). Diarrhoea is still, however, reported as one of the top 
three leading causes of childhood death. It was reported to account for 
10.2% of the 106 070 deaths of specified cause in children aged under 5 
years in 2000 (Bradshaw el ai, 2003b). 
1.1.3 In the study setting 
The South African Demographic Household Survey (SADHS) performed in 
1998 reported a 13% prevalence of diarrhoea for children under the age of 5 
years in the Western Cape (Department of Health. SADHS, 1998). Estimates 
were derived from the number of children who had diarrhoea in the 2 weeks 
prior to the survey. Interestingly, the increase in morbidity reported in the 
global burden of disease study (Kosek el ai, 2003) was also observed for the 
City of Cape Town, with an 8% increase in the number of children under 5 
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years with diarrhoea between 2000 (83.3 per 1000) and 2001 (91.8 per 1000) 
(Health Systems Trust, 2003). 
The Red Cross Children's Hospital, located in Cape Town South Africa, 
serves large parts of metropolitan Cape Town. According to routine hospital 
data for 2001 to 2003, 20% of non-surgical admissions annually are due to 
diarrhoea (Swingler, G. 2005. Personal Communication. 15 June, Institute of 
Child Health, Cape Town). 
1.2 Factors associated with diarrhoea 
1.2.1 Globally 
Diarrhoea is endemic to regions with poor socio-economic conditions. These 
conditions include poor nutritional status, lack of access to safe water and 
poor sanitation. These factors contribute to the burden of diarrhoeal disease. 
According to United Nations Children's Fund (UNICEF), one-quarter of 
people globally in the developing world are still malnourished, 1.1 billion do 
not have access to safe drinking water and 2.4 billion are without adequate 
sanitation (UNICEF, 2002). 
1.2.2 Socio-economic profile of South Africa 
South Africa is a country with a high prevalence of many conditions 
associated with diarrhoea. The country has a relatively youthful population, 
with a third of the population being under the age of 15 years (Bradshaw ef 
aJ., 2003b; Department of Health. SADHS, 1998). Overall, the social 
conditions in South Africa are poor. About 7% of the women of childbearing 
age (15-49 years) have received no education. Only 38.9% have piped water 
inside their house and 46% have their own flush toilet. Half (51 %) of the 
population have homes with plaster as the main wall finish and 12% have 
bare brick or cement blocks. The rest of the population live in houses made 
of plastic/cardboard (3.0%), mud (14.3%), mud and cement (8.9%), 
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corrugated iron/zinc (8.0%) and prefabricated materials (0.4%). These 
housing characteristics reflect poor socio-economic status and increased 
environmental exposure (Department of Health. SADHS, 1998). 
1.2.3 Socio-economic profile of the study setting 
Even though the Western Cape is one of the more affluent provinces in the 
country, 4% of the households still don't have piped water inside their houses 
and 2% of the women of childbearing age have no education. Cape Town is 
situated in the Western Cape Province, the Cape Town metropolis, 
accounting for approximately 70% of the province's population (Provincial 
Administration of the Western Cape, 1995). 
1.3 Electrolyte disturbances in childhood diarrhoea 
1.3.1 Why electrolyte disturbances are important 
After dehydration and malnutrition, electrolyte disturbances are an important 
contributor to morbidity and mortality in children with diarrhoea internationally 
(Islam & Khan, 1986; Puffer & Serrano, 1973; Purohit & Jyotsna, 1971; 
Raghu et al., 1981). 
Many electrolytes are essential in maintaining the normal functioning of the 
body, with plasma sodium and potassium being two of vital importance. 
Normal limits for plasma sodium are 135 - 150 mmol/I and for plasma 
potassium 3.5 - 5.3 mmolli. If water or electrolyte levels rise or fall beyond 
normalliniits many bodily functions fail to proceed at their normal rates. 
Plasma sodium,a predominant cation (positively charged ion) of extracellular 
fluid, is crucial in regulating fluid balance in the body. It also plays a vital role 
in the excitability of muscles and neurones. Plasma sodium levels are closely 
regulated by kidney function (Gibbs et a/., 2002:1724). Both abnormally low 
plasma sodium levels (hyponatraemia; plasma sodium below 135 mmol/l) 
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and abnormally high plasma sodium levels (hypernatraemia; plasma sodium 
above 150 mmol/l) are associated with severe complications of the central 
nervous system, namely cerebral oedema in hyponatraemia and shrinkage ·of 
the brain in hypernatraemia, ultimately resulting in neurological dysfunction 
and/or death, especially when hypernatraemia is above 158 mmol/I (Adelman 
& Solhung, 1996:218; Bruck et al., 1968; Caksen et al., 2001; Finberg, 1986, 
Islarn & Khan, 1986; Paneth, 1980). Other conditions associated with 
hypernatraemia are severe acidosis and respiratory failure (Haddow & 
Cohen, 1974; John Hopkins, 2002:244). 
Potassium is the major cation (positively charged ion) of intracellular fluid. As 
with plasma sodium, it is extremely important in the correct functioning of 
excitable cells such as muscles, neurones and sensory receptors. It is also 
vitally important in the regulation of fluid levels within the cell and in 
maintaining the correct pH balance within the body (Gibbs et al., 2002: 1727). 
Hypokalaemia (potassium levels <3.5 mmolll) can result in a range of severe 
disorders, for example, a paralytic ileus, muscle weakness, respiratory 
paralysis and arrhythmias leading to cardiac arrest (Mrozowski, 1996:322; 
Rudzinski et al., 1996:346). Very low potassium levels «2.5 !TImolll) may be 
life-threatening (Travis, 1996:1331). 
1.3.2 Magnitude of plasma sodium and potassium disturbances in 
diarrhoeal disease globally 
Hypernatraemia (plasma sodium >150 mmolll) is more prevalent in the 
developed world (from 19% to 63%) than in the developing world (from 1.5% 
to 21%) (Paneth, 1980) (Table 1.1). The prevalence of diarrhoea-related 
hyponatraemia and hypokalaemia are not well reported. Those studies that 
did report on diarrhoea-related hyponatraemia and hypokalaemia were 
performed in developing world settings. Three studies were identified that 
reported prevalen.ce for hyponatraemia in their study populations: one study 
in Bangladesh reported a 20.8% prevalence (plasma sodium <130 mmolll) 
for the duration of 1 year in the general ward of their health complex (Samadi 
5 
et a/., 1983); one in Cairo reported a 27% prevalence (plasma sodium ~130 
mmol/I) for the duration of 1 month in their oral rehydration ward (Cleary et 
a/., 1981), and one in Zimbabwe reported a 5.5% prevalence (plasma sodium 
<125 mmol/I) over 7-month period at their paediatric hydration unit in their 
central hospital (Nathoo et a/.! 1987). 
Table 1.1 
Developed countries 
Proportion of children « 4 years old) with dehydrating 
diarrhoea with hypernatraemia 
Location 'Of study . Hypernatraemia Source, year published 
(%) 
Manchester, UK 63 Ironside et aI., 1970 
Leeds, UK 60 Chambers & Steel, 1975 
Buffalo, USA 34 Bruck,1969 
± 
Manchester, UK 30 Macaulay & Blackhall, ]961 
Baltimore, USA 25 Finberg & Harris, 1955 
New York, USA 25 Rosenfeld et al., 1977 
Seattle, USA 23 Skinner & Moll, 1956 
Chicago, USA 21 DeYoung & Diamond, 1960 
Cleveland, USA 20 Weil & Wallace, 1956 
Manchester, UK 19 Jacobs et aI., 1970 
Developing cou otries 
Nigeria 21 Ahmed & Augusto-Odutola, 1970 
Saudi Arabia 12.6 Karrar & Abdullah, 1981 
Egypt 10 Fayad et al., 1992 
Zimbabwe 8.9 Nathoo et al., 1987 
South Africa *8 Prinsloo & Kruger, ] 970 
Bangladesh 6.4 Samadi et al., ] 983 
Saudi Arabia 4.8 Mehasi & Murthy, 1990 
South Africa 3.8 Beatty et aI., 1974 
South Africa 3.8 ±HiII et al., 1981 
South Africa 1't1.5 Kassel et al., 1970 
Serum sodium levels greater than "145 mmolfl and * J 44 mmolfl (Part of table extracted from Paneth, 1980). 
"'Age range not reported or unclear. 
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Two studies were identified that reported the prevalence of hypokalaemia in 
their study populations recruited over a 7-month period: one study performed 
in Bangladesh reported a prevalence of 67.1 % (potassium <4 mmol/l) at the 
International Centre for Diarrhoeal Disease Research (Zaman et al., 1985), 
and another performed in Zimbabwe reported a 27.5% prevalence 
(potassium <3 mmolll) at their paediatric hydration unit in the central hospital 
(Nathoo et al., 1987). 
1.3.3 Magnitude of plasma sodium and potassium disturbances in the 
study setting 
Analysis of routine laboratory records of children admitted to the Red Cross 
Children's Hospital's Rehydration Unit in Cape Town, from 1995 to 1997 
revealed that 11 % had plasma potassium levels below 2.5 mmol/l, 3% had 
plasma potassium levels below 2 mmolll, and 7% had plasma sodium levels 
above150 mmolll, with 1.8% being severely affected (>158 mmol/l) 
(unpublished). 
1.4 Purpose statement 
The purpose of the current research was to explore factors that could 
contribute to electrolyte disturbances in children with diarrhoea, specifically 
plasma sodium and potassium disturbances. Possible determinants of these 
electrolyte disturbances were explored as well as issues surrounding 
management and diagnosis of the disturbances. 
1.5 Rationale for this research project 
The high prevalence of these potentially harmful plasma sodium and 
potassium disturbances at the Red Cross Children's Hospital and in other 
settings raised a number of issues around i) prevention, ii) the ability to 
identify the disturbances when they do occur, and iii) management of them 
once they have been identified. These issues will be addressed in three 
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separate research studies. The three research studies and their rationale will 
be described in the sections 1.5.1 to 1.5.3 below. 
1.5.1 Determinants of plasma sodium and potassium disturbances in 
childhood diarrhoea 
Identification of aetiological factors in the development of electrolyte 
disturbances could inform public health interventions to prevent the 
development of such disturbances. An exploratory analysis of routine 
laboratory records over 2 years at Red Cross Children's Hospital revealed a 
striking seasonal variation in mean concentrations of plasma sodium and 
potassium, with lower levels of both electrolytes in summer and a possible 
socio-economic gradient in levels when analysed by postal code. The 
fluctuations did not appear to be due to sampling bias (see glossary) from 
admission or testing practices (Swingler & Power, 2002). These findings 
suggested that determinants of these electrolyte disturbances could also be 
seasonal in their distribution. 
The clinical importance of these seasonal fluctuations has been reported in a 
previous study (Swingler & Power, 2002) in which the prevalence ratio for 
severe hypokalaemia «2.0 mmol/l), in February compared with August of 18 
(7.2% vs 0.4%), and for severe hypernatraemia (>160 mmol/l) of 0.08 (0.4% 
vs 5.0%). These fluctuations thus accounted for approximately a 10- to 20-
fold variation in the prevalence of severe electrolyte disturbances and 
highlights the importance of identifying factors that could be associated with 
these seasonal fluctuations and that could result in prevention of these 
disturbances. The determinants appear to be operating in the whole 
population of children with diarrhoea, with an important 'spill-over' into, 
abnormally high sodium levels in winter, and abnormally low potassium levels 
in summer. 
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In this study, factors that could be associated with the seasonal fluctuations 
previously observed in plasma sodium and potassium levels in childhood 
diarrhoea will be investigated. 
1.5.2 Clinical signs of plasma sodium and potassium disturbances in 
childhood diarrhoea 
Electrolyte disturbances in childhood diarrhoea are usually easily corrected 
once detected, but detection requires laboratory measurement. Facilities for 
the measurement of electrolyte levels are seldom available in settings where 
children are treated for diarrhoea in the developing world. It is therefore 
important to identify children with suspected electrolyte disturbances so that 
they can be referred for confirmation and management of the abnormality. 
The identification of simple clinical features that accurately identify such 
children would be very useful. Clinical features of hypernatraemia, 
hyponatraemia and hypokalaemia are widely accepted, based on case series 
of children with the disturbances (Chhabra et al., 1995; Kuzemko, 1969). 
However, no studies have been reported on the diagnostic accuracy of these 
signs in distinguishing children with electrolyte disturbances from those 
without disturbances. This study will establish the clinical meaningfulness of 
those clinical features previously reported to be associated with plasma 
sodium and potassium disturbances, by assessing their diagnostic accuracy. 
1.5.3 Therapeutic impact of routine electrolyte measurement in 
management of plasma sodium and potassium disturbances in 
children with diarrhoea 
Although facilities to measure electrolytes are seldom available in settings 
where dehydrating diarrhoea is managed, when such testing is available, 
they are often routinely used in children admitted with diarrhoea. This is 
illustrated by the fact that the Standard Treatment Guidelines of the Essential 
Drugs Programme for hospital level paediatrics in South Africa devotes more 
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than 25% of the section on acute diarrhoea to the management of electrolyte 
and acid-base disturbances (Essential Drugs Programme South Africa, 
1998: 13, 14). This implies the liberal, if not routine, measurement of 
electrolytes in hospitals in order to detect abnormalities. However, neither the 
clinical benefit nor the amount of change in clinical management as a result 
of routine electrolyte testing, in low- and middle-income countries, where 
diarrhoea is more prevalent has been established. 
This study will report on the current management of electrolyte disturbances, 
identified by routine electrolyte testing, in children with diarrhoea at Red 
Cross Children's Hospital. 
1.6 Outline of thesis 
Since the study population, sampling and ethical considerations surrounding 
data collection for each study were similar and overlapped, an overall 
description of these is provided in Chapter Two. Details specific to each 
study are covered in more detail in the particular chapters dealing with them. 
Chapter Three reports on aetiological factors that are associated with either 
plasma sodium or plasma potassium disturbances; Chapter Four reports on 
the diagnostic accuracy of clinical signs used to identify plasma sodium or 
plasma potassium disturbances; Chapter Five reports on the therapeutic 
impact of routine electrolyte testing on management of patients and Chapter 
Six provides a summary of the research and recommendations. 
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CHAPTER TWO: OVERVIEW OF METHODS 
2.1 Objectives 
This thesis reports on three separate cross-sectional analytical studies of 
children with dehydrating diarrhoea that examine different .. aspects of 
disturbances of plasma sodium and potassium levels. These are: 
a) the clinical, nutritional, microbiological and environmental 
determinants of seasonal and socio-economic associations with 
plasma sodium and potassium concentrations, 
b) the diagnostic accuracy of clinical signs in the identification of 
disturbances of plasma sodium and potassium, and 
c) the utility of routine plasma sodium and potassium measurement in 
the clinical management of children with dehydrating diarrhoea. 
2.2 Study setting and population 
All three studies were performed in the short-stay Rehydration Unit at Red 
Cross Children's Hospital, Cape Town. This Unit admits approximately 2500 
children with dehydrating diarrhoea per year (unpublished data from routine 
hospital records, 2003-2004). Critically ill children requiring intensive care 
bypass this Unit, but almost all other children with dehydrating diarrhoeal 
disease presenting to the hospital are managed there. Medical care is 
provided according to treatment protocols that provide for the management of 
electrolyte abnormalities of different severities. The median duration of stay 
in this Rehydration Unit was 2 days (inter-quartile range 1-3 days) for the 
duration of this project. The Unit serves large parts of metropolitan Cape 
Town and receives virtually no referrals from other rehydration units. It thus 
serves a population of children broadly representative of those admitted to 
diarrhoeal rehydration units in metropolitan Cape Town. 
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2.3 Sampling 
All three studies were performed simultaneously over a period of 1 year, with 
overlapping data collection. In order to provide a sample approximately 
representing seasonal differences in the numbers of admissions in the 
summer and winter, target enrolment 'for each month was estimated by using 
the mean proportion of patients admitted to the Rehydration Unit from 1999 
to 2001 for each month. 
Systematic sampling was not feasible in the Rehydration Unit, which 
admitted children 24 hours per day every day. A prospective consecutive 
sampling technique during specified times was therefore used. The first 
patient admitted to the Rehydration Unit on each working day that met the 
inclusion criteria was approached to participate in the project. (The inclusion 
criteria differed for each study; differences are described under relevant 
chapters.) Enrolment continued each day until the target number for that day 
had been enrolled (depending on the study). When enrolment was behind 
target, all eligible patients were enrolled until the shortfall was made up. 
Enrolment started each working day at 10hOO and stopped at 18hOO. The 
principal investigator adjusted her working hours to accommodate the revised 
hours of enrolment. 
Enrolment took place over a full year, from 15 April 2002 to 14 April 200"3, to 
include seasonal fluctuations in the incidence and aetiology of diarrhoea. For 
this study seasons were determined by plasma sodium and potassium 
Huctuations (Swingler & Power, 2002) rather than by geographical seasons 
and were categorised as follows: i) November to January as summer, ii) 
February to April as autumn, ii) May to July as winter and iv) August to 
October as spring. Patients between 6 weeks and 2 years of age were 
recruited into the project as planned between 10hOO and 18hOO for the 
months of April 2002 to July 2002. A review of the project at the end of July 
showed a persisting ·shortfall of patients, since in the winter months (June to 
July) very few patients that met the inclusion criteria were being admitted. 
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Examination of admission records found that most of the patients were 
admitted soon after 18hOO. For the remainder of the study period (October 
2002 to April 2003), patients were recruited between 11 hOO and 19hOO. Any 
deviation from this sampling strategy will be described for the different 
studies in the relevant chapters. 
2.4 Ethical considerations 
The study was conducted in ways that were consistent with the University of 
Cape Town's ethical guidelines, the Declaration of Helsinki (World Medical 
Association, 2000) and the guidelines for the ethical conduct of medical 
research involving children (Royal College of Paediatrics and Child Health, 
2000); and the research was approved by the Research Ethics Committee of 
the University of Cape Town (ref. 097/2000 - Appendix 2.4). However, as 
children are a particularly vulnerable group in our society, some issues need 
particular attention and will be discussed in detail. 
2.4.1 Respect for persons 
Written informed consent was obtained from the caregiver in his/her choice of 
language (Appendices 2.1, 2.2, 2.3) before: i) administration of the 
questionnaire (see Appendices 3.3 and 3.4) and completion of clinical 
examination chart (see Appendix 4.4); ii) the collection of blood and stool 
samples that had not already been collected as part of routine clinical care 
(see Appendix 3.2); and iii) the collection of information on patient 
management from the patient's folder (see Appendices 5.3 and 5.4). 
Caregivers were provided with information in a language of their choice and 
in lay persons' terms. Consent forms were provided in English, Afrikaans and 
Xhosa. The principal investigator (fluent in English and Afrikaans) enrolled 
English- and Afrikaans-speaking caregivers. An interpreter (fluent in Xhosa) 
assisted with the enrolment of patients with Xhosa-speaking ,caregivers. The 
interpreter was provided with information on the studies and had discussion 
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sessions about the research projects with the principal investigator prior to 
commencement of the studies. The interpreter also assisted with the 
translation of the consent form into Xhosa. Any misunderstanding due to 
language and differences in cultural perceptions were minimized by this 
process. 
Caregivers were given sufficient information on which to decide whether or 
not to participate in the study, includ.ing the research procedure(s) and their 
purposes. Caregivers were given an opportunity to read the consent form 
and ask questions. They were told that participation was voluntary and 
refusal to participate in the studies would not affect the way the child would 
be treated. A statement offering the caregiver the opportunity to ask 
questions and to withdraw from the research at any time was included in the 
consent form and mentioned in the process of obtaining consent. 
For caregivers who were illiterate, the study was described in the presence of 
a witness who was not associated with the research projects, and affirmative 
consent was indicated by the caregiver making a cross on the consent form 
that was also signed by the witness, the principal investigator and the 
interpreter (in the case of Xhosa-speaking caregivers). 
A copy of the signed consent form, that also provided information on i) the 
research procedure(s), ii) their purposes, iii) how consenting to participate in 
the research projects would impact on the patient, and iv) the contact details 
of the principal investigator was given to the caregiver (Appendices 2.1, 2.2, 
2.3). The caregivers were also given an open invitation to contact the 
principal investigator if they had any queries regarding the research. More 
than one medical officer attended to the patient during their stay in the 
Rehydration Unit. The nature of the shift system and the rotation of staff 
every few hours in the Rehydration Unit made it difficult to provide a doctor's 
name on the consent form. 
The principal investigator attended the monthly meetings for the staff of the 
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Rehydration Unit prior to the commencement of the research to inform the 
staff of the research procedures. While the research was being conducted, 
she continued to attend these meetings to remind staff about the research 
procedure(s) and their purpose, and to report on the progress of the research 
projects. This enabled nursing staff to take a part in discussions of the 
projects with caregivers, if this was required, during or after the enrolment of 
patients. 
The questionnaire was administered before admission of the patient to the 
Rehydration Unit (if the caregiver was still waiting for the medical officer on 
duty to admit the patient) or after the patient was admitted. As the caregivers 
stayed in the Rehydration Unit for the duration of the patient's stay, 
administering of the questionnaire after admission was not an imposition on 
the caregiver's time. 
Confidentiality of patient data was maintained by de-linking the patient name 
from the study number after information was entered into a database. 
2.4.2 Beneficence and non-maleficence 
The approximately 10- to 20- fold variation in the prevalence of severe 
electrolyte disturbances between the cooler winter months versus the warmer 
summer months highlights the importance of identifying factors that could be 
associated with these seasonal fluctuations and which could result in 
prevention of these disturbances. The possibility of finding feasible and 
affordable interventions justified the exploratory nature of this study. Either 
positive or negative findings in the assessment of the reliability and 
diagnostic accuracy of clinical signs used to identify these electrolyte 
disturbances have important implications for a common problem in clinical 
practice, and the therapeutic impact of routine electrolyte testing in the 
management of the electrolyte disturbances provides important information 
for planning future research. All of these potential benefits would flow from 
the single data collection process. 
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Potential benefits of the research to future patients can be described as i) 
prevention of electrolyte disturbances if preventative causative factors were 
identified, ii) avoidance of unnecessary testing if testing of electrolytes 
resulted in no change in clinical management, iii) routine electrolyte testing of 
all children if testing were eventually found to produce sufficient clinical 
benefit to justify its use, given competing priorities for existing resources, and 
iv) early identification of electrolyte disturbances and treatment thereof if 
clinical signs were shown to provide accurate diagnosis. 
Minimal risk was imposed on the patients as apart 'from administration of the 
questionnaire, and collection of stool samples and venesection in the 10% of 
children who did not have blood taken as part of their usual care, the patients 
were not treated differently from other patients in any way. Venesection was 
part of routine hospital care for 90% of the patients and was performed by 
either the medical officer in the Outpatients' Unit or the Rehydration Unit. 
Venesection, even for purely research purposes, is regarded as low risk by 
the Royal College of Paediatrics and Child Health (2000). Psychological 
costs of this research were distress to the caregiver who often had to leave 
the examination mom during venesection, and the discomfort of venesection 
to the child. This procedure was performed for research purposes in only 
10% of the patients in this study and given the uncertainty around the 
benefits of blood sampling, the 10% of children could have benefited 'from 
this additional procedure. 
2.4.3 Justice 
The patients, by the nature of their condition, were from a socially 
disadvantaged group, dependent on the Hospital for their care during the 
diarrhoeal episode, and thus vulnerable to exploitation. Given these existing 
burdens, the additional burden of participation in the study might have been 
better placed on otherwise less burdened groups. However the topics under 
study related directly to the specific conditions of the patients studied, to the 
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extent that their socio-economic and other characteristics were a foclJs of the 
study. Justice was served in that the benefits of the research would 
consequently apply most immediately to the community being studied, as 
well as socially disadvantaged children elsewhere. 
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CHAPTER THREE: DETERMINANTS OF SEASONAL 
FLUCTUATIONS IN PLASMA SODIUM AND POTASSIUM 
LEVELS IN CHILDHOOD DIARRHOEA 
3.1 Background 
Globally, plasma sodium and potassium disturbances in children with 
diarrhoea can result in potentially harmful disorders (Adelman & Solhung, 
1996:218; Bruck et al., 1968; Caksen et al., 2001; Finberg, 1986; Mrozowski, 
1996:322; Paneth, 1980) and sometimes death (Islam &Khan, 1986; Puffer & 
Serrano, 1973; Purohit & Jyotsna, 1971; Raghu et al., 1981). The high 
prevalence of these disturbances at Red Cross Children's Hospital 
(Rehydration Unit), 7% with plasma sodium >150 mmol/l and 11 % with 
potassium <2.5 mmol/l (unpublished analysis of routine hospital records for 
the period 1995 to 1999), highlighted the importance of prevention of these 
disturbances, if possible. 
A study performed at Red Cross Children's Hospital reported seasonal 
variations in the annual distribution of plasma sodium and potassium levels 
(Swingler & Power, 2002) (Figure 3.1). 
Figure 3.1 Mean plasma sodium and potassium levels in dehydrated 
children with diarrhoea, by season of year (Swingler & 
Power, 2002). 
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These findings suggested that determinants of these electrolyte disturbances 
could also be seasonal in their distribution. 
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::r: 95% CI 
Previous studies have reported seasonal fluctuations of plasma sodium 
levels in children with diarrhoea, with hypernatraemia more common in winter 
months (Bruck, 1969; Fayad et a/., 1992; Finberg, 1973). The only report of a 
similar seasonal pattern in plasma potassium levels was the above-
mentioned study by Swingler & Power (2002), that reported hypokalaemia as 
being more common in the summer months. Even though the same seasonal 
incidence (with a winter peak) observed in Cape Town was reported by Bruck 
(1969) for hypernatraemia in Buffalo (USA), the Cape Town study had its 
peak diarrhoea season in summer while Buffalo's peak diarrhoea season 
was in winter. Bruck (1969) suggested that aetiological and climatic factors 
were possible contributors to the seasonal incidence of hypernatraemia, but 
did not elaborate on this. 
The fact that similar seasonal fluctuations were identified for plasma 
potassium as for plasma sodium suggests that a similar mechanism is at 
work in both, while the existence of similar reported fluctuations of plasma 
sodium in other countries suggests that the findings of Swingler & Power 
(2002) are not an artefact of sampling or testing practices. 
Potential determinants of these seasonal fluctuations in plasma sodium and 
potassium levels appear most likely to be those that themselves have a 
seasonal distribution. Enteropathogens (Table 3.1) have previously been 
reported to be seasonal in their occurrence in diarrhoea (Pavia, 2004:1446, 
1448). In South Africa, enterotoxigenic Escherichia coli (E coIl) has been 
reported to have a summer peak (Coltman, D. 1990. Unpublished research 
performed at Red Cross Children's Hospital), enteropathogenic E Coli a 
summer/autumn peak, Shigella and Campylobacter a sLimmer/autumn peak 




Table 3.1 Percentages of enteropathogens in people with diarrhoea in different geographical regions 
Organism Nepal Asia India Latin America Africa ' Peak seasons (Country) 
(%) (%) (%) (0/0) (%) 
Enterotoxigenic E. coli 20-28 0-37 24 26-72 33-71 Summer and autumn (Bangladesh) 
Shigella 10-23 0-13 10 0-30 0-15 Summer and autumn (South Africa) 
Campylobacter 4-28 * 3 * 5 Summer and autumn (South Africa), winter (Mexico, 
Morocco) 
Salmonella 3 0-33 10 0-16 3 Sporadic through out the year, but less common in 
summer (South Africa) 
Rotavirus 6-11 0-6 5 0-36 6 Early autumn and winter (South Africa) 
Cryptosporidium 4 * 2 * 0 
No pathogen * 43-94 45 22-83 29-64 
Results are compiled from studies of varying populations ranging from short-term tourists to military personnel and Peace Corps volunteers. Not all pathogens were sought in all 
studies. (Part of table taken from Pavia (2004: 1446 1448), and compiled from references: Black, 1990; Hoge et al., 1996; Househam et aI., 1988; Jiang et al., 2002; Qadri et al., 
2000; Taylor et al., 1988). 
*Not reported or unclear. 
Factors that increase the susceptibility of children to infection with 
enterapathogens are age, immune deficiency, malnutrition, exposure to 
unsanitary conditions, a low level of maternal education and infectious 
diseases (Pickering & Snyder, 2004:1274). Other factors associated with 
childhood diarrhoea are poor socio-economic conditions, limited access to 
safe drinking water and poor sanitation (WHO, 2000). Feeding practices in 
the first year of the life of the child have also been reported to influence the 
child's susceptibility to diarrhoea, with mixed-fed children being at higher risk 
of getting the disease than those being breast-fed (Ahiadeke, 2000). 
Several factors have been reported as determinants of disturbances of 
plasma sodium and potassium levels in children with diarrhoea. 
Hypernatraemia has been reportedly associated with oral rehydration 
solution (ORS) - either incorrectly prepared or ORS with a high plasma 
sodium content (Chatterjee et al., 1978; Farthing, 1992; Fayad et al., 1992), 
better nutrition (Fayad et al., 1992; Samadi et al., 1983), being continually 
bottle- and breast-fed with limited water intake (Ahmed & Agusto-Odutola, 
1970). younger age (Ahmed & Agusto-Odutola, 1970; Hill et al., 1981; 
Samadi et al., 1983), higher socio-economic status (Yousuf et al., 1988) and 
parental education (Fayad et al., 1992). Hyponatraemia has been reported to 
be associated with malnutrition (Samadi et al., 1983), longer duration of 
diarrhoeal disease (Fayad et al., 1992), and children that are either bottle-fed 
or are bottle-fed with a weaning diet (Banajeh & Hussein, 1999). 
Hypokalaemia has been associated with both children that are either bottle-
fed or on a boUle and weaning diet (Banajeh & Hussein, 1999), longer 
duration of diarrhoeal disease (Zaman et al., 1985) and malnutrition (Zaman 
et al., 1985). 
Even though most of the factors mentioned in the previous two paragraphs 
are not themselves seasonal, they will be investigated because they could be 
associated with seasonal electrolyte disturbances at the study site by means 
of confounding factors such as seas'onal variation in migration patterns 
and/or health service utilization, or with climatic variation. Inclusion of such 
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determinants in the analysis will help to establish their relative importance 
and adjusted for any confounding effects that may be occurring. 
If associations do exist between these factors and the previously observed 
seasonal fluctuations in plasma sodium and potassium concentrations, they 
could suggest public health interventions to prevent development of these 
disturbances. 
3.1.1 Review of the literature on the determinants of seasonal 
fluctuations in plasma sodium and potassium concentrations 
3. 1. 1. 1 Identification of relevant studies 
A PubMed search (search strategy reported in Appendix 3.1) was performed 
for the period 1966 to May 2005. Three-hundred and fifty-nine studies were 
identified in the search. The abstracts of these studies were screened by the 
principal investigator to identify those that met the criteria of reporting on i) 
aetiological factors ii) contributing specifically to seasonal fluctuations in iii) 
plasma sodium and potassium levels iv) in children v) with diarrhoea. Fifty-
four studies were deemed possibly relevant and full reports were obtained, to 
enable fuller assessment. The reference lists of identified studies were also 
screened for potentially relevant reports. 
3.1.1.2 Results of literature review 
None of the studies identified in the search met the inclusion criteria detailed 
in Section 3.1.1.1. Thus no studies investigated factors that could be possible 
determinants of the seasonal fluctuations in plasma sodium and potassium 
disturbances in children with diarrhoea. 
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2000). The determinants therefore appeared to be operating in the whole 
population of children with diarrhoea, causing an important 'spill-over' into 
abnormal levels. 
3.4.2 Sampling 
The sampling strategy has been described in section 2.3. In addition, 
between August 2002 and December 2002, patients adrnitted the previous 
evening were enrolled the following morning if electrolytes had been 
measured on admission and no antibiotics had been administered since 
admission to the Rehydration Unit. This was done to ensure sufficient 
numerical representation of stool specimens across seasons. The targeted 
number of enrolments per month is reported in Table 3.2. 
Table 3.2 Targeted enrolment of patients per month 
, Jan . Feb Mar Apr. May Jon· .lui Aug $ep Oct Nov Dec Tot.al 
Target 37 46 57 45 33 20 ]7 15 ]6 18 20 26 350 
3.4.3 Rationale for the selection of hypothesised determinants 
The pre-specified independent variables that constituted the hypothesised 
determinants of seasonal electrolyte disturbances in this prospective study 
were selected according to the following rationale: 
i) Associations with childhood diarrhoea that were themselves 
seasonally distributed appeared the most likely determinants of seasonal 
variation i.e. enteropathogens, particularly enterotoxigenic E. coli, 
enteropathogenic E. coli, enteroaggregative E. coli, Shigella, Salmonella, 
Campylobacter, Cryptosporidium and Rotavirus. 
ii) Socio-economic determinants were of particular interest because of an 
apparent gradient in the previous study of mean electrolyte levels according 
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3.2 Aims of the study 
The aim of this study was to identify associations, particularly those that were 
seasonal, with plasma sodium and potassium concentrations in young 
children admitted to hospital with dehydrating diarrhoea. 
3.3 Objectives 
a) To confirm by different sampling methods the findings of seasonal 
fluctuations in plasma sodium and potassium levels reported 
previously (Bruck, 1969; Fayad et a/., 1992; Finberg, 1973; Swingler & 
Power, 2002). 
b) To identify determinants for these seasonal fluctuations. 
c) To suggest determinants that could possibly be used to formulate 
public health interventions to prevent plasma sodium and potassium 
disturbances. 
3.4 Methods 
3.4.1 Inclusion and exclusion criteria 
Patients between 6 weeks and 2 years of age admitted to the Rehydration 
Unit during working hours were eligible .for this study. Patients were excluded 
if diuretics were part of the treatment regimen on admission, since these 
result in the loss of sodium and potassium through urine excretion. Patients 
residing in the Cape metropolis for less than one month were also excluded 
as their exposure to their previous environment could still be contributing to 
their current status. 
All patients meeting these criteria were included in the analysis, and not only 
those with abnormal electrolyte levels as the seasonal variation in a previous 
study of mean levels for all admissions resulted in approximately a 10- to 20-
fold variation in the prevalence of severe disturbances (Swingler & Power, 
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to the socio-economic status of area of residence (Swingler & Power, 2002). 
Socio-economic status is an elusive concept involving many inter-related 
individual and community variables. This study did not attempt to measure 
wealth per se, but rather the association of different socio-economic variables 
with electrolyte levels. Any such associations could have been direct or 
indirect using different pathways or they could have been confounding 
variables. For instance, the availability of piped water may indicate greater 
wealth, but could also reduce water collection times and make more time 
available to generate wealth. It could also, by a very different pathway, 
reduce the opportunity for infection by waterborne diarrhoea pathogens. To 
have created an index would have been complex, with difficulties in assigning 
weights to various assets, and potentially counter-productive. Hence it was 
decided to not construct an index but simply enter all variables individually in 
a multivariate regression model. This was the approach recommended by 
Montgomery et al. (1997) for use in mortality regressions using DHS data, 
and was expected to provide more specific and informative results in their 
analysis. The individual variables included in this study were: availability of 
electricity, type of stove (electric/or not), type of house (brick/shack), flush 
toilet (none/off-site/on-site/in-house), piped water (none/off-site/on-site/in-
house), use of appliances and parental education. The above factors relating 
to socio-economic status were chosen because they are known to partly 
mediate an association with diarrhoea. For instance, ownership of a fridge or 
deep-freeze would enable food to be kept fresh, and the availability of 
electricity was necessary to be able to use the appliance. The relationship 
between diarrhoea, water supply, sanitation (WHO, 2000) and parental 
education (Ahiadeke, 2000, Mahalanabis etal., 1996) is well established. 
iii) Duration of exposure to the local environment, and the degree of 
urbanisation i.e. duration of current residence, and duration of previous 
residence was proposed initially. It was planned to use the categorisation of 
the area of residence in the latest census as a measure of urbanisation, but it 
was not possible to access the census data due to financial constraints. 
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iv) Associations with childhood diarrhoea that were not themselves 
inherently seasonal but which could be associated with seasonal electrolyte 
disturbances at the study site by means of confounding factors such as 
seasonal variation in migration patterns and/or health service utilization, or 
with climatic variation. Such potential associations were: a) clinical 
determinants (age, gender, weight for height, height for age, duration of 
diarrhoea, duration of vomiting, adequacy of drinking, persistent diarrhoea, 
shock, co-morbidity, degree of dehydration, HIV status); b) treatment before 
admission (source of primary contact care, use of oral rehydration solution, 
other remedies); and c) diet (breast milk, any other type of milk, solids or 
semi-solids, sodium content of milk). 
v) Plasma pH, which affects particularly plasma potassium 
concentrations. 
3.4.4 Measurement of outcomes and data collection 
The medical officer on duty performed venesection on admission, either in 
the Outpatients' Unit or the Rehydration Unit. 
Dependent variables 
Plasma sodium and potassium concentrations were measured by the 
hospital's routine clinical laboratory using the direct ion-electrode method. 
The principal investigator extracted electrolyte results from computerised 
laboratory records (Appendix 3.2). 





Age* (per completed month), 
Extracted from routine clinical records from the principal investigator. The routine clinical 
records are structured to lend themselves to data extraction (see Appendix 5.3). 
26 
• Gender* (male, female), 
• Weighr (kilograms) for heighr (centimetres) as a measure of wasting 
(Z-score), 
• Heighr (centimetres) for age* (per completed month) as a measure of 
stunting (Z-score), 
• Duration of diarrhoeafl (per completed day), 
• Duration of vomitingfl (per completed day), 
• Adequacy of drinkingfl (not drinking at all/drinks less than normal/ 
drinks more than normal/drinks normally) 
• Persistent diarrhoeafl (number of previous admissions for diarrhoea), 
• Presence of shock* (yes/no), 
• Presence of co-morbidity* (yes/no), 
• Degree of dehydration ([{discharge weight admission 
weight}/discharge weight] X1 ~O), 
• Known HIV status* (positive/negative/exposed [defined as having a 
positive ELISA test and being under 18 months of age or mom is 
positive]/unknown). 
b) Treatment before admission: 
This was assessed by asking the caregiver if s/he had sought health care 
from any person for the current diarrhoeal episode. It was decided to record 
type of health care before admission rather than medications administered 
(other than oral rehydration therapy), as caregivers were presumed more 




Source of primary contact carefl (allopathic/or not), 
Extracted from routine clinical records from the principal investigator. The routine clinical 
records are structured to lend themselves to data extraction (see Appendix 5.3). 
Measured by the principal investigator. Length was measured with a measuring board. 
Measured by a pre-piloted questionnaire administered by the principal investigator 
(Appendices 3.3 and 3.4). 
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• Other remediesV, (any visits made to a traditional healer and/or any 
other practices including home remedies), 
• Oral rehydration solutionV, (was any administered prior to admission 
and if so the type). 
c) Biochemical determinants: 
Plasma pH was recorded only if the test was done as part of routine testing 
on admission to the Rehydration Unit. It was regarded as unethical to 
perform venesection again only to test pH if not needed for clinical 
management. The principal investigator extracted pH results from laboratory 
records (Appendix 3.2). 
d) Microbial determinants: 
The first stool passed by the patient after enrolment into the study was 
collected to establish the presence or absence of the following 
enteropathogens by stool culture in the routine clinical laboratory: 
• Shigella (yes/no), 
• Salmonella (yes/no), 
• Campylobaeter (yes/no), 
• Cryptosporidium (yes/no), 
• Rotavirus (yes/no), 
• ETEC [enterotoxigenic E. eolll (yes/no), 
• EPEC [enteropathogenic E. eolll (yes/no), 
• EHEC [enterohaemorrhagic E. eolll (yes/no), 
• EAEC [enteroaggregative E. eoll1 (yes/no). 
If stool samples were not collected by the time the principal investigator left, 
Measured by a pre-piloted questionnaire administered by the principal investigator 
(Appendices 3.3 and 3.4). 
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the nurses on night duty and the caregivers of patients participating in the 
study were informed that the first stool passed by the patient needed to be 
collected. The principal investigator followed through the next morning with 
the laboratory to ensure that the stool sample was collected and sent for 
analysis. The principal investigator extracted electrolyte and stool results 
from laboratory records (Appendix 3.2). 
Methods used to identify the different enteropathogens are described in 
Appendix 3.5. 
e) Diet: 
This was assessed by asking the caregiver if the patient was receiving 
nutrition from: 
• Breast milkfl (yes/no), 
• Any other type of milkfl (yes/no), 
• Solids or semi-solidsfl (yes/no), 
• Plasma sodium content of milk (mg/100 ml) was determined by taking 
the average plasma sodium content of the types of milk that were part 
of the patients' diet (Van der Spuy, D. 2003. Personal Communication. 
29 July, Red Cross Children's Hospital, Cape Town). The sodium 
content in the different formula feeds was provided by the Dietetics 
Unit at Red Cross Children's Hospital. 
f) Socio-demographic determinants: 
• Duration of current residencefl (months), representing an exposure to 
a current environment, 
• Previous residencefl (yes/no), representing exposure to previous 
environment, 
Measured by a pre-piloted questionnaire administered by the principal investigator 
(Appendices 3.3 and 3.4). 
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• Duration of previous residence'll (months). 
g) Socia-economic determinants: 
• Electricity'll (yes/no), 
• Type of stove'll (electric/or not), 
• Type of house'll (brick/shack), 
• Flush toilet'll (none/off-site/on-site/in-house), 
• Piped water'll (none/off-site/on-site/in-house), 
• Appliances'll (no electricity and no appliance (fridge or deep-freeze)/ 
electricity but no functional appliance/electricity and a functional 
appliance), 
• Parental education'll (the highest grade achieved by the parent present 
during admission; one unit increase was attributed above grade 12 for 
every year of post-matric education successfully completed). 
3.4.4. 1 Pilot study 
A pilot study was performed to assess the clarity of the questionnaire 
administered to the caregivers (Appendices 3.3 and 3.4). A small number of 
participants was deemed sufficient to establish this. Six caregivers from 
different areas (Khayelitsha, Parow, Parow Valley, Bishop Lavis, Goodwood 
and Thornton) speaking either English, Afrikaans or Xhosa completed the 
questionnaire with the assistance of the principal investigator. The Xhosa-
speaking caregiver included in the pilot preferred to speak English. 
3.4.4.2 Blinding 
Microbiological and electrolyte investigations were performed in different 
laboratories by different staff. The principal investigator, who administered 
Measured by a pre-piloted questionnaire administered by the principal investigator 
(Appendices 3.3 and 3.4). 
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the questionnaires, was not blinded to the electrolyte results. 
3.4.5 Analysis 
Associations between each independent variable and plasma sodium and 
potassium concentrations were first assessed individually by simple linear 
regression. Variables with statistically significant associations (p<0.10) with 
potassium or plasma sodium concentrations in the bivariate analyses were 
further assessed for associations (p<0.05) in multiple linear regression 
analysis. Mean substitution was performed on variables with less than 5% 
missing observations. Sensitivity analyses i) excluding variables with more 
than 5% of observations not reported; and ii) excluding patients enrolled that 
were admitted the previous night (see interim sampling strategy) were 
performed on multiple regression analysis. 
Colinearity between independent variables was determined by calculating the 
variance inflation factor (VIF). Variables with a VIF >10 were considered as 
colinear. These variables were tested individually in multiple regression 
analysis. The variable in the regression analysis with the higher mean VIF 
was included in the final regression model. 
The normality of the distribution of the residuals in the final regression 
analysis was assessed by the Sharpiro-Wilks test for normally distributed 
data (p>0.05). 
Potential effect modifiers of associations with plasma sodium or potassium 
concentrations were assessed by testing for interactions with the following 
variables in the regression models: age, nutritional status (Z-scores for height 
for age, and weight for height) and the degree of dehydration. 
The planned number of determinants assessed, including, individual 
enteropathogens, was 35. Using the rule of thumb of a minimum of 10 cases 
required for each determinant assessed (Altman, 1991 :349), approximately 
350 patients were required for analysis. 
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Data were managed using the Access 2000 program (Microsoft Corporation, 
1992-2001). Z-scores or nutritional variables were calculated using Epi Info 
2000 (version 1, US Centers for Disease Control and Prevention). Simple 
and multiple linear regression analysis were done using Stata 7.0 (Stata 
Corporation, 1984-2001). 
3.5 Results 
A total of 2270 patients were admitted to the Rehydration Unit from 1 April 
2002 to 31 March 2003 (data from unpublished routine hospital records). 
Three-hundred and ninety-seven patients were enrolled into the study over a 
closely related one-year period (15 April 2002 - 14 April 2003). Of these, 350 
(88.2%) patients who had cOlTlplete demographic data and produced a stool 
specimen were included the final analysis (Figure 3.2). The number of 
patients enrolled per month, together with the percentage of total admissions 
enrolled per month, are presented graphically in Figure 3.3 and 3.4. Figure 
3.3 shows a marked seasonal increase in numbers in the late summer and 
early autumn months as was observed by Swingler & Power (2002). Similar 
proportions of people were sampled during the various months except for the 
months between May and June (Figure 3.4). The mean plasma sodium and 
potassium concentrations per month are graphically displayed in Figure 3.5 
and the distribution of the concentrations for the duration of the study in 
Figure 3.6. A very similar distribution of mean plasma sodium and potassium 
as reported by Swingler & Power (2002) was observed (though with broader 
95% CI) (Figure 3.5). Sodium had a mean concentration of 138 mmol/l 
(standard deviation of 9.7mmol/l) and potassium had a mean concentration 
of 3.5 mmol/l (standard deviation of 1.0 mmolll) (Figure 3.6). 
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Figure 3.2 Profile of enrolment - determinants of the seasonal fluctuations in sodium and potassium concentrations 
I 
I 411 patients meeting inclusion criteria 
I 14 refused consent I I 
" 
397 enrolled into the study I 
41 patients discharged before stool specimen collected 
6 patients excluded from the analysis because 
~----------------------~ 
• Electrolytes not measured on admission (5) 
• Incomplete results for micro-organisms (1) 
) p~ltients inc:ludled in the analysis (27 admitted overnight before enrolment) 
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Mean = 138 .35 
Std Dev . = 9 .733 
N = 348 
Mean = 3.492 
Std . Dev. = 0.9538 
N = 347 
Of the 348 patients with plasma sodium results available, 121 (34.8%) were 
hyponatraemic «135 mmol/l), 25 (7.2%) hypernatraemic (>150 mmol/l); and 
13 (3.7%) severely hypernatraemic (>158 mmol/l). Of the 347 patients with 
plasma potassium results available, 160 (46.1 %) were hypokalaemic «3.5 
mmol/l) and 48 (13.8%) severely hypokalaemic «2.5 mmol/l) (Figure 3.7). 
More patients, 255 (72.9%), were enrolled between November and April 
(summer I autumn) compared to May and October (winter I spring), 95 
(27.1 %). A similar pattern was observed of all admissions to the unit during 
the same period i.e. 67.5% (vs. 72.9%; p=0.387) between November and 
April compared to 32.5% (vs. 27.1 %, p=O. 141) between May and October. 
3.5.1 Characteristics of patients 
The median duration of diarrhoea and vomiting was 3.5 days (inter-quartile 
range 2-7 days) and 2 days (inter-quartile range 1-4 days) respectively. 
Degree of dehydration had a median of 4.08% (inter-quartile range 1.6% to 
7.4%). Enteroaggregative Escherichia coli (122; 34.9%) was the most 
frequently isolated enteropathogen, with Shigella (10; 2.9%) the least 
frequently isolated. All the enteropathogens isolated had summer peaks in 
absolute numbers (Figures 3.8 to 3.13). Enterotoxigenic E. coli, 
Cryptosporidium, EAEC and Rotavirus had similar summer peaks in 
proportions for stool collected per month for the study. 
lVIost of the patients were.:::. 5% dehydrated (62.8%), were either normal or 
under-weight for age (74.6%) and had not had a prior diarrhoeal episode 
(80.3%). Other clinical characteristics are reported in Table 3.3. 
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Figure 3.8 Annual distribution of enterotoxigenic (ETEC) and enteropathogenic (EPEC) E. coli associated (p<O.05) 
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Figure 3.9 Percentage of total stool specimens infected with enterotoxigenic (ETEC) and enteropathogenic 
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Figure 3.13 Percentage of total stool specimens per month of enteropathogens without a significant association 
(p>O.05) with sodium and/or potassium concentrations (mmol/I) 
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Table 3.3 Percentage distribution of clinical characteristics of patients (N=350) 
Microbial aetiology 
n (%) 








Enterotoxigenic E. coli 
38(10.9) 














• Percentage missing data reported in Table 3.5. 
*Hydration *Peripheral perfusion 
n (%) n (%) 
2: 10% dehydrated Poor 
54(15.4) 33 (9.4) 
5% dehydrated Fair 
166 (47.4) 118 (33.7) 
+ Potentially dehydrated Good 
90 (25.7) 193(55.1) 
Good hydration 
38 (10.9) 
+ Potentially dehydrated is defined as no clear sign of dehydration but patient considered to be at risk for dehydra\lon . 
Prior diarrboeal episodes 
n (%) 
Five or more 
2 (0.6) 









±Normal lunder-weight for age 
261 (74.6) 
More than half (52.7%) of the patients were male. The median age was 8.5 
months (inter-quartile range 5-13 months). The median duration of current 
residence and previous residence was 7 months (inter-quartile range 4-12 
months) and 4 months (inter-quartile range 2-8.5 months) respectively. Most 
of the caregivers had some form of secondary education (78.3%) (Table 3.4). 
Other socio-demographic and socio-economic characteristics of the patients 
are reported in Table 3.4. 
The diet of 308 (88%) of the patients contained solids or semi-solids, 104 
(29.7%) breast-milk and 298 (85.1 %) any other type of milk. Allopathic care 
was reported as the primary source of contact for the current episode of 
diarrhoea in 295 (84.3%) of the patients, general practitioners (32.7%) being 
most commonly visited. Most patients (70.9%) had received oral rehydration 
solution (salt and sugar solution) prior to admission. 
3.5.2 Regression analysis 
A total of 348 (99.4%) and 347 (99.1 %) patients were included in the final 
analysis of plasma sodium and potassium levels respectively. Mean 
substitution was performed before multiple regression analysis for the 
variables parental education, piped water, flush toilet, hydration, peripheral 
perfusion, pH and Rotavirus, Cryptosporidium and Campylobacter since 
these variables had less than 5% of their observations missing. Severe 
malnutrition (48; 13.7%) and presence of co-morbidity (113; 32.3%) had 




Table 3.4 Percentage distribution of socio-demographic and socio-economic characteristics of patients (N=350) 
*Parent~t edu~atioli(level) 
'~(~j." ,; 
.~ "~'.\ ,," 
None 
4 (1.1) 
. : Appliances' 
,0 (%) 
,>" . ' •• ',. 










grade 8 to 12 
higher than grade 12 
81 (23.1) 
Electricity and a functional appliance 
202 (57.7) 
*Pereentage missing data reported in Table 3.5. 
+ 
Paraffin stove (133 [38.0%]); bums wood to cook (2 [0.57%]); gas stove (9 [2.57%]). 
191 (54.6) 
No Stove None None 
2 (0.6) 0 87 (24.9) 
Off-site Off-site 
150 (42.9) 92 (26.3) 27 (7.7) 
Electric On-site On-site 
198 (56.6) 101 (28.9) 90 (25.7) 
In-house In-house 
156 (44.6) 145 (41.4) 
Table 3.5 Independent variables with missing observations 
'Variable Numbetofmissing % ofN=350 
o'bservations 
Duration of vomiting (per complete day) 0.3 
Parental education (grade) 0.3 
Access to flush toilet 0.3 
Access to piped water 0.3 
Breast-fed 0.3 
Adequacy of drinking 2 0.6 
Hydration 2 0.6 
Cryptosporidium 2 0.6 
Rotavirus 6 1.7 
Peripheral perfusion 6 1.7 
Sodium content in formula milk (mg Nail 00 ml) 8 2.3 
Campylobacter 8 2.3 
pH 14 4.0 
Severe malnutrition 48 13.7 
Presence of co-morbidity 113 32.3 
*HIV status of child 215 61.4 
Shocked 250 71.4 
mv status of mother 251 71.7 
• HIV status was unknown as patients were not tested for HIV at the Red Cross Children's Hospital or prior to 
admission to the hospital 
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Variables with a statistically significant association (p<0.1) with plasma 
sodium and potassium on a bivariate analysis are shown in Table 3.6. 
Variables significantly associated with both plasma sodium and potassium 
levels were age, duration of diarrhoea, duration of vomiting, breast-fed, 
house type, flush toilet, piped water, duration of current residence, weight for 
height, degree of dehydration, plasma pH, Shigella, Rotavirus, 
Cryptosporidium and ETEC. 
3.5.2.1 Colinean"ty and distribution of the residuals 
In the multiple regression analysis with plasma sodium, age and duration of 
current residence were colinear. The model with age had a higher mean VIF 
(1.75) compared to duration of current residence (mean VIF=1.73), and age 
was thus included in the final model. The residuals of the. final analysis were 
not normally distributed (Shapiro-Wilks p=O, adjusted R2 = 0.2787, p=O). 
Plotting the residuals against the fitted values identified patients with plasma 
sodium levels above 155 mmol/l as outliers. Locally, such very high plasma 
sodium levels have been observed to occur with incorrect mixing of oral 
rehydration solutions with a high plasma sodium content. This was presumed 
to reflect a different pathophysiological process, and the 17 patients with 
plasma sodium levels greater than 155 mmol/l were removed from the 
analysis. This resulted in the residuals of the final regression analysis being 
normally distributed (Shapiro-Wilks p=0.071). The determinants of the 
multiple regression analysis of plasma sodium explained a statistically 
significant proportion (adjusted R2 = 0.3362, p=O) of the variability in plasma 
sodium levels. 
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Table 3.6 Associations (p <0.1) with sodium (n = 348) and potassium 
(n = 347) on bivariate analysis 
. Sodium Potassium· 
: Indeperident ·variable. . P coefficient p v~lue n p coefficient p value· 
Age (months) -0.563 <0.001 348 -0.023 0.011 
Duration of diarrhoea (per complete day) -0.191 0.009 348 -0.030 <0.001 
Duration of vomiting (per complete day) -0.189 0.053 34~ -0.023 0.020 
Breast-fed 1.938 0.089 347 0.352 0.001 
House type (brick/shack) 2.563 0.014 348 0.266 0.010 
Access to flush toilet -1.422 0.001 347 -0.114 0.007 
Access to piped water -2.319 0.0002 347 -0.139 0.025 
Duration of current residence (months) -0.475 <0.001 348 -0.026 0.005 
Weight for height (Z score) 1.221 0.001 348 0.083 0.027 
Degree of dehydration 0.277 0.022 348 -0.022 0.064 
Any other milk -0.283 0.048 
Parental education (grade) 0.036 0.069 
Severe malnutrition -0.267 0.093 
Presence of co-morbidity 0.287 0.025 
Hydration -0.161 0.006 
Peripheral perfusion 0.207 0.008 
Plasma pH -43.786 0 334 1.354 0.020 
Shigella -7.571 0.015 348 0.554 0.070 
Rotavirus 2.634 0.022 342 0.244 0.033 
Cryptosporidium -3.767 0.012 346 -0.582 <0.001 
ETEC -3.380 0.043 348 -0.284 0.083 
EPEC -5.809 0.001 348 
Campy lobacter -3.074 0.027 340 
Gender (male/female) 2.613 0.012 348 
Persistent diarrhoea -1.857 0.004 348 
Sodium content (mg Nail 00 ml) -0.148 0.001 341 
Previous residence 2.903 0.033 348 
























None of the variables were colinear (mean VIF=1.99) in the multiple 
regression analysis with plasma potassium. The residuals of the final 
analysis were not normally distributed (Shapiro-Wilks p=0.049, adjusted R2 = 
0.1540, p=O). Plotting the residuals against the fitted values identified a 
patient with a plasma potassium level of 6.8 mmol/l as the most prominent 
outlier. After removing this observation, the residuals were normally 
distributed (Shapiro-Wilks p=0.443). This unusually high level of plasma 
potassium in diarrhoea also appeared to be an outlier in pathophysiological 
terms and was thus excluded. The determinants of the multiple regression 
analysis of plasma potassium explained a statistically significant proportion of 
the variability in plasma potassium levels (adjusted R2 = 0.1643, p=O). 
3.5.2.2 Multiple regression analysis for plasma sodium 
Multiple regression models of variables associated (p<0.1) with plasma 
sodium in the bivariate analysis are reported in Table 3.7. Statistically 
significant positive associations (p<0.05) with plasma sodium in multiple 
regression analysis were being breast-fed and type of house. Statistically 
significant negative associations with plasma sodium in multiple regression 
analysis were age, plasma pH, ETEC infection and EPEC infection. 
3.5.2.3 Multiple regression analysis for potassium 
Multiple regression models of variables associated (p<0.1) with plasma 
potassium in the bivariate analysis are reported in Table 3.8. Statistically 
signi'f1cant positive associations (p<0.05) with plasma potassium in multiple 
regression analysis were parental education and plasma pH. Statistically 
significant negative associations with plasma potassium in multiple 
regression analysis were duration of diarrhoea before admission and 
Cryptosporidium infection. 
Table 3.9 summarises the associations for both plasma sodium and 
potassium for the multiple regression analysis. Plasma pH had a signi'ficant 
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I 
negative association with plasma sodium and a positive association with 
plasma potassium. 
3.5.2.4 Seasonality 
In order to assess potential confounding by factors such as migration 
patterns and health service utilisation, a post hoc analysis was performed of 
associations between season and i) age, ii) being breastfed, and iii) house 
type (for sodium); and i) duration of diarrhoea, and ii) parental education (for 
potassium). 
a) Seasonality for associations with sodium in the multiple regression 
analysis 
A statistically significant association was found between season and i) house 
type and ii) being breastfed. Patients living in brick houses were more 
common in the summer months (November to April) than in the winter 
months (58.8% vs. 43.2%; p=0.010). More patients were being breastfed in 
the winter months (May to October) than the summer months (38.3% vs. 
26.7%; p= 0.040). 
No statistically significant association was found between season and age 
(p=0.230). 
b) Seasonality for associations with potassium in the multiple regression 
analysis 
No statistically significant associations were observed between season and i) 
parental education (p=0.531) and ii) duration of diarrhoea (p=0.11 0). 
Analysis of seasonality of enteropathogens was performed a priori (Figures 
3.8 to 3.11). 
53 
Table 3.7 Multiple regression analysis on sodium (n = 331) 
Independent variable ~ 13 coefficient .' Std error. t p value '95% CI 
*Age -0.289 0.068 -4.21 0,000 -0.425 to -0.154 
Gender 1.215 0.619 1.96 0.051 -0.004 to 2.435 
Duration of diarrhoea (per complete day) -0.043 0.056 -0.78 0.438 -0.155 to 0.067 
Duration of vomiting (per complete day) 0.052 0.075 0.70 0.487 -0.096 to 0.202 
Persistent diarrhoea -0.511 0.384 -1.33 0.184 -1.268 to 0.245 
*Breast milk 1.914 0.767 2.49 0.013 0.404 to 3.425 
Sodium content in milk (mg Nail 00 ml) 0.018 0.031 0.56 0.573 -0.044 to 0.080 
*Type of house 2.659 0.929 2.86 0.005 0.829 to 4.488 
Access to flush toilet -0.363 0.510 -0.71 0.476 -1.367 to 0.640 
Access to piped water 0.472 0.773 0.61 0.542 -1.050 to 1.994 
Previous residence 1.044 1.225 0.85 0.394 -1.366 to 3.455 
Duration of previous residence (months) 0.086 0.163 0.53 0.597 -0.235 to 0.409 
Weight for height (Z-score) 0.064 0.238 0.27 0.787 -0.405 to 0.534 
Degree of dehydration 0.008 0.077 0.11 0.911 -0.1432 to 0.160 
*Plasma pH -22.127 4.013 -5.51 0.000 -30.024 to -14.231 
*ETEC -2.129 0.969 -2.20 0.029 -4.036 to -0.222 
*EPEC -5.118 1.017 -5.03 0.000 -7.119 to -3.116 
Shigella -2.283 ] .844 -1.24 0.217 -5.913 to 1.346 
Campy 1 obacter -0.534 0.833 -0.64 0.522 -2.173 to 1. 105 
Cryptosporidium -0.585 0.960 -0.61 0.542 -2.475 to 1.303 
Rotavirus 0.559 0.729 0.77 0.444 -0.875 to 1.994 
Constant 296.758 29.165 10.17 0.000 239.369 to 354.146 
"Significant at the 0.05 confidence level 
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Table 3.8 Multiple regression analysis on potassium (n = 346) 
p <oefficient, Stdertor t p value 
Age -0.0]2 0.015 -0.80 0.422 -0.043 to 0.018 
*Duration of diarrhoea (per complete day) -0.024 0.008 -2.85 0.005 -0.041 to -0.007 
Duration of vomiting (per complete day) 0.004 0.011 0.43 0.664 -0.017 to 0.027 
Breast milk 0.155 0.124 1.25 0.213 -0.089 to 0.399 
Any other milk -0.119 0.156 -0.76 0.446 -0.427 to 0.188 
*Parental education (grade) 0.043 0.019 2.26 0.024 0.005 to 0.081 
Type of house 0.215 0.139 1.54 0.124 -0.059 to 0.490 
Access to flush toilet -0.051 0.078 -0.65 0.517 -0.206 to 0.104 
Access to piped water 0.080 0.116 0.69 0.490 ·0.149 to 0,3] 0 
Duration of current residence (montl1s) -0.019 0.015 -1.22 0.224 -0.050 to 0.011 
Weight for height (Z-score) 0.026 0.036 0.73 0.467 ·0.045 to 0.099 
Degree of dehydration 0.002 0.011 0.18 0.859 ·0.021 to 0.025 
Hydration -0.081 0.065 -1.24 0.216 -0.209 to 0.047 
Peripheral perfusion -0.080 0.084 -0.95 0.340 ·0.246 to 0.085 
*Plasma pH 1.679 0.612 2.74 0.006 0.475 to 2.884 
ETEC -0.200 0.150 -1.33 0.183 -0.495 to 0.094 
Shigella 0.524 0.287 1.82 0.069 -0.040 to 1.090 
*Crytosporidium -0.334 0.145 -2.30 0.022 -0.621 to -0.047 
Rotavirus 0.125 0.111 1.12 0.262 -0.094 to 0.344 
Constant -8.591 4.472 -1.92 0.056 -17.389 to 0.205 
............. -~ 




Table 3.9 Summary of associations (p<O.05) with sodium (n = 331) and potassium (n = 346) on multiple regression 
analysis 
Sodium Potassium 
(3 coefficient Std error pvalue 95%CI (3 coefficient Std error p value 95%CI 
Duration of diarrhoea ~0.024 0.008 0.005 -0.041 to -0.007 
Parental education 0.043 0.019 0.024 0.005 to 0.081 
Cryptosporidium ~0.334 0.145 0.022 ~O .621 to -0.047 
Plasma pH ~22.127 4.013 0 ~30.024 to -14.231 1.679 0.612 0.006 0.475 to 2.88 
Age -0.289 0.068 0 -0.425 to -0.1 54 
Breast~fed 1.914 0.767 0.013 0.404 to 3.425 
Type of house 2.659 0.929 0.005 0.829 to 4.488 
EPEC -5.118 1.017 0 -7.119to-3.116 
ETEC -2.129 0.969 0.029 -4.036 to -0.222 
3.5.2.5 Effect modifiers 
Degree of dehydration was found to modify the association of being breast-
fed with plasma sodium levels (p=0.020). Patients being breast-fed that were 
more than 5% dehydrated had a 4.12 mmol/l (p=0.011) increase in plasma 
sodium concentration compared to those that were less than or 5% 
dehydrated (p coefficient = 1.07 mmol/l, p=0.230). Height for age, weight for 
height and age are probable confounding variables and not effect modifiers in 
the analysis for plasma sodium (Table 3.10). 
No effect modifiers were identified for associations with potassium. Degree of 
dehydration, height for age, weight for height and age are probable 
confounding variables and not effect modi'fiers in the analysis for potassium 
(Table 3.11). 
3.5.2.6 Sensitivity analyses 
Two sensitivity analyses were performed to assess the effect on multiple 
regression analysis of a) variables with greater than 5% o'f missing data; and 
b) patients enrolled who were admitted the previous night. 
a) Missing data 
The variables most affected by missing data were severe malnutrition and 
the presence of a co-morbidity, with only 204 cases consequently being 
included in the multiple regression analysis for plasma potassium. Sensitivity 
analyses were performed by doing regression analysis i) in the absence of 
both variables, ii) with severe malnutrition in the absence of co-morbidity, and 




Table 3.10 Analysis of pre-specified effect modifiers of associations (p<0.05) with sodium in multiple regression 
analysis 
Interaction variable ' .pcoeffici~nt Std error t p v~lue . 95%CI 
Age/age -0.013 0.010 -1.31 -1.31 -0.033 to 0.006 
Age/weight for height -0.006 0.039 -0.17 0.868 -0.083 to 0.070 
Age/height for age 0.025 0.015 1.66 0.098 -0.004 to 0.054 
Age/degree of dehydration -0.024 0.013 -1.82 0.069 -0.050 to 0.001 
Breast milk/age -0.138 0.130 -\.06 0.289 -0.396 to 0.118 
Breast milk/weight for height -0.185 0.471 -0.39 0.69 -1.113 to 0.743 
Breast milk/height for age 0.184 0.310 0.59 0.553 -0.425 to 0.794 
Breast milk/degree of dehydration 0.428 0.181 2.36 0.019 0.070 to 0.785 
Type of house/age 0.016 0.111 0.15 0.879 -0.201 to 0.235 
Type of house/weight for height 0.542 0.453 1.2 0.233 -0.350 to 1.435 
Type of houselheight for age 0.421 0.320 1.32 0.188 -0.207 to 1.051 
Type of house/degree of dehydration 0.067 0.150 0.45 0.655 -0.228 to 0.363 
pH/age 0.067 0.641 O. J.1 0.916 -1.195 to 1.330 
pH/weight for height -2.904 2.915 -1.00 0.320 -8.640 to 2.831 
pHlheight for age 0.033 0.018 1.79 0.075 -0.003 to 0.070 
pH / degree of dehydration -0.316 0.797 -0.40 0.692 -1.886 to 1.254 
01 
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Table 3.10 (continued) Analysis of pre-specified effect modifiers of associations (p<O.05) with sodium in multiple 
regression analysis 
.InteraCtion variable' " 
, 
, (l~oefficient ',~ ~,td'eiTor t pvalue '950/0 'CI' 
., '~ 
ETEC/age 0.293 0.167 1.75 0.081 -0.036 to 0.622 
ETEC/weight for height -0.545 0.874 -0.62 0.533 -2.267 to 1.175 
ETEClheight for age 0.071 0.187 0.38 0.705 -0.298 to 0.440 
ETEC/degree of dehydration 0.181 0.216 0.84 0.403 -0.244 to 0.606 
EPEC/age 0.006 0.198 0.03 0.900 -0.382 to 0.396 
EPEC/weight for height 0.965 0.801 1.20 0.229 -0.6] 1 to 2.541 
EPEClheight for age 0.529 0.674 0.79 0,433 -0.796 to 1.855 
EPEC/degree of dehydration -0.297 0.214 -1.39 0.166 -0.720 to 0.124 
Table 3.11 Analysis of pre-specified effect modifiers on associations (p<O.05) with potassium in multiple regression 
analysis 
Interaction variable P CO'efficitmt Std Error t .. P value ·95%.cl-
Parental education/age 0.0005 0.003 0.15 0.885 -0.006 to 0.007 
Parental education/weight for height 0.005 0.013 0.42 0.672 -0.020 to 0.032 
Parental education/height for age -0.001 0.002 -0.82 0.413 -0.006 to 0.002 
Parental education/degree of dehydration 0.0003 0.001 0.29 0.772 -0.001 to 0.002 
Duration of diarrhoea/age -0.0002 0.001 -0.17 0.867 -0.003 to 0.002 
Duration of diarrhoea/weight for height -0.008 0.005 -1.62 0.105 -0.019 to 0.001 
(j) 
a Duration of diarrhoealheight for age -0.004 0.002 -1.56 0.120 -0.009 to 0.001 
Duration of diarrhoea/degree of dehydration -0.002 0.001 -l.93 0.055 -0.005 to 0.00004 
pH/weight for height -0.376 0.436 -0.86 0.389 -1.234 to 0.481 
pHiheight for age -0.001 0.002 -0.50 0.619 -0.007 to 0.004 
pH/degree of dehydration 0.0002 0.001 0.14 0.888 -0.002 to 0.003 
pH/age 0.0512 0.096 0.53 0.596 -0.138 to 0.241 
Cryptosporidium/degree of dehydration -0.041 0.027 -1.52 0.131 -0.095 to 0.0124 
Cryptosporidium/weight for height -0.004 0.115 -0.04 0.97 -0.230 to 0.222 
Cryptosporidium/age -0.001 0.026 -0.07 0.947 -0.053 to 0.049 
Cryptosporidium/height for age -0.090 0.078 -1.16 0.248 -0.243 to 0.063 
I 
The sensitivity analysis (Table 3.12) found that duration of diarrhoea (n=346, 
p=O.005; and n=299, p=O.009), plasma pH (n=346, p=O.006; and n=299, 
p=O.006) and infection with Cryptosporidium (n=346, p=O.022; n=299, 
p=O.050) were statistically significant in the larger samples only, with 
significance increasing as sample size increased. However, the ~ coefficients 
were not meaningfully changed. The models that were statistically more 
powerful, without the variables severe malnutrition and co-morbidity, were 
thus used. Nutritional status was still represented in the models as height for 
age and weight for height. 
b) Overnight admissions 
The findings of multiple regression analysis for plasma sodium and 
potassium in the absence of the 27 patients recruited from overnight 
admissions are shown in Table 3.13. No meaningful differences were 
observed in the ~ coefficients. 
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Table 3.12 Sensitivity analysis - variables significantly associated (p <0.05) with potassium with and without severe 
malnutrition' and co-morbidity (multi-regression analysis) 
.p coeftideot '. p vahle 
0=346 0=299 n=~35 n=204 n"';'346 n==299 0=235 
Parental education 0.043 0.041 0.060 0.054 0.024 0.044 0.022 
Duration of diarrhoea -0.024 -0.022 0.005 0.009 
Plasma pH 1.679 1.836 1.655 0.006 0.006 
Cryptosporidium -0.334 -0.288 0.022 0.050 
Shigella 0.622 0.727 0.030 
Severe malnutrition -0.318 0.046 
"=346 - aLI determinants with p <0.05 except severe malnutrition and co morbidity; "=299 - all determinants with p <0.05 except 







Table 3.13 Sensitivity analysis - comparison of multiple regression analysis of sodium and potassium with and 
without patients admitted the previous night 
Sodium Potassium 
~ coefficient p value Variable ~ coefficieot p value 
*0=331 + 0=306 *0=331 + 0=306 *0=346 + 0~319 *0=346 + 0=319 
Age -0.289 -0.306 0 0 Parental education 0.043 0.043 0.024 0.032 
Plasma pH -22.127 -23.095 0 0 Duration of diarrhoea -0.024 -0.022 0.005 0.009 
EPEC -5.118 -4.297 0 0 Plasma pH 1.679 2.135 0.006 0.001 
ETEC -2.129 -1.976 0.029 0.037 Cryptosporidium -0.334 -0.323 0.022 0.027 
Breast-fed 1.914 2.185 0.013 0.006 
Type of house 2.659 2.604 0.005 0.005 




3.6.1 Interpretation of the principal findings 
This study, using a different prospective sampling strategy in a different full 
year, found a seasonal fluctuation in plasma sodium and potassium 
concentration very similar to those previously described locally. This 
excludes a possible sampling artefact in the previous study as an explanation 
for the findings, and provides strong confirmatory evidence of these seasonal 
fluctuations (Figures 3.1 and 3.5) (Swingler & Power, 2002). 
The analysis included a relatively large number of variables potentially 
affecting electrolyte levels via different pathways. These variables were of 
widely differing categories, ranging from enteropathogens to duration of 
diarrhoea to housing to parental education. Although very different, these 
categories are inter-related in complex ways. For instance, the infecting 
enteropathogens can affect the duration of diarrhoea; housing is related to 
sanitation and water supply which could affect the type and frequency of 
microbiological infection; and parental education, particularly maternal 
education, is related among other things to housing and to health-related 
behaviours that are both indirectly and directly related to diarrhoea. Because 
of these complex inter-relationships and multiple potential confounding 
factors, they were grouped together in multiple regression models to adjust 
for confounding and to identify the variables that were independently 
associated with electrolyte concentrations. 
As described in Section 3.4.3, the broad categories of variables were: i) 
those that were themselves seasonally distributed i.e. enteropathogens; ii) 
socio-economic determinants; iii) duration of exposure to the local 
environment; iv) associations with childhood diarrhoea that were not 
themselves inherently seasonal but which could be associated with seasonal 




such as seasonal variation in migration patterns and/or health service 
utilization, or with climatic variation; and v) plasma pH, which affects 
particularly plasma potassium concentrations. 
On bivariate (unadjusted) analysis many clinical, socio-economic, socio-
demographic, dietary and microbial factors were found to be significantly 
associated with both plasma sodium and potassium in the current study 
(Table 3.6). These were enteropathogens (Shigella, Rotavirus, 
Cryptosporidium and ETEC), socio-economic (house type, flush toilet, piped 
water), duration of current residence, associations with childhood diarrhoea 
that were not inherently seasonal (age, duration of diarrhoea before 
admission, duration of vomiting, being breast-fed, weight for height, degree of 
dehydration) and plasma pH. After adjustment for confounding in the multiple 
regression analyses, several of these variables lost statistical significance, 
reflecting confounding associations. 
3.6.1. 1 Multiple regression analysis for plasma sodium 
After adjustment for confounding in the multiple regression analysis, the 
following variables remained significantly associated with plasma sodium 
levels; ETEC, EPEC, type of housing, breastfeeding, age and pH. 
a) Seasonally distributed independent variables 
The patients infected with ETEC and EPEC had on average 5.12 mmol/I and 
2.13 mmol/I lower plasma sodium concentrations respectively compared to 
those without these infections. Both these enteropathogens were more 
common in summer/autumn, for both absolute numbers and proportions of 
total stool specimens collected per month (Figures 3.8 and 3.9), and both 
had summer /autumn peaks similar to those reported previously (Househam 
et aI., 1988; Qadri et al., 2000). Because of their seasonal variation in parallel 
with the fluctuations in plasma sodium levels, these organisms are the most 
directly related to the seasonal plasma sodium fluctuations, and appear, to be 
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their most likely direct explanation. This is the first report of such a finding. In 
the previous study in this setting, the seasonal difference in the monthly 
mean sodium levels of 6.0 mmol/l translated into a more than 12-fold 
difference in the prevalence of severe hypernatraemia (>160 mmol/l) 
between summer and winter months (Swingler & Power, 2002). The variation 
in sodium levels of 5.12 mmol/l and 2.13 mmol/l attributable to ETEC and 
EPEC infection respectively in the current study suggests that these 
enteropathogens are of considerable clinical and public health importance. 
This effect could be mediated by increased sodium losses in stools. Stool 
volume sodium concentration have been found to be higher in ETEC than in 
rotavirus infections, providing some support for this hypothesis (Molla et al., 
1981). 
b) Socio-economic variables 
Plasma sodium levels were associated with type of housing. Patients residing 
in brick houses had on average 2.66 mmol/l higher plasma sodium 
concentrations than those living in shacks. The association with type of 
housing is thus of a similar magnitude as EPEC infection, but housing is not 
inherently seasonal so it would not contribute to seasonal variations unless 
there were an unmeasured confounding factor. The type of housing may 
however reflect broader socio-economic status. This positive association of 
high levels of plasma sodium with higher socio-economic status has been 
previously reported (Yousuf et al., 1988). 
In this study housing could have influenced sodium levels by different 
pathways, as illustrated in the discussion in Section 3.4.3 of the potential 
impact of piped water. The availability of piped water and a flush toilet were 
also associated with sodium levels in the bivariate analysis, but these 
associations disappeared in the multivariate analysis, suggesting that they 
are confounders of the association with type of house. It remains unclear 
whether the type of housing itself or some other unmeasured confounder 
associated with socio-economic status is a determinant of the plasma sodium 
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levels, for example, health-seeking behaviour and subsequent treatment 
practices, as suggested by Yousuf et al. (1988). Children living in brick 
houses presented more frequently in summer, but this association is in the 
opposite direction to that required to explain seasonal fluctuations in plasma 
sodium levels. 
c) Associations with childhood diarrhoea that were not inherently 
seasonal 
Plasma sodium concentration decreased by 0.29 mmol/l with each one-
month increase in the patients' age. Assuming a linear association with 
plasma sodium, brick housing would have a similar strength of association as 
an increase of nine months in age, suggesting that the association of sodium 
levels with age is also of practical importance. This negative association 
between age and plasma sodium levels has been reported previously 
(Ahmed & Agusto-Odutola, 1970; Fayad et al., 1992; Samadi et al., 1983) 
and could be due to the fact that younger children have immature renal 
function and are unable to deal with a high solute load. There was however 
no significant association of age with season, so age does not explain the 
seasonal variation in plasma sodium levels. 
Patients who were breast-fed had on average 1.91 mmol/l higher plasma 
sodium concentration than those not drinking breast milk. The association 
with breast-feeding is surprising because of the lower plasma sodium content 
of breast milk compared with formula feeds. However this phenomenon has 
been reported previously for very young children when they were not 
exclusively breast-fed but were continually fed with both formula milk and 
breast milk (Ahmed & Agusto-Odutola, 1970). The many complex 
associations with breast-feeding, including nutritional and HIV status, make a 
simple explanation of its relationship with plasma sodium concentrations 
difficult. The higher prevalence oJ breastfeeding in winter could explain some 
of the observed seasonal fluctuations with seasonal association the result of 
an unknown confounding factor. 
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of one year in parental education. Assuming a linear association with plasma 
potassium, the presence of Cryptosporidium would have a similar strength of 
association as seven or eight years of education, suggesting that the 
association is less marked. The positive association between parental 
education and increased potassium could be explained by the fact that a 
increased parental education is known to be associated with decreased risk 
of diarrhoea (Ahiadeke, 2000; Mahalanabis et al., 1996) and specific care-
giving practices with respect to diarrhoea that were not recorded in the 
current study (like better hygiene). However, this finding could also reflect 
broader socio-economic status and be due to other unmeasured confounders 
associated with that status. There was however no significant association of 
parental education with season, so parental education does not explain the 
seasonal variation in plasma potassium levels. 
c) Associations with childhood diarrhoea that were not inherently 
seasonal 
Plasma potassium concentrations decreased by 0.02 mmolll for every 
additional day that the patient had diarrhoea before admission. The decrease 
in potassium levels as duration of diarrhoea increases was reported 
previously by Zaman et al. (1985) and could be due to ongoing potassium 
losses. There was however no significant association of duration of diarrhoea 
prior to admission with season, so duration of diarrhoea does not explain the 
seasonal variation in plasma potassium levels. 
d) Plasma pH 
The association of plasma potassium with pH was expected, as mentioned 
above in the case of plasma sodium levels. 
3.6.1.3 Effect modifiers 
Degree of dehydration was found to be an effect modifier of the association 
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between breast-feeding and sodium (Table 3.10). This association was 
stronger in patients that were more dehydrated. As with breast-feeding, this 
association is difficult to explain, particularly because the mechanism of the 
association itself is not understood. It should be noted that the probability of 
this finding occurring by chance was 0.01, and that it was the only statistically 
significant finding among 40 interactions examined. This finding may thus be 
due to chance and should be regarded with caution. 
3.6.1.4 Possible determinants of the parallel seasonal fluctuations of 
plasma sodium and potassium levels 
A striking feature of the seasonal fluctuations of plasma sodium and 
potassium that was confirmed by this study is the parallel nature of the 
fluctuations in both these electrolytes. This suggests that the fluctuations 
have some determinants in common. Of the variables measured in this study, 
only the enteropathogens appear to explain these fluctuations. Different 
organisms were significantly associated with plasma sodium and potassium 
levels - ETEC and EPEC with plasma sodium and Cryptosporidium with 
plasma potassium. However, ETEC and Cryptosporidium both have a similar 
seasonal distribution (Figures 3.8 and 3.10), and were both: i) associated 
with both plasma sodium and potassium in the bivariate analyses and ii) have 
associations in the same direction (whether significant or not) in the 
multivariate analyses. It appears that the seasonal fluctuations of plasma 
sodium and potassium levels are at least partly explained by both ETEC and 
Cryptosporidium working together, with ETEC having the larger effect on 
plasma sodium and Cryptosporidium the larger effect on plasma potassium. 
It is conceivable that the other variables associated with plasma sodium and 
potassium levels have had a seasonal effect via confounding factors such as 
migration, health service utilisation or climatic variation. Residing in a brick 
house (p=0.010) and being breastfed (p=O.040) were in fact seasonally 
distributed. The association with brick housing was in the opposite direction 
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to that required for it to explain the seasonal variation of plasma sodium 
observed on this study. The higher prevalence of breastfeeding in winter 
could explain some of the observed seasonal fluctuations, though 
presumably via an unknown confounding factor. No seasonal distribution was 
observed for age (p=0.230), parental education (p=0.531) and duration of 
diarrhoea (p=0.11 0). 
3.6.2 Strengths of the research 
The study population was broadly representative of children with dehydrating 
diarrhoea from urban and peri-urban areas as well as. informal settlements in 
the Cape metropolis. This increased the generalisability of the findings. 
The sampling strategy used captured the seasonal pattern of the aetiological 
factors being assessed, even though small numbers of patients were enrolled 
in the quieter winter months. Although an interim sampling strategy was used 
to ensure sufficient numerical representation of stool specimens across 
seasons, a sensitivity analysis showed that there was no significant 
difference between the patients admitted and recruited during work hours 
and those admitted overnight but enrolled the following day (Table 3.13). 
Socio-economic and socio-demographic data were collected prospectively, 
resulting in a greater level of accuracy in the information reported. 
Associations with aetiological factors and plasma sodium and potassium 
levels were determined by multiple regression analysis that adjusted for 
confounding effects between the factors. 
3.6.3 Limitations of the research 
Socio-economic status as a single composite variable was very difficult to 
define (Montgomery et al., 1997). A limited number of factors with 
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established associations with socio-economic status (Ahiadeke, 2000; 
Mahalanabis et a/., 1996; WHO, 2000) were chosen since they would have 
partly mediated an association with diarrhoea. Thus many other 
unrecognised factors could have been missed and these could have been 
responsible for some of the findings reported in the current study (such as 
the association between type of housing and plasma sodium, and that of 
paternal education and plasma potassium). 
The principal investigator was not blind to the plasma sodium and potassium 
results when administering the questionnaires. As a prerequisite for the study 
in Chapter Four, the principal investigator exarnined the patient's folder and 
concealed any electrolyte results before examination of the patient by the 
admitting medical officer. The patient's folder was thus examined 
immediately after the caregiver agreed to participate in the study and before 
the administration of the questionnaires. This was necessary to ensure that 
the medical officers participating in the study reported in Chapter Four were 
blinded to the measured outcomes as the medical officers assessed the 
clinical signs, not the principle investigator. This was unavoidable as 
overlapping data collection for two different studies was occurring 
simultaneously and resources were insufficient for an additional investigator. 
Lack of investigator blinding could potentially have introduced information 
bias particularly in the collection of more subjective data. However, no 
seasonal associations were found with these more subjective variables, 
whereas the observed significant associations were found with more 
objective micriobiological investigations which were performed by laboratory 
staff that were blinded to the electrolyte results. 
3.6.4 Implications for practice/public health responses 
The apparent seasonal variation of plasma electrolyte levels having a major 
impact on the prevalence of severe electrolyte disturbances has been 
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confirmed in this study, using different prospective methods of sampling. 
These fluctuations thus need to be taken seriously. 
Associations of electrolyte levels with the enteropathogens ETEC, EPEC and 
Cryptosporidium were identified and these explained a large proportion of the 
seasonal fluctuations observed in electrolyte levels that were large enough to 
be of clinical and public health importance. This study has however not 
identified specific focussed interventions to immediately and directly prevent 
electrolyte disturbances attributable to seasonal fluctuations in mean plasma 
sodium and potassium levels. Further evidence around the determinants of 
the microbial infections themselves is needed before specific action can be 
formulated. 
Socio-economic factors such as housing and parental education were 
identified as determinants of electrolyte levels, if not their seasonal 
fluctuations. Although electrolyte disturbances themselves do not appear to 
justify the considerable resources required to improve housing and 
education, these findings add a further reason to the many already existing 
for the improvement of socio-economic status, including housing and 
education. 
This study has highlighted the importance of interventions to improve 
parental education and socio-economic status, particularly housing, since 
these factors were shown to impact on the health of the child. They do not, 
however, suggest additional targeted interventions to prevent electrolyte 
disturbances in childhood diarrhoea. 
3.6.5 Implications for future research 
The most important and potentially most preventable determinants identified 
for the first time in this study are also in the area in which the most important 
gaps in knowledge still exist. Following the identification of the specific 
microbes, information is required on the determinants of the microbial 
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infections themselves. Further investigation of associations of nutritional and 
environmental factors with these enteropathogens, particularly in the context 
of childhood diarrhoea, would provide insight into prevention of the electrolyte 
disturbances. 
As a first step, an analysis of the existing database compiled for the current 
research to identify nutritional and environmental determinants of both ETEC 
and Cryptosporidium is currently under way. 
3.7 Conclusions 
Seasonal fluctuations in plasma sodium and potassium levels reported 
previously have been confirmed by the current study. 
Plasma sodium levels were negatively associated with age, ETEC infection 
and EPEC infection, and positively associated with being breast-fed and 
living in a brick house. The clinically meaningful seasonal fluctuations of 
plasma sodium levels are at least partly determined by ETEC and EPEC. 
The negative association between plasma sodium levels and ETEC and 
EPEC infection is a new contribution to the present body of research. 
Plasma potassium levels were positively associated with increased parental 
education, and negatively associated with the numbers of days with 
diarrhoea before admission and Cryptosporidium infection. As with plasma 
sodium levels, the clinically meaningful seasonal fluctuations in plasma 
potassium levels are at least partly determined by infection with 
Cryptosporidium. The negative association between plasma potassium levels 
and Cryptosporidium infection is also a new contribution to the present body 
of research. 
The striking parallel seasonal fluctuations of plasma sodium and potassium 
levels are at least partly explained by both ETEC and Cryptosporidium 
working together, with ETEC having the larger effect on plasma sodium 
levels and Cryptosporidium on plasma potassium levels. 
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I 
Identification of the specific determinants of ETEC and Cryptosporidium 
infection could help formulate a more specific approach to preventing 
disturbances in plasma sodium and potassium levels. 
These findings provide further support for existing interventions to improve 
parental education and socio-economic status (including housing). They do 
not, however, suggest additional targeted interventions to prevent the 
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CHAPTER FOUR: UTILITY OF CLINICAL SIGNS IN THE 
DIAGNOSIS OF PLASMA SODIUM AND POTASSIUM 
ABNORMALITIES IN CHILDHOOD DIARRHOEA 
4.1 Background 
Clinical examination (history and physical examination of the patient) can be 
a powerful tool for establishing diagnosis and prognosis, and guiding 
treatment of the presenting patient. However, the usefulness of such an 
examination is dependent on the accuracy of clinical features used to identify 
possible target conditions in the patient (Sackett et a/., 1991 :19). 
Several clinical signs of hypernatraemia, hyponatraemia and hypokalaemia 
are generally accepted (Chhabra et a/., 1995; Rudzinski et a/., 1996:342, 
346). These clinical signs of plasma sodium and potassium disturbances 
appear to have been based on case series of children with the electrolyte 
disturbances. Such case series are of limited usefulness, as they do not 
include patients without the abnormalities and provide no information on 
whether a specific clinical 'feature is helpful in discriminating those children 
with the disturbance from those without it. Signs reported to be associated 
with abnormal plasma sodium levels are irritability (Kuzemko, 1969; 
Rudzinski et a/., 1996:342), seizures (Rudzinski et al., 1996:342), depressed 
level of consciousness (Kuzemko, 1969; Rudzinski et al., 1996:342), a 
wooden feel to the skin (Rudzinski et al., 1996:342), weakness (Barkin, 1997, 
cited in Johns Hopkins, 2002:244) and increased biceps and knee reflexes 
(Johns Hopkins, 2002:244). Signs reported to be associated with abnormally 
low potassium levels are hypotonia, physical weakness (Barkin, 1997, cited 
in Johns Hopkins, 2002:241; Chhabra et al., 1995; Rudzinski et a/., 
1996:346), ileus (Chhabra et al., 1995; Rudzinski et al., 1996:346) and 
abdominal distension (Chhabra et al., 1995). 
The utility of clinical signs in the diagnosis of a target condition also depends 
on the ability of the clinical feature to distinguish children with the disorder of 
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interest from those without the disorder in a clinical context where other 
conditions may produce similar signs. An example of this, hypotonia occurs 
in hypokalaemia (Chhabra et al., 1995) and a depressed level of 
consciousness in hypernatraernia (Rudzinski et al., 1996:342); however, both 
are important features of shock due to dehydration (American Academy of 
Pediatrics, 1994:2-6) and can appear together with, or independently of, 
electrolyte disturbances. Hypotonia occurring in dehydration will therefore not 
necessarily indicate hypokalaemia, nor will a depressed level of 
consciousness necessarily indicate hypernatraemia. Equally, because not all 
children with hypokalaemia are hypotonic, the absence of this sign does not 
necessarily exclude hypokalaemia. 
False-negative (see glossary) signs can lead to important conditions being 
missed and not receiving attention, while false-positive (see glossary) signs 
may result in parental anxiety and exposure to unnecessary and potentially 
harmful further investigations or treatment. 
4.1.1 Review of the literature on diagnostic accuracy of clinical signs 
for plasma sodium and potassium abnormalities in children less 
than 2 years old with diarrhoea 
4.1.1.1 Identification of relevant studies 
A PubMed search (search strategy reported in Appendix 4.1) was performed 
for the period 1966 to May 2005. One-hundred and eighty-six studies were 
identified in the search. The abstracts of these studies were screened by the 
principal investigator to identify those that met the criteria of reporting on i) 
the diagnostic accuracy ii) of clinical features to detect iii) plasma electrolyte 
disturbances iv) in children v) with diarrhoea. Sixty-six studies were deemed 
possibly relevant and full reports were obtained, to enable fuller assessment. 





4.1.1.2 Results of literature review 
After reading full reports, of articles that were potentially eligible for inclusion, 
no studies were found that were specifically designed to assess the 
diagnostic accuracy of clinical signs of electrolyte disturbances in children 
with dehydrating diarrhoea. However, tbree studies were identified that 
related to the research question and these will be discussed. 
a) Reliability of clinical signs in diarrhoea and other childhood illnesses 
One study was identified that reported on the reliability of clinical signs in sick 
children in Tanzania but no reference standards were used Kabigwa et al., 
2002). They assessed inter-observer variability of clinical signs used for the 
diagnoses of malaria, pneumonia, malnutrition, anaemia and diarrhoea in 
327 sick children admitted to a hospital in Tanzania. Clinical officers 
performed the assessment of signs in any child between 4 months and 6 
years of age being admitted to their paediatric ward. The authors concluded 
that signs were more likely to be agreed upon by clinicians if they involved 
inspection rather than auscultation. Clinicians showed only fair agreement 
(Kappa score [see glossary] 0.21-0.40) in the detection of neck stiffness and 
chest in-drawing, and slight agreement in the detection of dehydration 
(Kappa score 0.2). Objective assessment of neurological signs was less 
reliable in infants than in older children, and there were difficulties 
surrounding the diagnosis of impaired consciousness in young children (ibid). 
The validity of the signs in detecting a target condition was not assessed. 
b) Clinical signs of hypernatraemia in a developing country 
Hill et al. (1981) performed a comparative study that attempted to define 
clinical signs that were useful in distinguishing between hypernatraemic and 
non-hypernatraemic cbildren by determining if there was a significant 
difference in the groups with and without the signs. No formal assessment of 
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the diagnostic accuracy or reliability of clinical signs was performed, but 
measures of diagnostic accuracy could be calculated from data extracted 
from the report (Table 4.1). 
One hundred and ninety-seven patients admitted to the drip room (now the 
Rehydration Unit) at Red Cross Children's Hospital were enrolled into the 
study. All patients with serum sodium levels >150 mmolll, regardless of time 
of presentation, were enrolled into the study. This group was compared to a 
consecutive sample of patients with normal serum sodium levels enrolled 
during specified work hours during the week. One hundred and forty-seven of 
the patients (74.6%) were hypernatraemic (ibid). 
Contingency tables of data used to calculate measures of diagnostic 
accuracy are presented in Appendix 4.2 ... Iitteriness was 100% specific for 
hypernatraemic patients, with no false-negatives and a positive predictive 
value of 100%. It was, however, not sensitive (14%), with a negative 
predictive value of 35%. Similarly, coma/convuisions/drowsy were very 
specific (96%), with high positive predictive values (95%), but not very 
sensitive (31 %), with low negative predictive values (35%). 
Coma/convulsions/drowsy had a clinically meaningful association with 
hypernatraemia. 
Some aspects of the study design need to be considered when interpreting 
the findings, as these could have contributed to an exaggerated estimate of 
diagnostic accuracy. These are the following: i) clinical signs were assessed 
with the knowledge of the serum sodium levels (the reference standard) thus 
introducing potential test review bias (see glossary); ii) different sampling 
techniques were used to enrol hypernatraemic and non-hypernatraemic 
patients thus introducing potential selection and spectrum bias (see 
glossary); and iii) only one clinician performed all the clinical assessments, 
and not a representative range of clinicians, limiting the applicability of the 





Measures of diagnostic accuracy (for binary responses) calculated from extracted data (Hill et al., 1981) 
'"' <. , Jittery • _ Com~/~,obVulsioh~/drowsy , 
" ,." .; _ .• .0.,. - ,~L-., . "I~ "_ -
tSensitivity (%) 14 31 
95%CI 7.52 to 20.8 23.2 to 39.0 
tSpecificity (%) 100 96 
95% CI 92.6 to 100 86.3 to 99.5 
tpositive predictive value (%) 100 95 
95% C1 78.2 to 100 84.0 to 99.4 
tNegative predictive value (%) 35 35 
95%CI 26.6 to 42.4 26.6 to 42.4 
* Unable to calculate as the denominator was zero and the likelihood ratios approached infinity. 
tSee glossary for definitions. 
Even though the prevalence of hypernatraemia was high, the sample was 
small, therefore some of the estimates lacked precision (broad 95% 
confidence intervals), implying that the findings could be due to chance. 
c) Clinical signs of hypernatraemia in a developed country 
Another study (Tjon A Ten, 1999) was identified that reported on the 
frequency and management of electrolyte disturbances in children with acute 
diarrhoea admitted to their hospital between January 1992 and December 
1999. Unclear reporting of the study methods made appraisal of the validity 
of the findings difficult. The report implied that a consecutive sampling 
technique was used for enrolment into the study. Two hundred and sixty-five 
children were enrolled into the study; however, serum sodium levels were 
only available for 192 of these patients (ibid). As part of the study, data were 
presented on how often children that were hypernatraemic and those that 
were normal presented with clinical dehydration. These data were extracted 
and measures of diagnostic accuracy were calculated (Table 4.2), making 
the considerable assumption that those patients with missing data for serum 
sodium levels all had normal serum sodium levels. 
Table 4.2 Measures of diagnostic accuracy (for binary responses) 





'tPositive predictive value (%) 
95%CI 
~egative predictive value (%) 
95% CI 




2.23 to 15.1 
98 
95.5 to 99.7 
63 
24.5 to 91.5 
73 
67.7 to 78.6 
Eight (3%) of the patients were hypernatraemic. Contingency tables for data 
used to calculate measures of diagnostic accuracy are reported in Appendix 
4.2. Clinical dehydration was very specific (98%) but not sensitive (7%). 
Clinical dehydration had a limited clinically meaningful association with 
hypernatraemia. Estimates of diagnostic accuracy lacked precision (broad 
95% CI) and could be due to chance. 
The above study was performed in Holland where dehydrating diarrhoea is 
less common, and children are expected to be generally healthier and 
present with milder dehydration and better nutritional status. Only 74 (27.9%) 
of the 265 children were in fact assessed as being dehydrated. 
4.1.1.3 Summary of the literature review 
One study was found that reported on inter-observer agreement for a number 
of clinical signs used to identify a broad spectrum of conditions, including 
diarrhoea. Agreement was better when signs involved inspection than when 
they involved auscultation, there was slight agreement in the detection of 
dehydration (Kappa score 0.2), and objective assessment of neurological 
signs and impaired consciousness were less reliable and difficult in infants 
and younger children (Kahigwa et aI., 2002). 
Two other studies designed and performed for other primary objectives 
reported data that could be re-analysed to assess diagnostic .accuracy of a 
limited number of signs. One of these studies (Hill et al., 1981) suggested 
potentially useful accuracy of jitteriness and disturbances of level of 
consciousness in detecting hypernatraemia, but the findings are susceptible 
to bias because of several aspects of the study design. The second study 
(Tjon A Ten, 1999) enabled only a very approximate estimate of dehydration 
as a sign of hypernatraemia in a sample of children not representative of 
those in low- and middle-income countries where dehydrating diarrhoea is 
more prevalent. 
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4.1.2 Review of the literature on diagnostic accuracy of clinical signs 
for plasma sodium and potassium abnormalities in children less 
than 2 years old in conditions other than diarrhoea 
4.1.2.1 Identification of relevant studies 
A broad and sensitive PubMed search was performed, using the "Clinical 
Queries" strategy for the period 1966 to December 2005, for clinical signs of 
electrolyte disturbances in children under 2 years of age. It identified 152 
studies for hypokalaemia, 120 studies for hypernatraemia and 268 studies for 
hyponatraemia (search strategy reported in Appendix 4.1). The abstracts of 
these studies were screened by the principal investigator to identify those 
that met the criteria of reporting on i) the diagnostic accuracy ii) of clinical 
features to detect iii) plasma electrolyte disturbances iv) in children less than 
2 years old. Three studies were deemed possibly relevant and full reports 
were obtained, to enable fuller assessment. The reference lists of identified 
studies were also screened for potentially relevant reports. 
4.1.2.2 Results of literature review 
None of the studies met the inclusion criteria reported in section 4.1.2.1. 
There are thus no reliable data, in children, on the diagnostic accuracy of 
clinical tests for important electrolyte disturbances. This is particularly 
important in children with dehydrating diarrhoea as these children are usually 
managed in settings where facilities for laboratory diagnosis of electrolyte 
disorders are not easily available, if they are at all. This study will investigate 
the diagnostic accuracy of clinical features in detecting plasma sodium and 
potassium disturbances in childhood diarrhoea. 
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4.2 Aims of study 
The aim of this study was to assess the diagnostic accuracy and reliability of 
clinical signs previously reported to be associated with electrolyte 
disturbances in children admitted to a diarrhoea Rehydration Unit. 
4.3 Objectives 
a) To determine the likelihood ratios for the presence or absence of 
clinical signs, or a combination of clinical signs, for: 
• hypernatraemia, 
• severe hypernatraemia, 
• hypo natraem ia, 
• hypokalaemia, 
• severe hypokalaemia. 
b) To determine the sensitivity, specificity and predictive values for the 
clinical signs with a binary response. 
c) To measure inter-observer variation (reliability) in assessing these 
clinical signs. 
4.4 Methods 
4.4.1 Inclusion and exclusion criteria 
All patients with the primary diagnosis of diarrhoea between 6 weeks and 2 
years of age admitted to the Rehydration Unit at Red Cross Children'S 
Hospital, Cape Town, during work hours were enrolled into the study after 
written informed consent was obtained from the caregiver. Patients with any 





A consecutive sampling technique was used and is described in detail in 
section 2.3. Table 4.3 reports the number of enrolments targeted per month. 
Table 4.3 Targeted enrolment per month 
Month .Jan .. feb Mar Apr May. Jun Jul AugSep Oct. Nov Dec· Todd 
Target 75 90 ] 14 92 65 41 33 30 32 36 40 52 700 
4.4.3 Data collection 
All medical officers working in the Rehydration Unit were provided with an 
information sheet on the study at the beginning of their two-month rotation in 
the Unit (Appendix 4.3). Patients referred to the Rehydration Unit were 
enrolled into the study on arrival, before they were examined by the admitting 
medical officer on duty. During the admission examination this medical officer 
recorded on the data capture sheet (Appendix 4.4) attached to the patient's 
folder the clinical findings detailed in section 4.4.3.2 below. The medical 
officers were typically either doctors performing statutory community service 
immediately post internship, or other recently qualified medical practitioners. 
4.4.3.1 Reference standard (target conditions studied) 
Measured plasma sodium and potassium concentrations were used as the 
reference standards. Plasma potassium and plasma sodium concentrations 
were measured by the hospital's routine clinical laboratory using the direct 
ion-electrode method. 
Electrolyte disturbances were defined as: 
Hypernatraemia 
Severe hypernatraemia 
Plasma sodium above 150 mmolll 





Plasma sodium below 135 mmol/I 
Plasma potassium below 3.5 mmolll 
Plasma potassium below 2.5 mmol/I 
Results were extracted from routine laboratory records by the principal 
investigator and recorded on the laboratory results data extraction form (see 
Appendix 3.2). 
4.4.3.2 Clinical signs studied 
a) The foUowing clinical signs were assessed for plasma sodium 
disturbances. The levels of response for each sign are reported in the outer 
brackets. 
• Irritability (reported by the caregiver to have occurred for the current 
episode of diarrhoea) (crying consolably or inconsolably/normal), 
, 
• Seizures (reported by the caregiver to have occurred 24 hours prior to 
admission) (yes/no), 
• Level of consciousness (Glasgow Coma Score [see Table 4.4]) «8 /8-
12/ >12), 
• Weakness: 








Kicks away (complete leg extension from flexion) 
(yes/maybe/no), 
Pushes away (gravity overcome) (yes/maybe/no), 
Lifts head from bed (prone, ~ 6 weeks) (yes/maybe/no), 
Sits unsupported ~ 7 months) (yes/maybe/no), 
Rolfs over ~ 9months) (yes/maybe/no), 
Stands (~12months) (yes/maybe/no), 
• Wooden feel to skin (yes/maybe/no), 
• Tendon reflexes, namely biceps and knee (reduced/normal/brisk), 
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• Adequacy of peripheral perfusion (poor/fair/good), 
• Degree of dehydration (10% / 5% /potentially dehydrated/good). 
b) The following clinical signs were assessed for potassium disturbances. 
The levels of response for each sign are reported in the outer brackets. 
• Level of consciousness (Glasgow Coma Score [see Table 4.4]) «8/8-
12/ >12), 
• Hypotonia: 
o Lies in frog's leg position (yes/maybe/no), 
o Marked head lag on pulling to sit (if >3 months) (yes/maybe/ 
no), 
o Marked truncal slump on sitting (if> 7 months), (yes/maybe/ 
no), 
• Weakness: 








Kicks away (complete leg extension from flexion) 
(yes/maybe/no) , 
Pushes away (gravity overcome) (yes/maybe/no), 
Lifts head from bed (prone, ~ 6 weeks) (yes/maybe/n<o), 
Sits unsupported (~ 7 months) (yes/maybe/no), 
Rolls over (~9months) (yes/maybe/no), 
Stands (~12months) (yes/maybe/no), 
• Ileus (yes/maybe/no), 
• Abdominal distension (in an non-obese child, elevation of the 
abdominal wall higher than the chest wall when viewed from the side) 
(yes/maybe/no), 
• Adequacy of peripheral perfusion (poor/fair/good), 
• Degree of dehydration (~1 0% / 5% /potentially dehydrated/good). 
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Provision was made on the data capture sheet for clinical signs not assessed 
because they were: not applicable (age-dependent); difficult to assess (not 
elicited); or not reported (not done). 
Although not mentioned in the initial protocol, data on the adequacy of 
peripheral perfusion and degree of dehydration were prospectively collected 
and included in the analysis because they appeared to be potentially 
important signs for the operational management of electrolyte disturbances, if 
sufficiently accurate. 
4.4.3.3 Rationale for category cut-off points 
All categories of response for clinical signs and levels of plasma sodium and 
potassium used to define the different electrolyte disturbances were chosen 
prior to commencement of the research. 
Hypernatraemia has a well-recognised cut-off level of >150 mmolli. Cut-offs 
for severe hypernatraemia (158 mmolll) and severe hypokalaemia «2.5 
mmolll) were chosen because concentrations beyond these levels have been 
reported sometimes to be life-threatening (Adelman & Solhung, 1996:218; 
Travis, 1996:1331). The levels chosen for hyponatraemia «135 mmolll) and 
hypokalaemia «3.5 mmolll) were the laboratory cut-offs at Red Cross 
Children's Hospital. 
Operational definitions were provided for clinical signs, but clear-cut offs 
between normal and abnormal were often difficult to define because of the 
clinical judgement required in the context of the smooth continuum between 
normal and abnormal. To accommodate this ambiguity an equivocal category 
was included, in addition to "yes" and "no", and was analysed with the use of 
likelihood ratios and weighted Kappa (section 4.4.4 and 4.4.5). 
The Glasgow Coma Score is made up of the components reported in Table 
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4.4. This score is widely used to describe the level of consciousness and cut-
offs were those being used in current clinical practice at Red Cross 
Children's Hospital. 
Table 4.4 Description of Glasgow Coma Score as used at Red Cross 
Children's Hospital 
. Component of Score· . Level of response 
Eyes opening 
Best motor response 













Coos and babbles 
Irritable/cries 
Cries in response to pain 
Grunts 
No response 















Patients' folders were examined by the principal investigator prior to clinical 
examination of the patient by the admitting medical officer. Any electrolyte 
results already available in the folder were concealed with a removable self-
adhesive label to ensure that the medical officer made the clinical 
assessment before obtaining access to the electrolyte results. Blinding was 
not tested because it was judged not to be possible. 
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4.4.4 Measures of diagnostic accuracy 
Likelihood ratios (LRs) were used as· the primary measure of diagnostic 
accuracy. An LR is the ratio of the likelihood that a given test result is 
expected in a patient with the target disorder, compared to the likelihood that 
that same result is expected in a patient without the target disorder 
(Jaeschke et a/., 2002:198). 
These ratios incorporate both sensitivity (the proportion of patients with the 
target disorder with a positive test) and specificity (the proportion of patients 
without the target disorder with a negative test) to describe the change in 
odds favouring the presence of the target disorder given a particular test 
result (Jaeschke et a/., 2002:203). LRs are more useful to clinicians than 
sensitivity and specificity since they reflect the change in the odds of the 
condition due to the test result in an individual patient before the disease 
status of the patient is known (Simel et a/., 1991). Other advantages that LRs 
have over sensitivity and specificity are that they can be calculated for 
several levels of the sign or test (for example, they can include an equivocal 
category) and they can be used to combine the results of multiple diagnostic 
tests (Sackett eta/., 1991:120, 131). 
LRs are also advantageous over predictive values (see glossary) since they 
are not dependent on prevalence of the target condition (Altman, 1991 :411) 
like predictive values. 
LRs of 1 indicate no association between the target disorder and the sign or 
test; LRs greater than 1 indicate that the test result increases the probability 
that the target disorder is present (the higher the LR, the greater the increase 
in probability), while LRs less than 1 indicate that the test result decreases 
the probability of the target disorder (the smaller the LR, the greater the 
decrease in probability) (Jaeschke et aI., 2002:199). Table 4.5 suggests a 
broad interpretation of the meaning of LRs of different sizes. 
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Table 4.5 Suggested interpretation of likelihood ratios 
No use at all 
Alters probability to a small (and rarely important) degree of 
the target condition 
Generates small (but sometimes important) changes in 
probability of the target condition 
Generates moderate change from pre-test to post-test 
probability (see glossary) of the target condition 
Generates large and often conclusive change from pre-test 
probability to post-test probability of the target condition 
laeschke et al., 2002: 199. 
4.4.5 Reliability of clinical signs 
Likelihood ratios 
Positive test Negative test 
I - 2 0.5 - 1 
2-5 0.5 - 0.2 
5 - 10 0.1 - 0.2 
>10 0.1 
Inter-observer variation was assessed by two medical officers eliciting the 
same clinical signs on the same patient, within 10 minutes of each other, 
without knowledge of electrolyte results or their colleague's assessment. This 
reliability study was performed between October 2003 and March 2004, 
using convenience samples of children in the Rehydration Unit at times 
convenient to the medical officers who were recruited for this study. Three 
medical officers participated in different pairs. Two of these medical officers 
had participated in the clinical examination of patients recruited to the study 
of diagnostic accuracy, and the third was a clinicar researcher who had 
recently also worked as a medical officer in the Rehydration Unit. 
The proportion of potential agreement beyond chance between two medical 
officers was determined using the weighted Kappa score. The advantage of 
using the weighted Kappa score rather that the Kappa score is that it makes 
provision for the different levels of response and weights the degree of 
disagreement. This means that greater credit is given for minor 
disagreements than wide disagreements (Altman, 1991 :406; Sackett et al., 
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1991 :30, 55). The weighted Kappa score was calculated for each clinical sign 
to measure agreement between the medical officers. 
The following guide has been published for the interpretation of weighted 
Kappa scores using the following qualitative categories (Sackett et al., 
1991 :30): 
o = no agreement better than chance, 
0- 0.2 = slight agreement, 
0.2 - 0.4 = fair agreement, 
0.4 - 0.6 = moderate agreement, 
0.6 - 0.8 = substantial agreement, 
0.8 - 1.0 = almost perfect agreement. 
Negative values indicate worse than chance agreement. 
4.4.6 Analysis 
Methods of estimation rather than hypothesis testing were used as 
recommended by Standards for Reporting of Diagnostic Accuracy (80ssuyt 
et aI., 2003). LRs for the presence and absence of clinical signs, with 95% 
confidence intervals, were calculated (Simel et al., 1991) for each clinical 
sign for each outcome. Each sign (except history of seizures and irritability) 
was assessed using more than two levels of response (Appendix 4.4). A 
decision was made against re-categorising multi-level responses to binary 
responses in order to calculate sensitivity, specificity and predictive values 
because important information on definite versus equivocal signs would have 
been lost (Jaeschke et al., 2002:206). 
Logistic regression analysis was planned using clinical signs that showed a 
clinically meaningful (LR >5), statistically significant association with plasma 
sodium or potassium disturbances to develop predictive models for the 
different target conditions. 
Receiver operating characteristic curves (see glossary) were planned for the 
predictive models determined by logistic regression analysis for the different 
target conditions to assess the sensitivity and specificity of different numbers 
of signs from the same model. 
Sample size calculations for studies of diagnostic accuracy can be guided by 
estimating a meaningful confidence interval around the desired LR and then 
using the confidence interval to estimate sample size for the diagnostic test 
(Simel et al., 1991). The largest sample size was needed for the study of 
severe hypernatraernia because it was expected to have had the lowest 
expected prevalence (2.7%). A sample of 700 children would have provided 
the following approximate 95% confidence intervals for the specified LRs 
(Table 4.6): 
Table 4.6 Expected 95% CI for different estimated likelihood ratios, 
given a sample of 700 and a prevalence of severe 
hypernatraemia of 2.7% 
Likelibood ratios 
Positive test 950;(.CI .Negative test 95%CI 
1.0 0.65 to 1.50 1.00 0.65 to 1.50 
3.5 2.70 to 4.60 0.29 0.13 to 0.61 
7.0 5.40 to 9.00 0.14 0.05 to 0.44 
10.0 7.70 to 13.00 0.10 0.03 to 0.37 
These confidence limits appeared to adequately differentiate different ranges 
of diagnostic accuracy, except for LRs below 0.20 for negative signs for 
severe hypernatraernia. Estimates of accuracy below 0.20 would thus 
indicate useful diagnostic accuracy, but with insufficient precision to 
determine the degree of usefulness. More useful differentiation between 
these ranges of diagnostic accuracy for severe hypernatraemia would have 
required at least twice as many cases. 
The precision of estimates of target disorders of higher prevalence, such as 
severe hypokalaemia, were all higher than for severe hypernatraemia. 
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Data were managed in the Access 2000 program (Microsoft Corporation, 
1992-2001) and analysed in the Excel 2000 program (Microsoft Corporation, 
1985-2001). 
4.5 Results 
A total of 2270 patients were admitted to the Rehydration Unit from 1 April 
2002 to 31 March 2003 (data from unpublished routine hospital records). 
Four-hundred and seventy-six patients were enrolled into the study over a 
closely related one-year period (15 April 2002 - 14 April 2003). Of these, 475 
(99.8%) were included in the final analysis for plasma sodium and 471 
(98.9%) for plasma potassium (Figure 4.1). Two hundred and fifty-seven 
patients (54.1%) had normal plasma sodium levels (135-150 mmolll), 187 
(39.4%) were hyponatraemic, 31 (6.5%) hypernatraemic and 15 (3.2%) 
severely hypernatraemic. Two hundred and thirty-five patients (49.9%) had 
normal potassium levels (3.5-5.3 mmolll). 236 (50.1 %) were hypokalaemic 
and 89 (18.9%) severely hypokalaemic (Figure 4.2). 
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Figure 4.1 Profile of enrolment - diagnostic accuracy of clinical signs 
I 
14 refused consent 
I 
I 
1 patient was excluded as plasma 
sodium was not measured 
I 
494 patients meeting inclusion criteria 
" 
476 enrolled into the study 
I 
4 patients were excluded as they 
were developmentally delayed 
5 patients excluded as plasma 
potassium was not measured 
475 patients included in the final 
analysis for SODIUM 
471 patients included in the final 
analysis for POTASSIUM 
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4.5.1 Characteristics of the patients 
The median age of patients was 16 months (inter-quartile range 9-21 
months). One hundred and ninety-three patients (40.0%) presented with 
some *co-morbidity. The male to female ratio was 1 :1.2. Other 
characteristics of the patients are listed in Table 4.7. 





K wash iorkor 
8 (l. 7) 
Marasmus 
43 (9.0) 














Peripheral perfusion Gender 
n (%) n (%) 
Poor Males 
43 (9.0) 257 (54.0) 
Fair Females 
175 (36.8) 219(46.0) 
Good 
246 (51.7) 
Missing data: * Co-morbidity 154 (32.4%). nutrition (63 (13.2%]), hydration (6 (1.3%]), peripheral pel"fusion (12 
(2.5%]). 
4.5.2 Elicitation of clinical signs 
Fifty-seven different medical officers and one experienced paediatrician (39 
assessments, 8.2%) performed the clinical assessments for this study. 
Tables 4.8 and 4.9 reports the percentage of observations for clinical signs 
not elicited and not done. Medical officers experienced difficulty in the 
assessment of the following signs: sits, rolls over, stands, truncal slump and 
tendon reflexes. 
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Table 4.8 Missing data for clinical signs in the analysis of sodium disturbances 
Signs for sodium For the study of diagnostic accuracy For the study of reliability 
Missing data % of475 Not elicited % of475 Not done % of475 Not elicited % of 50 
(n) (n) (0) 
History of irritability 123 25.89 0 0 123 25.89 
History of seizures 4 0.84 0 0 4 0.84 
Level of consciousness 3 0.64 0 0 3 0.64 0 0 
Resists procedures 45 9.47 37 7.79 8 \.68 21 42 
Kicks away 5 1.05 2 0.42 3 0.63 0 0 
<0 Pushes away 5 1.05 0.21 4 0.84 0 0 (Xl 
Lifts head 6 1.26 3 0.63 3 0.63 0 0 
Wooden feel to skin 3 0.63 0 0.00 3 0.63 0 0 
Biceps, tendon reflexes 19 4.00 9 1.89 10 2.11 2 
Knee, tendon reflexes 17 3.58 7 1.47 10 2.11 2 
Peripheral perfusion (N= 528) 13 *2.46 0 0 13 *2.46 
Degree of dehydration (N=528) 6 * 1.14 0 0 6 * 1.14 
·Sits (N=302) 4 * 1.32 4 * 1.32 0 0 12 24 
• Rolls (}/= 25 2) 20 *7.94 12 *4.76 8 *3.17 20 40 
·Stands (N- 184) 4 *2.17 3 * 1.63 *0.54 20 40 
• Age·dependent variables. * Percentage calculated according to N in brackets. 
Table 4.9 Missing data for clinical signs in the analysis of potassium disturbances 
Signs for potassium For the study of diagnostic accuracy For the study of reliability 
Missing data % of 471 Not elicited % of 471 Not done % of471 Not elicited % of 50 
{n} {n} {n} 
Level of consciousness 3 0.64 0 0.00 3 0.64 0 0 
Lies in a frog legs position 6 1.27 0.21 5 1.06 0 0 
Resists procedures 44 9.34 37 7.86 7 1.49 21 42 
Kicks away 5 1.06 2 0.42 3 0.64 0 0 
Pushes away 5 1.06 0.21 4 0.85 0 0 
<.D 
<.D Lifts head 6 1.27 3 0.64 3 0.64 0 0 
Ileus 4 0.85 0.21 3 0.64 0 0 
Abdominal distension 0.2 0 0 0.2 0 0 
Peripheral perfusion (N=525) 13 *2.48 0 0 13 *2.48 
Degree of dehydration (N=525) 6 * 1.14 0 0 6 * 1.14 
·Sits (N=299) 4 * 1.34 4 * 1.34 0 0 12 24 
·Rolls (N=251) 20 *7.97 12 *4.78 8 *3.19 20 40 
·Stands (N= 184) 4 *2.17 3 * 1.63 *0.54 20 40 
·Marked headlag (N=426) 7 *1.64 3 *0.70 4 *0.94 4 8 
·Truncal slump (N=299) 10 *3.34 7 *2.34 3 * 1.00 12 24 
• Age-dependent variables. * Percentage calculated according to N in brackets. 
Clinical signs with more than 5% of their observations not reported were: i) 
resistance to venesection, and ii) the ability of the patient to roll over. Both 
were used to assess weakness in patients. Data were not available since 
most patients had venesection before admission to the Unit and many 
patients were unwilling to roll over. For plasma sodium, patients' history of 
irritability for the current episode of diarrhoea was not reported in 25.9% of 
the patients. This was due to investigator error as a result of incorrect coding 
of questionnaires (Tables 4.8 and 4.9). 
4.5.3 Reliability 
There was substantial agreement between clinician pairs' in the assessment 
of the following clinical signs: abdominal distension (weighted Kappa score 
0.70; 95% CI 0.49 to 0.91); ability to sit (weighed Kappa score 1.0; 95% CI 
1.0 to 1.0); and to stand (weighed Kappa score 0.72; 95% CI 0.44 to 0.99). 
Clinicians had no agreement as to whether there was a wooden feel to the 
patients' skin (weighed Kappa score -0.02; 95%CI -1.24 to 1.21). All 
reliability assessments had broad confidence intervals (Tables 4.10 and 
4.11). Contingency tables of raw data are presented in Appendix 4.5. 
4.5.4 Diagnostic accuracy 
4.5.4. 1 Multi-level responses 
Summaries of measures of diagnostic accuracy are shown in Tables 4.10 
and 4.11 and contingency tables of the raw data in Appendices 4.6 to 4.10. 
None of the clinical signs showed clear clinical usefulness (LR greater than 5 
or less than 0.20). Signs showing limited clinical meaningfulness (LR 
between 2 and 5 or 0.2 and 0.5) for plasma sodium and potassium 
abnormalities were: the presence of an ileus (LR 3.08; 95% CI 0.64 to 14.87) 
in hypokalaemic patients; the inability of a patient to sit (LR 2.15; 95% CI 
1.12 to 4.13); lack of resistance during venesection (LR 3.22; 95% CI 1.48 to 
100 
7.00) and the presence of a truncal slump (LR 2.89; 95% CI 1.75 to 4.76) in 
severely hypokalaemic patients; and a wooden feel to the skin (LR 2.44; 95% 
CI 1.14 to 5.21) in hyponatraemic patients. Even though a depressed level of 
consciousness showed some association with hypernatraemia (LR 2.22; 95% 
CI 0.93 to 5.30) and hyponatraemia (LR 4.33; 95% CI 0.46 to 40.37), there 
was no gradient in LRs across the different levels of response. Poor 
peripheral perfusion was associated with: severe hypokalaemia (LR 3.11; 
95% CI 1.18 to 5.16; n=512); severe hypernatraemia (LR 2.94; 95% CI 1.41 
to 6.13; n=515); and hypernatraemia (LR 2.07; 95% CI 1.04 to 4.13, n=515. 
Ten percent dehydration on admission was associated with severe 
hypokalaemia (LR 2.13; 95% CI 1.07 to 4.25; n=519) and severe 
hypernatraemia (LR 2.00; 95% CI 0.46 to 8.68, n=522). 
Good hydration showed some association with the absence of severe 
hypokalaemia (LR 0.40; 95% CI 0.17 to 0.90). 
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Table 4.10 Likelihood ratios and observer agreement (weighted Kappa) for clinical signs associated with sodium 
disturbances 
Signs (n) Severe hypernatraemia Hypernatraemia Hyponatraemia Weighted Kappa; 
(sodium> 158 mmolJ]) (sodium> 150 mmol/l) (sodium <135 mmolJ]) [95%CII 
LR 95% CI LR 95% CI LR 95% CI 
Level of consciousness (472) 0.66; [0.43 to 0.90] 
(Glasgow Coma Score) 
<8 * *Undefined * *Undefined 4.33 0.46 to 40.37 
8 < 12 1.74 0.46 to 6.58 2.22 0.93 to 5.30 0.49 0.24 to 1.01 
.....lo. 
0 >12 1.01 1.00 to 1.02 1.01 1.00 to 1.02 0.99 0.97 to 1.00 N 
Resists procedure (430) -0.13; [-1.35 to 1.09] 
Present 0.96 0.78tol.18 0.97 0.86 to 1.11 0.97 0.92 to 1.03 
Uncertain 1.75 0.63 to 4.86 1.35 0.59t03.12 0.84 0.51 to 1.38 
Absent 1.57 0.24 to 10.53 1.38 0.35 to 5.51 1.43 0.66 to 3.10 
Kicks away (470) 0.52; [0.06 to 0.97] 
Present 0.92 0.69 to 1.24 0.86 0.67 to 1.10 0.98 0.90 to 1.07 
Uncertain 1.01 0.27 to 3.75 1.52 0.71 to 3.24 0.90 0.56 to 1.46 
Absent 1.38 0.50 to 3.82 1.73 0.89 to 3.38 1.09 0.71 to 1.68 
*Unable to calculate as the denominator was zero and the likelihood ratios approached infinity. 
Table 4.10 (continued) Likelihood ratios and observer agreement (weighted Kappa) for clinical signs 
associated with sodium disturbances 
Signs (n) Severe hypernatraemia Hypernatraemia Hyponatraemia Weighted Kappa; 
(sodium> 158 mmolll) (sodium >150 mmolll) (sodium <135 mmolll) [95%CII 
LR 95% CI LR 95% CI LR 95%CI 
Pushes away (470) 0.50; [0 .04 to 0.96] 
Present 0.85 0.60 to 1.23 0.73 0.53 to 0.99 1.04 0.96 to 1.29 
Uncertain 1.66 0.70 to 3 .95 1.24 0.59 to 2 .62 0.82 0.54 to 1.27 
Absent 1.83 0 .68 to 4 .94 2 .71 1.53 to 4.83 0.79 0.49 to 1.29 
Li fts head from bed (469) 0.64 ; [0.29 to 1.00] 
Present 0.50 0.23 to 1.09 0.52 0.32 to 0.85 1.10 0 .98 to 1.24 
........ 
0 Uncertain 2.69 1.1 J to 6.51 1.61 0.69 to 3.76 0.74 0.42 to 1.31 w 
Absent 2.32 1.45 to 3.73 2.35 1.67 to 3.33 0.78 0.56 to 1.08 
Sits unsupported (298) 1.0; [1.0 to 1.0] 
Present 1.13 1.09 to 1.18 0.64 0.34 to 1.2\ 1.04 0.95tol . 13 
Uncertain * *Undefined * *Undefined 0.32 0.09 to 1.14 
Absent * *Undefined 3.97 1.58 to 9.96 0.75 0.39 to 1.44 
Rolls over (232) 0.27 ; [-0.30 to 0.85] 
Present 1.22 *Undefined 0.81 0.37 to 1.79 0.93 0 .82 to 1.05 
Uncertain * *Undefined 2.04 0.36 to 11.51 1.09 0.55to2.16 
Absent * *Undefined 1.90 0 .37 to 9.71 1.4 1 0 .77 to 2.60 




Table 4.10 (continued) Likelihood ratios and observer agreement (weighted kappa) for clinical signs associated with 
sodium disturbances 
Signs (n) Severe Hypernatraemia Hypernatraemia Hyponatraemia Weighted Kappa; 
(sodium> 158mmolll) (sodium> 150mmolll) (sodium <135mmolll) [95%CI] 
LR 95% CI LR 95% CI LR 95% CI 
Stands ( 180) 0.72; [OA4 to 0.99] 
Present 1.39 *Undefined 0.69 0.26 to 1.83 088 0.72 to 1.06 
Uncertain * *Undefined * *Undefined 1.52 0.64 to 3.63 
Absent * *Undefined 1.81 0.66 to 4.99 IA2 0.85 to 2.38 
Wooden feel to skin (472) -0.02; [-1.24 to 1.21] 
Present IA5 0.22 to 9.65 1.95 0.63 to 6.04 2A4 1.14to5.21 
Uncertain 4.15 IAOto 12.37 1.94 0.61 to 6.13 1.02 OA7 to 2.21 
Absent 0.97 0.82 to 1.16 0.94 0.83 to 1.08 0.94 0.90 to 1.00 
Biceps, tendon reflexes (456) 0.21; [-0.26 to 0.68] 
Brisk IA5 0.60 to 3.52 1.43 0.70 to 2.93 0.78 OA4 to 1.37 
Normal 0.70 OA1 to I. 18 0.82 0.60 to 1.11 1.07 0.95 to 1.20 
Reduced 0.81 OA2 to 1.56 0.82 0.50 to 1.35 1.11 0.89 to 1.39 




Table 4.10 (continued) Likelihood ratios and observer agreement (weighted kappa) for clinical signs associated with 
sodium disturbances 
Signs (0) Severe hypernatraemia Hypernatraemia Hyponatraemia Weighted Kappa; 
(sodium> 158mmolf) (sodium >150mmolf) (sodium <135mmolf) [95%CI] 
LR 95% CI LR 95% CI LR 95% CI 
Knee, tendon reflexes (458) 0.37; [0.03 to 0.70] 
Brisk 1.34 0.75 to 2.40 1.55 1.08 to 2.24 0.72 0.50 to 1.03 
Normal 0.87 0.55 to 1.37 0.86 0.62 to 1.20 1.11 0.97 to 1.27 
Reduced 0.66 0.21 to 2.08 0.48 0.18 to 1.30 1.36 1.00 to 1.85 
Peripheral petfusion (515) 
Poor 2.94 1.41 to 6.13 2.07 1.04 to 4.13 1.61 0.95 to 2.75 
Fair 0.63 0.27 to 1.50 0.80 0.48 to 1.33 1.61 1.29 to 2.0 I 
Good 0.71 0.46 to 1.09 0.84 0.66 to 1.07 0.92 0.82 to 1.02 
Degree of dehydration (522) 
~lO% 2.00 0.46 to 8.68 1.90 0.58 to 6.13 1.28 0.45 to 3.6 
5% 1.50 1.01 to 2.22 1.27 0.87 to 1.84 1.10 0.85 to 1.4 
Potentially dehydrated * *Undefined 0.37 0.02 to 6.37 0.78 0.42 to 1.4 
Good * *Undefined 0.26 o to 34530.3 0.77 0.11 to 5.16 




Table 4.10 (continued) Likelihood ratios for clinical signs associated with sodium disturbances 
Signs (n) 
±History of irritability for current episode of diarrhoea (352) 
Yes 
No 





LR 95% CI 
1.3 I 1.11 to 1.56 
0.26 0.04 to 1.71 
* *Undefined 
1.07 1.04 to 1.09 
± 
Weighted Kappa was not calculated for clinical assessments reported from patient's history. 
*Unable to calculate as the denominator was zero and the likelihood ratio's approached infinity 
Hypernatraemia 
(sodium> 150m mol/l) 
LR 95% CI 
1.18 0.96 to 1.43 
0.58 0.24 to 1.44 
1.09 0.28 to 4.33 
0.99 0.90 to 1.09 
Hyponatraemia 
(sodium <135mmol/l) 
LR 95% CI 
0.78 0.67 to 0.92 
1.72 1.25 to 2.38 
0.62 0.28 to 1.36 




Table 4.11 Likelihood ratios and observer agreement (weighted Kappa) for clinical signs associated with potassium 
disturbances 
Signs (n) Severe hypokalaemia Hypokalaemia Weighted Kappa 
(potassium <2.5 mmolll) (potassium <3.5 mmolll) [95%CI] 
LR 95% CI LR 95% CI 
Level of consciousness 0.66 [0.43 to 0.90] 
(Glasgow Coma Score) (468) 
<8 *Undefined *Undefined *Undefined *Undefined 
8 ::::.)2 1.41 0.69 to 2.87 1.00 0.54 to 1.85 
>12 0.95 0.90 to 1.00 1.02 1.00 to 1.04 
Lies in a frog's legs position (465) 0.33; [-0.33 to 1.00] 
Present 1.68 1.01 to 2.79 1.27 0.79 to 2.01 
Uncertain 1.56 0.92 to 2.63 1.30 0.81 to2.10 
Absent 0.90 0.79 to 1.02 0.96 0.88 to 1.04 
Marked headlag (419) 0.65, [0.35 to 0.95] 
Present 1.99 1.48 to 2.66 1.36 0.99 to 1.85 
Uncertain 1.06 0.62 to 1.82 1.39 0.88to2.19 
Absent 0.65 0.50 to 0.84 0.87 0.76 to 1.00 
Truncal slump (289) 0.49; [- 0.21 to 1.18] 
Present 2.89 1.75 to 4.76 1.32 0.77 to 2.27 
Uncertain 1.31 0.73 to 2.36 1.45 0.81 to 2.59 
Absent 0.72 0.59 to 0.89 0.94 0.84 to 1.06 




Table 4.11 (continued) Likelihood ratios and observer agreement (weighted Kappa) for clinical signs associated with 
potassium disturbances 
Signs (0) Severe hypokalaemia Hypokalaemia Weighted Kappa 
(potassium <2.5 mmolll) (potassium <3.5 mmolll) [95%CII 
LR 95% CI LR 95% CI 
Resists procedure (427) -0 . 13; [-1.35 to 1.09] 
Present 0.89 0.79 to 0.99 0.96 0.9 J to 1.02 
Uncertain 2.35 1.45 to 3.85 l.49 0.91 to 2.43 
Absent 3.22 1.48 to 7.00 l.73 0.78 to 3.86 
Kicks away (466) 0. 52 [0.06 to 0.97] 
Present 0.83 0.71 to 0.97 0.93 0.85 to 1.0 I 
Uncertain 2.02 l.25 to 3.26 1.04 0.65 to 1.65 
Absent l.98 1.26t03.11 1.44 0.93 to 2.23 
Pushes away (466) 0.50 [0 .04 to 0.96] 
Presel7t 0.84 0.72 to 0.98 0.98 0.91 to 1.07 
Uncertain 2.20 1.46 to 3.33 1.36 0.90 to 2.07 
Absent 2.10 1.28 to 3.45 1.09 0.68 to 1.74 
Lifts head from bed (465) 0.64 [0.29 to 1.00] 
Present 0.77 0.63 to 0.95 1.00 0.89 to \. 13 
Uncertain 1.39 0.76 to 2.55 1.03 0.61 to 1.75 
Absent 1.66 1.21 to 2.29 0.99 0.73 to 1.34 
Table 4.11 (continued) Likelihood ratios and observer agreement (weighted Kappa) for clinical signs associated with 
potassium disturbances 
Signs (n) Severe bypokalaemia Hypokalaemia Weighted Kappa 
(potassium <2.5 mmolll) (potassium <3.5 mmolll) [95%CI] 
LR 95%CI LR 95% CI 
Sits unsupported (295) 1.0; [1.0 to 1 .0] 
Present 0.89 0.79 to 1.00 1.00 0.92 to 1.09 
Uncertain 0.95 0.27 to 3.34 1.19 0.40 to 3.56 
Absent 2.15 1.12 to 4.13 0.97 0.50 to 1.86 
.....lo. 
Rolls over (231) 0.27 [-0.30 to 0.85] 
0 Present 0.94 0.79 to 1.11 1.02 0.90 to 1.17 
CD 
Uncertain 1.28 0.60 to 2.72 1.40 0.68 to 2.88 
Absent l.29 0.68 to 2.46 0.91 0.51 to 1.63 
Stands (180) 0.72; [0.44 to 0.99] 
Present 0.78 0.58 to 1.04 0.82 0.68 to 0.99 
Uncertain 2.06 0.90 to 4.71 3.44 1.05 to 11.3 1 
Absent 1.67 1.02 to 2.73 1.74 0.99 to 3.04 
Ileus (467) 0.48; [-0.003 to 0.97] 
Present 1.52 0.32 t07.29 3.08 0.64 to14.87 
Uncertain 2.15 1.00 to 4.63 1.46 0.69 to 3.08 
Absent 0.99 0.95 to 1.03 0.98 0.96 to 1.01 
Table 4.11 (continued) Likelihood ratios and observer agreement (weighted Kappa) for clinical signs associated with 
potassium disturbances 
Signs (n) 














(potassium <2.5 mmol/l) 











0.77 to 2.67 
1.02 to 3.46 
0.86 to 1.05 
1.88 to 5.16 
1.16 to 1.84 
055 to 0.90 
1.07 to 4.25 
0.98 to 1.324 
0.39 to 0.67 
0.17toO.90 
Hypokalaemia 
(potassium <3.5 mmolll) 











0.92 to 2.73 
1. 12to3 .82 
088 to 1.01 
0.89 to 2.58 
1.12to1.78 
0.85 to 1.02 
0.53 to 5.07 
0.93 to 1.60 
0.3 5 to 1. 15 
0.08 to 3.81 
Weighted Kappa 
195%CII 
0.70; [0.49 to 0.91] 
4.5.4.2 Binary responses 
Sensitivity and specificity were calculated for signs with a binary response, 
namely, i) irritability (history of crying during the current episode of diarrhoea) 
for increased levels of plasma sodium, and ii) history of seizures in the last 
24 hours prior to admission to the Rehydration Unit for increased and 
decreased levels of plasma sodium. Irritability was sensitive for severe 
hypernatraemia (92% sensitive) but not specific (30% specific). The same 
was noted for hyponatraemia (60% sensitive, 23% specific). History of 
seizures was more specific than sensitive in patients with plasma sodium 
disturbances: hyponatraemia (4% sensitivity, 93% specific), hypernatraemia 
(6% sensitivity, 94% specific) and severe hypernatraemia (94% specific, 
unable to assess sensitivity as no severely hypernatraemic patients had 
seizures) (Table 4.12). 
Both irritability and seizures had large negative predictive values for severe 
hypernatraemia (99% and 97% respectively), and hypernatraemia (96% and 
93% respectively). Negative predictive values for hyponatraemia were 51 % 
with irritability and 60% with seizures (Table 4.12). 
4.5.4.3 Logistic regression analysis 
Logistic regression analysis was not performed as none of the clinical signs 
showed statistical significance and clinical meaningfulness (LR >5 or <0.2). 
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Table 4.12 Measures of diagnostic accuracy of binary responses for abnormal sodium levels 
History of irritability for current episode of diarrhoea 
Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) 
Severe hypernatraemia (sodium> 158 mmol/I) 92 30 5 99 
95% Cl 64.0 to 99.8 24.9 to 34.7 2.5 to 8.2 94.7 to 100 
Hypernatraemia (sodium> 150 mmol/I) 83 30 8 96 




Hyponatraemia (sodium <135 mmol/I) 60 23 30 51 
95% Cl 51.8 to 68.9 17.5 to 28.5 24.7 to 36.1 41.3 to 60.7 
Table 4.12 (continued) Measures of diagnostic accuracy of binary responses for abnormal sodium levels 
History of seizures in the last 24 hours pre-admission 
Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) 
Severe hypernatraemia (sodium> 158 mmol/J) 0 94 0 97 
95% CI o to 21.8 91.2 to 95.9 o to 12.3 94.5 to 98.1 
Hypernatraemia (sodium> 150 mmol/l) 6 94 7 93 
-->. 
95% CI 0.79to21.4 91.5 to 96.1 0.87 to 23.5 90.7 to 95.6 
-->. 
(.oJ 
Hyponatraemia (sodium <135 mmol/l) 4 93 29 60 
95% cr 1.9 to 8.3 89.4 to 95.7 13.2to48.7 55.5 to 64.6 
4.6 Discussion 
4.6.1 Interpretation of the principal findings 
In general, clinical signs were neither useful nor reliable in actual practice at 
any pre-specified cut-off level. Some of the signs were unhelpful because 
they could not easily be performed, both in the study of reliability and of 
diagnostic accuracy (Table 4.8 and 4.9). Examples of these were: i) 
assessing the patient's ability to rollover and/or sit and/or stand; ii) whether 
the patient had a truncal slump; and iii) assessment of the tendon reflexes. 
The practical application of these signs was difficult. Reliability of the signs 
was most often low and probably contributed to the poor diagnostic accuracy 
(Bossuytetal., 2003). 
4.6.1.1 Reliability of the clinical signs 
Signs that were shown to be reliable in clinical practice were ability to sit 
(100% agreement), stand (72% agreement) and abdominal distension (70% 
agreement). The 95% confidence intervals for these estimates were broad, 
making interpretation difficult. For example, clinician pairs could have 
anything between 49% to 91 % agreement as to whether a patient's abdomen 
was distended. An anomaly observed in the reliability study was that 
clinicians were in complete agreement about whether a patient could sit 
(weighed Kappa score 1; 95% CI 1 to 1). This sign was not assessed in 24% 
of the patients (Table 4.8 and 4.9) and may therefore be spurious; it should 
be interpreted with caution. Even though a wooden feel to the skin is stated 
in literature (Rudzinski et aI., 1996:342) to indicate hypernatraemia, this study 
showed that the reliability of this sign (-0.02%; 95%CI -1.24 to 1.21) was 
extremely poor (no agreement between medical officers). 
The setting for the reliability study could mean that the generally poor 
agreement is actually an overestimate of that in actual clinical practice. Two 
of the three doctors in the reliability study had been part of the study of 
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diagnostic accuracy and were thus familiar with the study protocol. The third 
doctor was currently involved in research and understood the importance of 
accurately reporting the clinical signs. She had also recently worked in the 
Rehydration Unit. All three doctors performed clinical assessments in their 
free time (with no other competing responsibilities) and were compensated 
financially for their assistance. They were thus provided with an incentive to 
perform the assessments to the best of their ability resulting in an improved 
accuracy of the findings. 
Although operational definitions for signs were given when thought 
appropriate, no training was provided in eliciting the signs. These findings 
represent actual practice in a well-resourced teaching hospital in a middle-
income country and reliability is unlikely to be better in actual practice 
elsewhere, where larger case loads could reduce reliability. This low reliability 
is expected to compromise diagnostic accuracy. 
4.6.1.2 Diagnostic accuracy of clinical signs 
The findings on the diagnostic accuracy of the clinical signs need to be 
interpreted in the light of the reliability of the signs reported in section 4.6.1.1. 
None of the clinical signs had LRs that were greater than 5 or less than 0.2. 
Even when LRs were estimated potentially clinically meaningful (LR between 
2 and 5 or 0.2 and 0.5), there was often no gradient with different levels of 
response. That is, there was no progression in the size of the LR from 
negative to equivocal to positive. An example of this is a wooden feel to the 
skin in severely hypernatraemic patients: the presence of a wooden feel to 
the skin had an LR of 1.45 and the absence of the sign an LR of 0.97, while 
the equivocal level had an LR of 4.15. This probably reflects low statistical 
power and caution should be used when interpreting such findings since they 
could be due to chance. 
The lack of statistical power is also illustrated in the wide 95% confidence 
intervals for some of the signs. Even though the presence of an ileus showed 
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some association with patients that were hypokalaemic (LR 3.08; 95% CI 
0.64 to 14.87), the 95% confidence intervals were broad, indicating that the 
result could be due to chance. This was also true for the association between 
10% dehydration on admission and severe hypernatraemia (LR 2.00; 95% CI 
0.46 to 8.68, n=522). In these cases, however, the broad 95% confidence 
intervals are partly due to the low prevalence of the sign (ileus; 1.7%) or of 
the target condition (severe hypernatraemia; 3.2%). 
Even when signs showed a statistically significant or more precise estimate, 
association with the target condition was not clinically meaningful. This was 
the case for the associations of a patient's inability to sit (LR 2.15; 95% CI 
1.12 to 4.13) with severe hypokalaemia; poor peripheral perfusion with 
severe hypokalaemia (LR 3.11; 95% CI 1.88 to 5.16; n=512), severe 
hypernatraemia (LR 2.94; 95% CI 1.41 to 6.13; n=515) and hypernatraemia 
(LR 2.07; 95% CI 1.04 to 4.13; n=515); and being 10% dehydrated on 
admission with severe hypokalaemia (LR 2.13; 95% CI 1.07 to 4.25; n=519). 
For example, poor peripheral perfusion showed a statistically significant 
relationship with severe hypokalaemia and had a relatively high LR. 
However, the probability of severe hypokalaemia in the sample as a whole 
was 18.9%, in those with poor peripheral perfusion 42.2%, in those with 
equivocal perfusion 25.4% and in those with good perfusion 14.2%. Thus 
peripheral perfusion has limited usefulness in distinguishing severely 
hypokalaemic children from other children. Similarly, poor peripheral 
perfusion had an LR of 2.94 for severe hypernatraemia, which had a 
prevalence of 3.2% in the sample as a whole, meaning that only 8.8% of the 
patients that had poor peripheral perfusion and about 2.2% of the patients 
that had good peripheral perfusion were actually severely hypernatraemic. 
These examples illustrate the limited clinical usefulness of peripheral 
perfusion as a sign to distinguish i) patients with plasma sodium disturbances 
from those that are normal, ii) patients with plasma potassium disturbances 
from those that are normal, and iii) patients with plasma sodium and 
potassium disturbances from each other in children with diarrhoea in the 
study setting. 
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The absence of dehydration showed some clinical association with severe 
hypokalaemia (LR 0.40; n=519). With an overall prevalence of 18.9% in this 
sample, the presence of good hydration would therefore lower the probability 
of severe hypokalaemia to 8.5%. If it is judged acceptable to miss severe 
hypokalaernia in 8.5% of cases, good hydration could be regarded as a 
useful sign of severe hypokalaemia at this prevalence. However, this finding 
has limited usefulness in a ward designed for children who are not well 
hydrated. 
History of irritability for the current episode of diarrhoea (with a binary 
response) had a high sensitivity (92%) for severe hypernatraemia, but a low 
specificity (30%). Absence of irritability thus makes severe hypernatraemia 
unlikely (negative predictive value in the sample 99%), but the presence of 
irritability has a poor positive predictive value (5%) because of the low 
spe~ificity of the test and the low prevalence of severe hypernatraemia 
(3.2%) in the current study. 
In contrast, a history of seizures within 24 hours prior to admission had a high 
specificity (94%) for hypernatraemia, but a low sensitivity (6%). Absence of 
seizures thus makes severe hypernatraemia unlikely (negative predictive 
value in the sample 93%), but the presence of seizures has a poor positive 
predictive value (7%), this time because of the low sensitivity of the test and 
the low prevalence of hypernatraemia (6.5%). 
Interestingly, the low prevalence of hypernatraemia in the current study 
results in low positive predictive values and high negative predictive values 
for both tests, with markedly contrasting sensitivities and specificities. This 
illustrates the importance of prevalence of the target condition in interpreting 
the test results. As the prevalence of the condition decreases, so does the 
positive predictive value. Due to the low prevalence of most target conditions 
in the current study (except hyponatraemia and hypokalaemia), positive 
predictive values were generally low. For example, as tests for 
hypernatraemia, the positive predictive value for irritability was 8% and for 
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history of seizures 7%. This implies the need for 13 and 14 confirmatory tests 
respectively in order to correctly identify one case of hypernatraemia in the 
study setting compared to 15 tests, if testing was performed routinely on all 
admissions. Use of the clinical signs to marginally reduce the number of tests 
to detect one abnormality would be counter-balanced by missing some cases 
of hypernatraemia. In the case of history of seizures, 94% of all cases would 
be missed (sensitivity of 6%). These examples illustrate the principle that, 
unless very accurate, diagnostic tests are of limited usefulness for conditions 
of low prevalence (Sackett et al., 1991 :91). 
The low prevalence of the severe electrolyte disturbances thus has two 
important implications for the interpretation of the findings. Firstly, there is 
uncertainty around the point estimates of accuracy (wide 95% CI), because 
of low statistical power. Secondly, taking this uncertainty into account, none 
of the clinical signs appear sufficiently accurate to be useful in these 
conditions of very low prevalence. For example, the higher upper 95% CI for 
the estimate of the LR for a positive test for a wooden feel to the skin for 
severe hypernatraemia was 9.7. The presence of a wooden feel to the skin, 
with this LR, would increase the probability of severe hypernatraemia to only 
24.3%. 
4.6.2 Comparison with past studies 
Even though no studies were identified that explicitly studied the diagnostic 
accuracy of clinical signs for plasma sodium and potassium disturbances, 
data were extracted from two reports (Hill et al., 1981 and Tjon A Ten, 1999), 
and measures of diagnostic accuracy were calculated (see section 4.1.1). 
The estimates calculated from data extracted from Hill et al. (1981) showed a 
statistically significant, clinically meaningful association with hypernatraemia 
for coma/convulsions/drowsy (LR 7.77; 95% CI 1.98 to 30.48; specificity 
96%, sensitivity 31 %, positive predictive value 95%, negative predictive value 
35%) (Table 4.1). Being jittery was 100% specific, with a positive predictive 
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value of 100% for hypernatraemia. Comparison of these estimates and the 
current research is difficult since no description of how signs were defined 
and/or elicited was reported and no signs appeared directly comparable. 
However, the accuracy of coma/convulsions/drowsy appears to be 
significantly better than for level of consciousness reported in the current 
study. Elements of study design in the Hill et al. (1981) study could have 
introduced potential bias, resulting in an overestimate in the findings. These 
elements have been reported in section 4.1.1 and can be summarised as 
selection bias, spectrum bias and test review bias (see glossary). The current 
study has been designed to eliminate these potential sources of bias, and 
this is reported under the "strengths of the research" (section 4.6.4). 
Calculations based on data extracted from the study performed by Tjon A 
Ten (1999) are likely to over-estimate accuracy because of the considerable 
assumption that all (presumably less dehydrated) cases without serum 
sodium measurements had a normal serum sodium levels. Despite this, the 
LR calculated from extracted data indicated that it was not clinically 
meaningful (LR 4.30, 95% CI 1.07 to 17.30) (Table 4.2). Comparison 
between Tjon A Ten (1999) and the current study is difficult as different 
definitions were used for dehydration and different spectra of patients were 
assessed in both studies, as mentioned in section 4.1.1. Again, Tjon A Ten's 
(1999) findings have limited applicability to the current study setting, since 
their study was conducted in the developed world (Holland), where the 
prevalence of sodium disturbances were lower (a 3% prevalence of 
hypernatraernia over a period of five years in Holland compared to 6.5% over 
a period of one year in the current study). Also, unclear reporting of the study 
methodology made appraisal of the validity of the findings difficult for Tjon A 
Ten's (1999) study and broad 95% confidence intervals implied that the 
finding could be due to chance. 
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4.6.3 Generalisability of the findings 
Although operational definitions for signs were given when thought 
appropriate, no training was provided in eliciting the signs. The findings thus 
represent actual practice in a well-resourced teaching hospital in a rniddle-
income country and accuracy is unlikely to be better in actual practice 
elsewhere in low- and middle-income countries. 
The estimates of sensitivity, specificity and the LRs are likely to be applicable 
to similar groups of children, but estimates of predictive values are limited to 
a setting with the same prevalence of plasma sodium and potassium 
disturbances as in the current study. 
4.6.4 Strengths of the research 
The sample of patients in this study is broadly representative of children 
admitted to diarrhoeal rehydration units in metropolitan Cape Town. This not 
only increases the generalisability of the findings but also provided a clinically 
meaningful spectrum of patients (that is, children were not selected by the 
presence or absence of the plasma sodium and potassium disturbances, 
demographic features and co-morbidities), thus minimising spectrum bias 
(see glossary). 
A prospective, consecutive sample (during specified hours) of .patients was 
enrolled into the study, reducing selection bias (see glossary), 
Laboratory testing of plasma sodium and potassium levels (reference 
standard) were not done on the basis of the presence or absence of clinical 
signs, and vice versa, minimising verification bias (see glossary). 
In both the reliability study and the study of diagnostic accuracy, all clinical 
assessments were performed with the medical officers blinded to the plasma 
sodium and potassium levels of the patient. This reduced the possibility of 
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test review bias (see glossary) that distorts (over-estimates) the measures of 
diagnostic accuracy of the clinical sign because of knowledge of the result of 
the reference standard. Also, in the reliability study, the medical officers were 
unaware of their colleague's assessment of the clinical signs. 
The assessments of clinical signs were done by a wide range of medical 
officers (56) in actual practice, making the results a reasonable reflection of 
current practice in a teaching hospital in a middle-income country. However, 
many medical officers were junior doctors in competition for longer-term 
employment at Red Cross Children's Hospital and may have performed their 
jobs with greater vigilance and care than average. This could have resulted in 
an over-estimation of accuracy in other settings in low-and middle-income 
countries. 
4.6.5 Limitations of the research 
Because of the shortfall in numbers targeted for enrolment, the findings could 
be limited by lack of power to detect meaningful diagnostic accuracy for less 
prevalent conditions, for example; hypernatraemia, severe hypernatraemia 
and severe hypokalaemia. The lack of evidence of diagnostic accuracy thus 
does not necessarily constitute evidence of lack of accuracy. The consistent 
pattern of low accuracy across all tests, however, provides an additional 
indication of unhelpful accuracy. 
Lack of statistical power was most evident for conditions of low prevalence. 
Because diagnostic test results are clinically less meaningful at low 
prevalence of the target condition (Sackett et aI., 1991 :91), tests for these 
conditions appear likely to be of limjted value, even if their accuracy was 
substantially higher than expected. The lack of meaningful clinical 
association (even though there is some association) between severely 
hypokalaemic patients and the age-dependent signs of sitting (n=295) and/or 
a truncal slump (n=289) could be a result of the small sample available for 
analysis; even so, the 95% CI were all below 5 and were narrow. 
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The current study was of clinical signs as elicited in actual practice. The 
possibility that accuracy could be improved by careful operational definitions 
and training in the detection of the signs was not addressed by this study. 
4.6.6 Implications for practice 
No clinical signs (as defined in the study) were identified that were clinically 
useful in actual practice. Although meaningful diagnostic accuracy has not 
been excluded for all signs examined, none appear likely to be useful at the 
low prevalence of severe abnormalities in children with diarrhoea. 
The 'negative' findings in this study of the poor diagnostic accuracy of 
commonly used clinical signs further add to the importance of the findings, in 
that many of the signs assessed are currently, thOUgh misleading, used in 
everyday practice. 
Considerable caution should thus be used when interpreting these clinical 
signs. False positive signs will carry the potentially harmful effects and 
expense of unnecessary treatment or transfer of patients. False negative 
signs will result in the potentially harmful effects of the disorders not being 
treated. 
Unless the accuracy of the signs can be improved by clearer definition and/or 
training (see Section 4.6.7), alternative approaches to reliance on clinical 
signs may need to be considered. In settings where resources permit, routine 
electrolyte testing of children admitted to hospital with diarrhoea may need to 
be considered. Where resources do not permit, adjustment of standard 
clinical procedures, such as the use of more supplemental oral potassium for 
all admitted patients, needs consideration, taking the specific conditions of 
each setting into account. 
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4.6.7 Implications for research 
It is possible that clearer definitions of clinical signs could improve the 
reliability and validity of these signs. A study incorporating these features 
would be required to demonstrate this. 
Alternatively, strategies to avoid reliance on clinical testing need to be 
investigated. These could include routine electrolyte testing of children 
admitted to hospital with diarrhoea (see Study 3 in Chapter 5), or the use of 
more supplemental oral potassium for all admitted patients. 
4.7 Conclusion 
This is the first systematic study of the diagnostic accuracy of clinical signs of 
plasma sodium and potassium disturbances in children with diarrhoea. The 
clinical signs assessed were neither useful nor reliable in clinical practice. 
Although there is uncertainty around the estimates of diagnostic accuracy for 
less prevalent conditions like hypernatraemia, severe hypernatraemia and 
severe hypokalaemia because of low statistical power, th~ most optimistic 
plausible levels of accuracy are not clinically meaningful, given the low 
prevalence of the target conditions. The lack of evidence of diagnostic 
accuracy therefore does not necessarily constitute evidence of lack of 
accuracy. 
These findings are based on the elicitation of the signs in usual practice. 
Training of practitioners in how to elicit signs could increase the reliability and 
accuracy of these signs. 
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CHAPTER FIVE: THERAPEUTIC IMPACT OF ROUTINE 
ELECTROLYTE MEASUREMENTS ON MANAGEMENT OF 
ABNORMAL PLASMA SODIUM AND POTASSIUM LEVELS IN 
CHILDHOOD DIARRHOEA 
5.1 Background 
Routine electrolyte testing of children with dehydrating diarrhoea is usually 
not possible in settings where diarrhoea is more prevalent, due to the lack of 
testing facilities. However, when facilities to perform such testing are 
available, electrolytes are liberally tested. Ninety percent of the children being 
admitted to the Rehydration Unit at Red Cross Children's Hospital have their 
electrolytes tested on admission (Swingler, G. 2005. Personal 
Communication. 17 March, Institute of Child Health, Cape Town), and routine 
testing for inpatients is implied by the Standard Treatment Guidelines of the 
Essential Drugs Programme for hospital level paediatrics in South Africa 
(Essential Drugs Programme South Africa, 1998:13, 14). A report prepared 
by the Maryland School of Medicine (USA) also emphasised routine 
electrolyte testing as a part of the physical examination in the management of 
diarrhoea (Woodward & Woodward, 1986). 
The potential benefits of such testing are the detection of otherwise 
undetected and potentially fatal abnormalities, enabling correction of the 
abnormality and prevention of potential morbidjty or death. However, in the 
developing world, where dehydrating diarrhoeal disease is more prevalent, 
few medical facilities have on-site laboratories or even access to any 
laboratory facilities to perform such testing. The costs of electrolyte testing 
include: i) a distressing process for the parent who often has to leave the 
examination room, ii) the discomfort of venesection to the child, and iii) the 
financial costs to the service. The financial costs encompass: i) the costs of 
the tests and materials to perform the tests; ii) the time of the clinician and 
nursing sister required to perform the test; iii) the transport of the blood 
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specimens to the laboratory for analysis, and iv) the time of the laboratory 
technician to determine the blood result and convey that information to the 
clinician either telephonically or via the hospital's central computer data base. 
If the practice does produce benefit, it is important to determine the size of 
the benefit so that the need for the extension of testing facilities can be 
weighed against the costs and competing claims on scarce resources. If 
there is no clinical benefit from such testing, it should be discontinued 
because of the wastage of already limited financial resources (particularly in 
the developing world), the discomfort to the child and the distress to the 
parent. 
5.1.1 Review of the literature for reports on therapeutic impact of 
routine electrolyte testing 
5. 1.1. 1 Identification of relevant studies 
A PubMed search (search strategy reported in Appendix 5.1) was performed 
for the period 1966 to May 2005. Two-hundred studies were identified in the 
search. The abstracts of these studies were screened by the principal 
investigator to identify those that met the criteria of reporting on i) the 
therapeutic impact of ii) routine electrolyte testing when managing iii) children 
with diarrhoea. Twenty-one studies were deemed possibly relevant and full 
reports were obtained, to enable fuller assessment. The reference lists of 
identified studies were also screened for potentially relevant reports. 
5. 1. 1.2 Results of the literature review 
After reading full reports of articles that were potentially eligible for inclusion, 
one study was found that met the inclusion criteria detailed in Section 5.1.1.1. 
This single study (Tjon A Ten, 1999) took place in a hospital in Holland and 
reported on the frequency and management of electrolyte disturbances in 
children with acute diarrhoea admitted to the hospital between January 1992 
and December 1999. A total of 265 patients were enrolled, of whom 8 (3%) 
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had serum sodium levels >150 mmolll, 1 (0.4%) a serum sodium level <130 
mmol/l and 1 a serum potassium level <3.0 mmoili. Sodium abnormalities 
were more common in dehydrated than non-dehydrated children, for 
example, with hypernatraemia 5 (1.9%) were dehydrated and 3 (1.1 %) were 
non-dehydrated and with hyponatraemia 1 (0.4%) was dehydrated and none 
were non-dehydrated. The only potassium abnormality found was in a 
dehydrated patient. The author concluded that measuring electrolytes in 
children with acute diarrhoea was not necessary in all cases, but could be 
useful in dehydrated children. This study also found that when abnormally 
low levels of electrolytes were reported, it seldom led to changes in 
treatment. Only the single case with hypokalaemia had treatment changed 
based on the laboratory results (ibid). The number needed to be tested to 
identify one patient with hypokalaemia was 265 (95% CI -277 to 90). Due to 
the low prevalence of hypokalaemia, this estimate was not statistically 
significant. This study was performed in an industrialised setting where only 
74 (27.9%) of the children were presumably mildly dehydrated and electrolyte 
abnormalities were less prevalent than expected in sicker children, reducing 
the applicability of the findings in settings where dehydrating diarrhoea is 
more prevalent. 
The overall benefit or harm of routine electrolyte testing needs to be 
established in a setting where dehydration and plasma sodium and 
potassium disturbances in children with diarrhoea are more prevalent. 
Clinical benefit would require a change in clinical management as a result of 
routine electrolyte testing. 
5.2 Aim of study 
This study aimed to perform an exploratory assessment of the amount of 
change in clinical management as a result of routine electrolyte testing in 
children admitted to hospital for diarrhoea in a developing country. 
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5.3 Objectives 
To determine the proportion of children with dehydrating diarrhoeal disease 
who are routinely tested for electrolyte abnormalities and in whom i) 
abnormalities are detected and ii) clinical management is changed as a result 
of the abnormalities. 
5.4 Methods 
5.4.1 Inclusion and exclusion criteria 
All patients enrolled in the studies described in Chapters Three and Four 
were included (see sections 3.4.1 and 4.4.1). There were no additional 
inclusion or exclusion criteria for enrolment into this study. Therefore the 
caregivers of all patients between 6 weeks and 2 years of age admitted to the 
Rehydration Unit at Red Cross Children'S Hospital during working hours were 
approached to participate in the study. Patients excluded were those that i) 
had any neurological disorders, for example, cerebral palsy or developmental 
delay; ii) were taking diuretics as part of their treatment regimen on 
admission; or iii) had been residing in the Cape metropolis for less than 1 
month. 
5.4.2 Sampling 
The same sampling technique used to enroll patients in the studies outlined 
in Chapters Three and Four was used. This technique is described in section 
2.3. 
5.4.3 Measurement of outcomes and data collection 
Clinical practice in the Rehydration Unit was specified by a clinical protocol. 
The prescribed management for plasma sodium and potassium abnormalities 
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for the duration of this study is shown in Appendix 5.2. The outcomes for this 
study were thus taken as the management prescribed (in the clinical notes) 
that: i) was consistent with protocol management of electrolyte abnormalities 
on admission of the patient and ii) could feasibly be measured retrospectively 
from the clinical notes (Appendices 5.3 and 5.4). 
The specified management changes investigated in this study were: 
• potassium less than 3.0 mmolll: 
prescribed oral daily dose of potassium above 1.5 g (all ages) in the 
first 24 hours after admission (a higher dose than routinely prescribed 
on admission); 
• potassium less than 2.0 mmolll and less than 1.0 mmolll: 
oral potassium chloride (KCI) as above and intravenous fluid 
containing more than 17 mmol/l of potassium (this is not given if 
potassium ~2 mmol/l). The concentration in the routinely administered 
half dextrose Darrows solution is 17 mmol/l; 
• plasma sodium less than 125 mmolll: 
intravenous fluid containing more than 51 mmolll of plasma sodium 
(the concentration in the routinely administered half dextrose Darrows 
solution is 51 mmol/l); 
• plasma sodium more than 155 mmolll: 
performance of at least one further plasma sodium measurement. 
The principal investigator extracted electrolyte results from routine laboratory 
records (see Appendix 3.2). Management was assessed by exarnination of 
the routine clinical records to identify the pre-specified management changes 
recorded in the file that were consistent with the treatment protocol for the 
electrolyte abnormalities occurring in that patient. The pro forma structure of 
the clinical notes used in the Rehydration Unit facilitated the extraction of 
data (Appendix 5.3). Only treatment procedures recorded in the clinical 
records were included. 
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5.4.4 Analysis 
Methods of estimation rather than hypothesis testing were used for a more 
meaningful analysis of the amount of management change to be expected in 
different settings. The proportion (with 95% CI) of patients in whom 
management was changed was calculated for each electrolyte abnormality 
individually, and also for all electrolyte disturbances combined. The number 
needed to test (see glossary) (with 95% CI) was reported, to give an 
indication of the amount of effort required to identify one patient with the 
target condition of interest in whom management was changed. 
5.5 Results 
A total of 2270 patients with diarrhoea were admitted to the Rehydration Unit 
at Red Cross Children's Hospital from 1 April 2002 to 31 March 2003 (data 
from unpublished routine hospital records). Five hundred and thirty-five 
patients between the ages of 6 weeks and 2 years were enrolled into the 
study (Figure 5.1) for the period 15 April 2002 to 14 April 2003. Of these five 
patients had neither plasma sodium nor plasma potassium levels measured 
on admission and were thus excluded from the study. The median age was 
16.5 months (inter-quartile range 9.7-23.5 months). Two hundred and twelve 
patients (40.0%) had some *co-morbidity. Most of the patients (63.3%) were 
5% dehydrated or more. Other patient characteristics are reported in Table 
5.1. Plasma sodium levels were available for 528 (99.6%) patients and 
plasma potassium for 525 (99.1 %) patients. The proportions of children with 
electrolyte disturbances are shown in Table 5.2. 





Figure 5.1 Profile of enrolment - impact of routine electrolyte measures 
14 refused consent 
7 patient were excluded as plasma 
sodium was not measured 
549 patients meeting inclusion criteria 
535 enrolled into the study 
10 patients were excluded as plasma 
potassium was not measured 
528 patients included in the final analysis for SODIUM 525 patients included in the final analysis for POTASSIUM 
Table 5.1 Characteristics of patients included in the analysis (N=530) 
Nutrition Hydration Peripheral perfusion Gender 
n (%) n (%) n (%) n (%) 
Marasmus/K washiorkor ~ 10% dehydrated Poor Males 
I (0.2) 80 (15.1) 46 (8.7) 289 (54.5) 
Kwashiorkor 5% dehydrated Fair Females 
8 (1.5) 250 (47.2) 191 (36.0) 241 (45.5) 
-->. Marasmus Potentially dehydrated Good w 
-->. 
47 (8.9) 143 (27.0) 280 (52.8) 
Under-weight for age Good hydration 
\42 (26.8) 51 (9.6) 
Normal 
258 (48.7) 
Missing data: Nutrition (74 [14.0%]), hydration (6 [1.1 %]), peripheral perfusion (13 [2.5%]). 
5.5.1 Identification of abnormalities 
Testing identified 55 (10.4%) with abnormal plasma sodium levels, 18 (3.4%) 
of which were below 125 mmol/l, 37 (7.0%) above 150 mmol/l and 23 (4.4%) 
above 155 mmoi/i. One hundred and sixty-six patients (31.6%) had low 
potassium levels; with 40 (7.6%) below 2 mmol/l and 13 (2.5%) below 1.5 
mmolll (Table 5.2). 
Table 5.2 Proportions of patients with electrolyte abnormalities and 
the number needed to test (NNT) in order to detect such an 
abnormality 
Target condition n (%) ofN 95% CI NNT 95%CI 
Plasma sodium < 125 mmolll 18(3.41) [2.03 to 5.33] 29 [20-54] 
Plasma sodium> ISO mmol/l 37 (7.01) [4.90 to 9.50] 14 [I 1-21 ] 
Plasma sodium> 155 mmo]/i 23 (4.36) [2.78 to 6.46] 23 [ 16-38] 
Potassium < 3 mmol/l 166 (31.60) [27.6 to 35.6] 3 [3-4] 
Potassium < 2 mmol/l 40 (7.62) [5.5 to 10.2] 13 [10-19J 
Potassium < J.5 mmol/l 13 (2.48) [1.32t04.19] 40 [26-87] 
N for plasma sodium '" 528; N for plasma potassium = 525. 
Twenty-nine patients needed to be tested to identify one patient with plasma 
sodium below 125 mmolll, and 23 for a plasma sodium level above 155 
mmoi/i. Three to four patients needed testing in order to identify one patient 
with hypokalaemia, 13 patients to identify one patient with a potassium level 
below 2 rnmol/l and 40 to identify one patient with a potassium level below 
1.5 mmoi/i. 
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5.5.2 Change in management as a result of testing 
5.5.2. 1 Plasma sodium abnormalities 
Of the 18 patients with plasma sodium levels below 125 mmol/l, 11 (61.1 %, 
95% CI 35.7% to 82.7%) received increased plasma sodium concentrations 
in intravenous fluids. Forty-eight patients were tested (95% CI 30 to 116) for 
each such management change. Of the 23 patients with plasma sodium 
above 155 mmol/l, 21 (91.3%, 95% CI 72% to 98.9%) had a repeat plasma 
sodium measurement. Twenty-five patients were tested (95% CI 18 to 43) for 
each such management change. 
5.5.2.2 Plasma potassium abnormalities 
Management changes in patients witl1 hypokalaemia are shown in Table 5.3. 
Fifty six percent of patients (95% CI 48.6 to 64.2) with plasma potassium 
levels below 3 mmol/l received additional potassium supplementation, and 
82% (95% CI 66.5 to 92.5) with a level below 2 mmol/l received the required 
intravenous supplementation. The proportion of children receiving additional 
oral supplementation increased with decreasing potassium, as did 
intravenous supplementation. 
Six patients needed to be tested for one patient to receive additional KCI 
orally for potassium levels of <3 mmol/l, 19 patients for a potassium level of 
<2 mmol/l and 44 for potassium levels of <1.5 mmol/l (Table 5.4). Sixteen 
patients needed testing for one to receive intravenous supplementation for a 
plasma potassium level below 2 mmoi/i. 
Two hundred and two patients (38.2%, 95% CI 34% to 42.2%) had either 
abnormal plasma sodium or abnormal plasma potassium or both. Three 
patients were tested (95% CI 2 to 3) for each electrolyte abnormality 
detected. 
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Table 5.3 Management of plasma potassium abnormalities - proportions of adherence to protocol 
Hypokalaemia Severe hypokalaemia 
<3 <2 * <1.5 
% of 95% CI % of 95% CI % of 95%CI 
Oral KCI > 1.5 g per 24 hours 56.4 156 [48 .6 to 64.2] 75 .8 37 [58 .8 to 88.2] 92.3 12 [64 .0 to 99 .8] 
Additional KCI in intravenous fluids 82.1 39 [66.5 to 92.5] 92.3 12 [64 .0 to 99 .8] 
*No patients had a potassium level < 1.0 mmoi/ i. 
Table 5.4 Number needed to test (NNT) to change management of one patient with plasma potassium abnormalities 
Hypokalaemia Severe bypokalaemia 
<3.0 <2.0 <1.5 
NNT 95% CI NNT 95% CI NNT 95% CI 
Oral KCL > 1.5g per 24 hours 6 [5 to 7] 19 [14 to 29] 44 [28 to 99] 
Additional KCL in intravenous fluids 16 [12 to 25] 44 [28 to 99] 
5.5.3 Sensitivity analyses 
Two sensitivity analyses were performed (post hoc) to assess the difference 
that patients enrolled into the study, who were admitted the previous night, 
had on a) the proportion of management of electrolyte abnormalities 
according to protocol; and b) the number of patients that needed to be tested 
to change management the of one patient with an electrolyte abnormality. 
a) Management of electrolyte abnormalities in accordance with protocol 
Three patients had abnormal plasma sodium levels. Of these, one patient 
had a plasma sodium level below 125 mmol/l and received increased plasma 
sodium concentrations in the intravenous fluids. Two patients had plasma 
sodium levels above 155 mmol/l and had a repeat plasma sodium 
measurement. One patient had a plasma potassium level <3 mmol/l and 
received additional potassium supplementation. Exclusion of patients 
admitted after hours resulted in no meaningful changes in the proportion of 
patients that were managed according to protocol (Table 5.5). 
b) Number needed to test to change management of one patient with an 
electrolyte abnormality 
The number needed to test to change management of one patient with either 
a plasma sodium or plasma potassium abnormality was unchanged when 
children admitted after hours were excluded from the analysis (Table 5.6). 
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Table 5.5 Sensitivity analysis excluding patients admitted after hours - management of electrolyte abnormalities 
(proportions of adherence to protocol) 
Patients admitted during the Excluding patients admitted 
day aDd overnight overnight 
% of 95% CI 0/0 of 95% CI 
Plasma sodium <125 mmolll and received additional plasma sodium in intravenous fluids 61.1 18 35.7 to 82.7 58.8 17 32.9 to 81.6 
Plasma sodium> 155 molll and had a repeated plasma sodium measurement 91.3 23 72.0 to 98.9 90.5 21 69.6 to 98.8 
Plasma potassium <3 mmolll and oral KCL> I .5g per 24 hours 56.4 156 48.6 to 64.2 56.1 155 48.3 to 63.9 
Table 5.6 Sensitivity analysis excluding patients admitted after hours - number needed to test (NNT) to change 
management of one patient with electrolyte abnormalities 
Patients admitted during Excluding patients 
the day and overnight admitted overnight 
NNT 95% CI NNT 95% CI 
Plasma sodium <125 mmolll and received additional plasma sodium in intravenous fluids 48 [30 to 116] 48 [3 I to 128] 
Plasma sodium> 155 molll and had a repeated plasma sodium measurement 25 [18 to 43] 25 [18 to 47] 
Plasma potassium <3 mmolll and oral KCL > 1.5g per 24 hours 6 [5 to 7] 6 [5 to 7] 
5.6 Discussion 
5.6.1 Interpretation of the principal findings 
A fairly high propoliion of patients were appropriately managed according to 
the treatment protocols. However, the number of patients that needed to be 
tested for each change in management was high, because of the relatively 
low prevalence of some abnormalities. An example of this is plasma 
potassium levels <1.5 mmol/l, with a prevalence of 2.5% and the number 
needed to test between 40 and 44 patients for any management change. 
This low prevalence also means that confidence intervals around many 
estimates were broad; for example, for potassium <1.5 mmol/l, 95% CI for 
number needed to test for any management change ranged between 29 and 
99 patients. Even larger numbers (48 patients, 95% CI 30 to 116) were 
tested for one management change in the case of hyponatraemia (plasma 
sodium <125 mmol/l). For more prevalent and less severe conditions, for 
example, hypokalaemia (potassium <3 mmolll), fewer patients (3 to 4) 
needed testing to identify one patient and to change management (5 to 7 
patients). 
Although a small number of patients were recruited into the study that were 
admitted overnight, a sensitivity analysis excluding these patients showed 
that inclusion of the patients did not bias the findings (Tables 5.5 and 5.6). 
The current study has established that routine electrolyte testing does result 
in management change. However, the benefits derived from detecting each 
abnormality need to be weighted against the effort and costs involved in 
performing many tests to identify one case of such abnormality. The 
appropriateness of such testing (when available) will depend on the 
prevalence of the target conditions and the balance between the expected 
benefits of testing and the costs thereof, both in terms of the adverse affects 
(for example, the discomfort and risk to the patient) and the use of resources 
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(both material and staff) in a context where there are usually many competing 
priorities. All such judgements depend on assumptions about the benefits 
expected from changes in clinical management and will vary from setting to 
setting. 
5.6.2 Comparison with past studies 
Previous research performed in Holland (Tjon A Ten, 1999) reported that 
when abnormally low levels of electrolytes were identified by routine 
electrolyte tests, it seldom led to change in treatment. In Tjon A Ten's (1999) 
report 8 (3%) of the patients had serum sodium levels >150 mmolll and 1 
(0.4%) had a serum sodium level <130 mmol/l and 1 a serum potassium level 
< 3.0mmol/l. Only the 1 case with hypokalaernia had management changed 
and 265 patients needed to be tested for one such management change to 
occur. The current study had a higher prevalence of hypernatraemia (plasma 
sodium levels >150 mmol/l, 7%), hyponatraemia (plasma sodium levels <125 
mmol/l, 3.4%) and hypokalaemia (potassium levels <3 mmol/l, 31.6%) than 
the Holland study. The patients in the current study were more dehydrated, 
with 62.3% of the patients ~5% dehydrated compared to Tjon A Ten's (1999) 
study where only 27.9% were reported as dehydrated. The higher prevalence 
of electrolyte abnormalities in the current study is to be expected because of 
the greater severity of dehydration in the sample, and the finding of more 
frequent abnormalities in dehydrated patients in Tjon A Ten's (1999) study. 
It is difficult to make a direct comparison between the two studies since a 
different spectrum of patients was studied (children were presumably not as 
sick or malnourished in the Dutch study). Even so, Tjon A Ten's (1999) study 
reported that knowledge of an electrolyte abnormality (obtained by routine 
electrolyte testing) resulted in changed management even though the 
estimate was not statistically significant. 
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5.6.3 Generalisability of the findings 
The findings of this study have a generalisability limited to well-resourced 
teaching hospitals in middle-income countries. The therapeutic impact of 
routine electrolyte measures seen in this study would generally be greater 
than in some other settings since the research was performed in a protocol-
driven practice. Routine testing could be useful in settings with a higher 
prevalence of plasma sodium and potassium disturbances in children with 
dehydrating diarrhoea. 
5.6.4 Strengths of the research 
The sample of patients in this study was broadly representative of children 
admitted to diarrhoeal rehydration units in metropolitan Cape Town. This 
increased the generalisability of the findings, since the sample included 
patients from both urban and peri-urban areas and informal settlements. 
Examining the patients' folders to determine a change in management 
associated with electrolyte disturbances was done without the medical 
officers being informed of this aspect of the project, and often occurred more 
than 24 hours after admission. The medical officers were therefore unlikely to 
have managed the patients any differently than they would have in everyday 
practice. 
The study was performed in a protocol-driven practice with clear policies 
determining what should happen and when. Changes in management as a 
result of an electrolyte abnormality could thus be identified relatively easily as 
new treatment in keeping with protocol management for that disorder. 
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5.6.5 Limitations of the research 
Information was collected retrospectively from the patients' folders to ensure 
that the study was performed unobtrusively. It was therefore not possible to 
put measures in place to control for inaccurate reporting by medical officers. 
The crude criteria used to assess management change could have missed 
other subtle changes that were not a part of the protocol but performed on 
the basis of clinical judgement. These would not have been detected or 
recorded by the principal investigator. Therefore, changes in management 
reported in this study could be an underestimation. 
Changes in management depend on recognition of the abnormal result and 
consequent protocol-based action. The extent to which the protocols were 
implemented is not known. This information would have helped to determine 
the measured changes in management. 
The study was conducted predominantly in children admitted during working 
hours, when staffing and supervision may have been greater. The findings 
may thus not be generalisable to after-hours conditions, in which case the 
findings would probably represent an over-estimate of the therapeutic impact 
of routine testing. 
5.6.6 Implications for practice 
The findings of this study suggest that routine testing, even if feasible, is 
unlikely to result in sufficient benefit to justify the use of considerable 
resources in most of the resource-constrained settings where diarrhoea is an 
important problem. 
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5.S.7 Implications for future research 
A more valid and meaningful evaluation of the impact of routine testing on 
clinical outcome would require a randomised controlled trial of the effect of 
routine management on meaningful clinical outcomes. Such a trial would also 
quantify the size of any benefit and thereby enable a more informed 
comparison with competing priorities. 
5.7 Conclusion 
Routine testing resulted in the detection of plasma sodium and potassium 
abnormalities. 
When abnormalities had a relatively low prevalence, large numbers of 
patients needed to be tested for each case of management change. The 
benefit of such testing needs to be weighed against the costs of performing 
many tests before one abnormality is identified and treated, taking into 
consideration other health priorities, financial constraints, limited facilities and 
staffing in most settings were dehydrating diarrhoea is prevalent. 
A randomised controlled trial would provide a more valid and meaningful 
evaluation of the impact of routine testing on clinical outcomes. 
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CHAPTER SIX: SUMMARY AND RECOMMENDATIONS 
6.1 Determinants of seasonal plasma sodium and potassium 
disturbances in childhood diarrhoea 
6.1.1 Literature review 
No studies were identified that reported on determinants of the seasonal 
fluctuations in plasma sodium and potassium disturbances. 
6.1.2 Contribution of this research 
The seasonal fluctuations in plasma sodium and potassium levels are 
partially explained by both enterotoxigenic E. coli and Cryptosporidium 
working together, with enterotoxigenic E. coli having the larger effect on 
plasma sodium and Cryptosporidium the larger effect on plasma potassium. 
These findings are a new contribution to the current body of research. 
Previously described associations with other non-seasonal factors were 
confirmed in this study, that is: higher levels of plasma sodium with younger 
age, breast-feeding and living in a brick house; higher levels of plasma 
potassium with increased parental education and lower levels of plasma 
potassium with longer duration of diarrhoea. 
6.1.3 Implications for practice/public health responses 
The findings of this study are not sufficiently specific to suggest public health 
interventions that would target seasonal plasma sodium and potassium 
disturbances. 
144 
6.1.4 Implications for research 
A study to identify determinants of the both enterotoxigenic E. coli and 
Cryptosporidium could inform public health interventions that target 
prevention of seasonal plasma sodium and potassium disturbances. 
6.2 Utility of clinical signs in diagnosis of plasma sodium and 
potassium abnormalities in childhood diarrhoea 
6.2.1 Literature review 
No reported studies have been specifically designed to assess the diagnostic 
accuracy of clinical signs associated with plasma sodium and potassium 
abnormalities in childhood diarrhoea or any other condition in children. 
6.2.2 Contribution of this research 
This study makes an important contribution to health by providing an 
understanding of the utility of clinical signs in the detection of electrolyte 
abnormalities in children. It is novel, being the first systematic study of clinical 
signs used in the detection of clinically important electrolyte disturbances in 
an unquestionably important condition. 
Clinical signs were generally not useful and showed poor reliability in actual 
practice. The consistent pattern of low accuracy across all tests does, 
however, indicate unhelpful accuracy. Even though there is uncertainty 
around the estimates of diagnostic accuracy for less prevalent conditions 
because of low statistical power, the most optimistic plausible levels of 
accuracy are not clinically meaningful, given the low prevalence of the target 
conditions. 
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The 'negative' findings in this study of the poor diagnostic accuracy of 
commonly used clinical signs further add to the importance of the findings, in 
that many of the signs assessed are currently, though misleading, used in 
everyday practice. 
6.2.3 Implications for practice 
No clinical signs (as defined in the study) were identified that were clinically 
useful in actual practice. Although meaningful diagnostic accuracy has not 
been excluded for all signs examined, none appears likely to be useful at the 
low prevalence of severe abnormalities in children with diarrhoea. 
6.2.4 Implications for research 
It is possible that clearer definitions of clin ical signs could improve the 
reliability and validity of these signs. A study incorporating these features 
would be required to demonstrate this. 
6.3 Therapeutic impact of routine electrolyte measurement in 
management of plasma sodium and potassium disturbances 
6.3.1 Literature review 
No studies have reported on the therapeutic impact of routine electrolyte 
testing in low- and middle-income countries, where dehydration and plasma 
sodium and potassium disturbances in child ren with diarrhoea are more 
prevalent and where resource constraints on routine testing are most 
marked. One study in Dutch children with mostly non-dehydrating diarrhoea 
reported a low prevalence of plasma sodium and potassium abnormalities 
(Tjon A Ten, 1999). Testing did not result in significant management change 
in their practice. 
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6.3.2 Contribution of this research 
This is the first exploratory study to report on the therapeutic impact of 
routine electrolyte testing in a low- or middle-income country. Even though 
plasma sodium and potassium disturbances identified by routine testing 
resulted in changed management, large numbers of patients needed to be 
tested for each case detected and management change in abnormalities with 
a relatively low prevalence. 
6.3.3 Implications for practice 
The appropriateness of routine testing (when available) will depend on the 
prevalence of the target conditions and the balance between the expected 
benefits of testing and the costs, both in terms of the adverse affects (for 
example, discomfort and risk to the patient) and the use of resources in a 
context where there are usually many competing priorities. All such 
judgements depend on assumptions about the benefits expected from 
changes in clinical management. 
6.3.4 Implications for future research 
A more valid and meaningful evaluation of the impact of routine testing on 
clinical outcome would require a randomised controlled trial of the effect of 
routine management on clinically meaningful outcomes. Such a trial would 
also quantify the size of any benefit and thereby enable a more informed 
comparison with competing priorities. 
6.4 Applicability and generalisability of the findings 
The children studied were drawn predominantly from socially disadvantaged 
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areas of Cape Town (informal settlements) such as Khayelitsha, Nyanga and 
Guguletu, but included children from other urban and peri-urban areas in 
metropolitan Cape Town. The findings for all three studies are therefore 
applicable to a broad spectrum of patients aged between 6 weeks and 2 
years. 
Findings regarding the clinical identification of electrolyte disturbances and 
routine electrolyte testing as a management tool have limited generalisability 
to well-resourced teaching hospitals in middle-income countries with a similar 
prevalence of plasma sodium and potassium abnormalities. 
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APPENDICES: CHAPTER TWO 
Appendix 2.1 Consent form for study of electrolyte levels in childhood 
diarrhoea 
Description of the study 
The levels of salt in the blood of children with diarrhoea can sometimes be abnormal. To 
treat these abnormal levels we need to know more about what causes them and how to 
check for the abnormalities. The purpose of this research study is to try to understand 1) 
what things influence the levels of salts in the blood of children with diarrhoea and 2) the 
best way to check for abnormalities of the levels of salts in the blood when examining 
children with diarrhoea. 
In this study we will collect information by asking questions, dOing laboratory tests and 
examining the children's folders for information about how they were treated. We will not 
change any treatment. We will be doing tests on some of baby's stool/blood. The nurse will 
be taking some stool from baby's nappy / The doctor will be taking blood from baby. We 
need to study 700 children in order to get reliable results. 
What this means for you and your child is that: 
1. We would ask you questions about baby's illness and what baby eats. 
2. We would ask you a few questions about your schooling, where you live and family 
income. 
3. We would take blood from your child to measure the levels of salt in the blood. This is 
usually done as a part of the child's ordinary care, even if he/she is not in the study. 
4. We would collect a specimen of stool from your child's nappy and send it to the 
laboratory to test for germs that may be causing the diarrhoea, and for salt levels. 
5. Your child's treatment will not be changed in any way. 
6. The results of this study will be presented at medical conferences and in articles in 
medical journals, but in such a way that it will be impossible to identify your child 
individually. 
7. Taking part in this study is completely VOluntary and you may withdraw at any time 
without giving an explanation. 
8. Your child's care will not be affected if you do not agree to take part or if you withdraw 
from the study. 
9. We may store some stool to be tested at a later stage for any other germs. 
_________________ the mother/father/guardian of 
_____________________ --,---____ verify that; 
1. I understand the information that has been given to me. 
2. The information is in the language of my choice, or through an interpreter. 
3. I have been given a chance to ask questions. 
4. I may consult with family and friends before agreeing to take part. 
5. I have a copy of this consent form, with the researcher's contact information. 
Person giving consent Researcher Witness 
Date: ______ _ 
Victoria Pillar- Red Cross Hospita~ Dept of Paediatrics and Child Health, Ph: 021 6585120 
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Appendix 2.2 Toestemmingsvorm vir deelname aan navorsingstudie oor 
elektrolise-vlakke in kinders met diaree 
Beskrywing van navorsingstudie 
Die soutvlakke in die bloed van kinders met diaree is soms abnormaal. Ten einde hierdie 
abnormale soutvlakke te behandel, is dit nodig om te weet wat die oorsaak is van hierdie 
afwyking en hoe om te toets vir hierdie abnormaliteite. Die doel van hierdie navorsingstudie 
is om te bepaal wat 1) die faktore is wat bloedsoutvlakke in kinders met diaree beTnvloed en 
2) die bes moontlike wyse(s) om te toets vir abnormaliteite in bloedsoutvlakke in kinders met 
diaree wanneer hulle ondersoek word. 
In hierdie studie wit ens inligting insamel deur vrae te vra, laboratoriumtoetse te doen en die 
kinders se I~ers te inspekteur (om uit te vind hoe hulle behandel is). Ons sal nie afwyk van 
die roetine behandeling wat baba moet ontvang nie. Toetse sal gedoen word op baba se 
stool gang bloedmonster. Die verpleegster sal verantwoordelik wees om stool gang van 
baba se doek te neem I Die dokter sal bloedmonsters van baba neem. Ons benodig 700 
kinders om deel te neem aan die navorsingstudie om betroubare resultate te kry. 
Vir u en u kind beteken dit dat: 
1. Ons sal vir u vrae vra oor die baba se siekte en eetgewoontes. 
2. Ons sal vir u 'n paar persoonlike vrae vra oor u opleiding, waar u woon en u 
huishouding. 
3. Ons sal bloedmonsters neem van u kind ten einde bloedsoutvlakke te meet. Dit is deel 
van roetine behandeling vir aile kinders met diaree, ongeag of hy/sy in die studie is of 
nie. 
4. Ons sal 'n stool gang van 'n baba se doek neem en laboratoriumtoetse doen om 
soutvlakke te meet en agente (kieme) wat diaree veroorsaak te identifiseer. 
5. Daar sal nie afgewyk word van die roetine behandeling wat u kind ontvang nie. 
6. Die resultate van die navorsing sal voorgel~ word by mediesekongresse en gepubliseer 
word in mediese tydskrifte, maar die identiteit van 'n kind sal nie bekend gemaak word 
nie. 
7. Deelname aan hierdie studie is vrywillig, en u mag enige tyd onttrek sonder dat dit nodig 
is vir 'n verduideliking. 
8. U kind se sorg sal nie beTnvloed word indien u besluit om nie deel te neem aan hierdie 
studie, of deelneem en later onttrek van die studie nie. 
9. Ons mag stool gang oorhou om op 'n later stadium te toets vir enige ander kieme. 
Ek _________________ die moeder/vader/voog van 
__________________________ verklaar dat; 
1. Ek verstaan die inligting wat vir my gegee is, 
2. Die inligting verskaf is in 'n taaJ van my keuse, of deur 'n tolk, 
3. Ek is 'n kans gegun om vrae te vra oor ander aspekte waaroor ek onduidelik is, 
4. Ek mag my gesin en vriende raadpleeg voor ek toestemming gee aangaande deelname aan die studie. 
5. Ek het 'n afskrifvan hierdie toestemmingvorm met die navorser se kontak besonderhede. 
Persoon wat toestemming gee Navorser Getuenis 
Datum: _____ _ 
Victoria Pilla~ Red Cross Chl'ldren's Hospital Dept of Paediatrics and Child Health Ph: 021 6585120 
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Appendix 2.3 Isiqinisekiso sesivumelwano ngophando Iwemilinganiselo 
yeetyuwa kwintsana ezino-Rhudo 
Inkcazelo ebanzi ngophando 
Umlinganiselo wetyuwa esegazini kubantwana abane sifo sorhudo maxa wambi sibenza 
babe buthathaka. Ukunyanga Ie milinganiselo kufuneka sazi ngokubanzi ukuba kwenziwa, 
kwaye iyintoni ebangela 010 xinzeleleko. Isizathu sokwenza olu phando kukufuna ukuqonda 
1) Ingaba zintoni ezibanga lemilinganiselo yetyuwa esegazini labantwana abanesifo so 
rhudo, 2) Eyona ndlela yokukhangela olu xinzeleleko Iwale milinganiselo yetyuwa esegazini 
xa kuxilongwa abantwana abanorhudo. 
Kolu phando Iwezizifundo sakuthi siqokelele ulwazi ngokuthi sibuze imibuzo, 
ngokusebenzisa uphando kunye noxilongo gazi kwifolda zabantwana ukufumana inkcazelo 
engakumbi ukuba lulu phi unyango abathe balufumana. Asiyi kuyitshintsha indlela yonyango 
abathe balufumana. Sobe sisenza uphando kugutyulo Iwelindle okanye kwigazi. Umongikazi 
wothabatha inxalenye yogutyulo olufumaneka esishubeni somntwana, yena ugqirha watsala 
igazi emtwaneni lowo. Sifuna ukwenza uphando ukuyakufika kuma 700 abantwana 
ukwenzela sifumane ezona ziphumo zigqibeleleyo ngolu phando. 
Ingaba kuthetha ukuthini oku kuwe kunye nontwana, 
1. Sakuthi sibuze imibuzo ngokuphathelele ukugula komntwana kwakunye nokutya 
akutyayo. 
2. Sakuthi sibuze imibuzo embalwa ngemfundo yakho, ukuba uhlalaphi kwaye usebenzisa 
malini nyanga nganye. 
3. Sakuthi sithabathe igazi emntwaneni wakho ukuze sikhangele umlinganiselo wetyuwa 
esegazini.Oku kuvame ukwenzeka njengenxalenye yonyango ingekuba uzele uphando. 
4. Sakuthi sithabathe inxenye yogutyulo oluphuma kwishuba somtwana, esakuthi 
sisithumele kwigumbi lophando zintsholongwane ezibangela urhudo kwakunye 
nemilinganiso yetyuwa egazini. 
5. Unyango lomntwana wakho aluyi kutshintsha nangayiph' indlela. 
6. Iziphumo zolu phando zonikezelwa kwinkongolo yezonyango kwakunye nezicatshulwa 
zonyango, oku kuya kuthi kubenzima ukuveza ukuba ngubani na Iowa kuphandwa 
ngaye. 
7. Ukuthabatha inxaxheba kolu phando kokokuzithandela akusosiso isinyanzelo, kwaye 
unokurhoxa nagaliphi ixesha ufuna kungekhona nankcazelo. 
8. Inkathalo engontwana wakho ayisayi kuphazamiseka kuba ungafuni kuthabatha 
inxaxheba okanye ukurhoxa koluphando. 
9. Sinako ukugcina inxalenye yogutyulo ukwenzela ukuphanda kwakhona kwixesha elizayo 
malunga nentsholongwane ezikulo. 
Mna ___________________ MamafTata/Mgcini ka 
_____________________ ndivumelana nokuba 
1. Ndiyaqonda ngenkcazelo endiyixelelweyo. 
2. Lenkcazelo ingolwimi Iwam Iwentando, nangoku phuhliswa yitoliki. 
3. Ndilinikiwe ithuba lokubuza imibuzo. 
4. Ndinako ukunxulumana nosapho okanye izizalwana phambi kokwenza isigqibo sokuthabatha inxaxheba. 
5. Ndinaso isiqinisekiso sesivumelwano esinenkcazelo ngomphandi wemfunalwazi. 
Umzali Umphandi Itoliki 
Umhla: _____ _ 
Victoria Pillay, Red Cross Children's Hospital, Dept of Paediatrics and Child Health, Ph: 021 6585120 
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Appendix 2.4 Ethical approval for research from the Research Ethics 
Committee 
UNIVERSITY OF CAPE TOWN 
03 May 2000 
. REC REl1':09712000 
Dr G SWIngIer 
Paediatrics . 
Red Cross Hospital 
. Deilr Dr Swingler 
Resell/'cll El/lics Committee 
FncII'lty ofMcdicillc 
Autio Uoad, Obscnrntol'Y, 7925 
QtieJ'ies : Martha Jacobs 
Tcl: (02i) 406~6492 :Fnx: (021) 406-6390 
E-mail: lVlatllln@mcdicille.llct.ac.za 
ELECTROLYTE DlS'tUnJlANCES iN. CHILDHOOD DIAltl.Ul0EA 
thnnkyou for your application submitted to the Research. Ethics COIllmittee on 
31 March' 1999. 
'[ have pleasure in .informing Y01I that the Reseai'ch EthicsColluilittee has fOl'lllally 
1iPI)l'Ov~d the above study. on 02 May :2000. 
You may proceed :with the tdal once the 'finailcia.1 agreemelltlcontract and protocol 
have been processed through the department of Research Dcvelopment and duly 
sigiled by the authorised UliiversityofCape Town signatories. 
Includcd'is a list of Rcscnrcll Ethics·COlIun.ittec·Mclllocrs who havc formally approved 
your protocol. . 
Please quote the abovc Reference llumber in aJJcotrespondence. 
Y Oi1fS sincei"eiy, '. 
~ 
PHOFESSOR PM DENT 
ACTlNG-Cl1AmrEHSON 
Queries: Martha Jacobs 
.Researclj·Ethics Committee 
Room 212 Werner and Beit 
UCT Medical School 
Anzio Road, Observ.atory, 7925 
Tel: (021) 406-6492 Fax: (021) 406-6390 
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APPENDICES: CHAPTER THREE 
Appendix 3.1 PubMed search strategy for determinants of electrolyte 
disturbances: period 1966 to May 2005 
#1 Search Diarrhea 
#2 Search Diarrhoea 
#4 Search "Diarrhea"[MeSH] 
#5 Search flHyponatremia"[MeSH] 
#6 Search "Hypematremia"[MeSH] 
#7 Search "Hyperkalemia!l[MeSH] 
#8 Search "Hypokalemia"[MeSH] 
#9 Search "Potassiumlblood"[MeSH] 
#10 Search "Sodium/blood" [MeSH] 
#11 Search # 1 OR #2 OR #4 
#12 Search #5 OR #6 OR #7 OR #8 OR #9 OR #10 
#13 Search "Causality"[MESH] 
#14 Search "Hyponatremialetiology" [MESH] 
#15 Search "Hypematremialetiology" [MESH] 
#16 Search "Hyperkalemial etiology" [MESH] 
#17 Search "Hypokalemiaietiology"[MESH] 
#18 Search #11 AND #12 AND #13 
#19 Search #14 OR #15 OR #16 OR #17 
#20 Search #11 AND #19 
#21 Search # 18 OR #20 Limits: Humans 
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Appendix 3.2 Gastro Electrolyte Study: LABORATORY RESULTS 
ON -.:.:.:.:] 
Name: -------------------
Folder No: ________ _ 
D.O.B: ___ _ RIS: 
Date of admission: I I 
Biochemistry 
Plasma Na+: ---------
pH: ______________ _ 
Microbiology 
Stool collected YIN 








Enteropathogenic E. coli 
Enterotoxigenic E. coli 
Enteroaggregative E. coli 
Enterohaemorrhagic E. coli 
> than one E. coli type 
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Appendix 3.3 Gastro Electrolyte Study: BASELINE DEMOGRAPHIC 
QUESTIONNAIRE 
Date of admission: I I 
Folder No: _________ _ 
Name: __________ _ 
DOB: RIS: __ _ 
Eligibility 
Ma'am, how old is Baby? months 
Were you sent here from another hospital or ward? 
Has baby been in a research study with me before? 
Is baby on diuretics? 
History 




Can you please tell me the following things about baby's illness 
How long has baby been sick with diarrhoea? _________ Day(s) 
Has baby been vomiting? YIN 
If yes 
For how 10ng: ______________ Day(s) 
Is baby drinking as well as s/he usually does: 
If no 
Less than usual 




How many times has baby had diarrhoea in the past three months where baby needed to be 
taken to a doctor? _________________ _ 
Has baby had fits in the last 24 hours? 
Has baby been crying more than usual? 
If yes 
Crying but you can calm baby 






Ma'am, can you please tell me the following things about baby's feeding habits. 
Is baby on the breast only? YIN 
If no 
Is baby bottle-fed? YIN 




Is baby on solids? ____________________________ ~--Y/N 
Does baby drink any thing else? YIN 
If yes could you tell me what 
Treatment before admission 
Ma'am I am now going to ask a few questions about how you have been treating the 
diarrhoea before you camehefe today. 
Have you needed to visit anybody for treatment of baby's diarrhoea 
before coming the to RCCH? 
'Traditional' IPharmacist IClinic nurse I Clinic doctor I GP 
Have you been giving baby anything to drink as treatment 
for the diarrhoea? 
If yes, what did you give baby? 
Sachet: ________________ _ 





o Other: _________________ _ 
How did you make it? 
What liquid did you use and how much? _________ ml 
No. spoons salt: ______________ _ 
No. spoons sugar: _____________ _ 
Ma'am could you please show me from all the spoons in the box which size spoon 
you used. 
A B C 
Other treatments 
Have you been giving baby anything else to treat the diarrhoea? YIN 
If yes describe 
166 
Ma'am I am now going to ask a few questions about yourself and where you live. 
What is the highest education level you have reached? 
No education 
School (Std I Grade): ________ _ 
Tertiary education passed 
Training college (no of years): ________ _ 
Technikon (no of years): __________ _ 
University (no of years): __________ _ 
Other: ________________ _ 
In what type of house do you live in? 
House on a separate site 
Hut/traditional house 
Flat in a block of flats 
Semi-detached/cluster/town house 
House or a flat in the backyard 
Shack in the backyard 
Shack not in the backyard 
Room in a hostel or compound provided for you by your boss 
Other: ___________________ _ 





In house On site 
Flush toilet D D 
























Please tell me which of the following things you have in the house and whether they 
are working or not. 
Y 
Electricity 1 
Stove (electric, gas, coal, wood, paraffin [primus])1 







Yes but not working 
(explain) 
3 ____ _ 
3 ____ _ 
3 ____ _ 
Where do you live? ____________________ _ 
When did you move into this area? _______________ _ 
Has baby always lived here? 




With whom and for how long (> than 1 month): ___________ _ 
Where: _________________________ _ 
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Appendix 3.4 Gastro Electrolyte Study: BASELINE DEMOGRAPHIC 
QUESTIONNAIRE 
T oelatingsdatum : ___ ----'-, _-----', __ Tyd: _____ _ 
Leer No: _____________ _ 
Naam: ______________ _ 
D.O.B:' , RIS: __ _ 
Toelati ngskriteria 
Hoe oud is Baba: ________ maande 
Is dame na hierdie hospitaal verwys deur 'n ander hospitaal of 'n ander 
saal in hierdie hospitaal? 
Het dame al vantevore 'n vraelys by my ingevul oar hierdie baba? 
Drink baba medisyne vir die hart? 
Geskiedenis 
Kan dame vir my asseb/ief meer vertel oor u baba se siekte? 
Hoe lank het die baba diarree ("loop magie")? 
Vomeer die baba (gooi op)? 
Indien ja, 
________ Dag(e) 
Hoe lank gebeur dit al? ____________ Dag(e) 
Drink die baba 5005 gewoontlik? 
Indien nee, 
Minder as gewoontlik? 
Glad nie? 








drie maande moes baba mediese sorg kry vir diaree? ________ _ 
Oor die afgelope 24 uur, het baba enige stuipe gekry? 
Huil baba meer as gewoontlik? 
Indien ja, 
Kan baba kalmeer. 







Kan dame vir my asseblief meer verlel oor baba se eetgewoontes: 
Drink baba net borsmelk? (en geen ander formule ["poeier"] melk nie) 
Indien nee, 
Kry baba formule ["poeier"] melk? 
J/N 
J/N 
Watter forumule melk gebruik baba ? _________ _ 
Eet baba vaste stowwe? __________________ -1 N 
Drink baba enigiets anders? (Koffie, tee, Coke, ens.) 
Indien ja, kan jy vir my s~ wat? 
Behandeling voor toelating 
Kan dame vir my meerverlel oor hoe u baba se diarree behandel het voor u na die 
hospitaal gekom het: 
Het u enige iemand besoek om baba se diarree te behandel 
voor u na die RKKH gekom het? 
Indien ja, wie? 
Traditionele' IApteek IKlinieksuster/Kliniekdokter I H uisdokter 
J/N 
Het u vir baba enigiets gegee om te drink om die diaree te behandel? J I N 
Indien 'Ja', wat ? 
D Sakkie {van apteek): ______________ _ 
D Sout en suiker oplossing: _____________ _ 
D Ander: __________________ _ 
Hoe het u die oplossing gemaak? 
Met watter vloeistof het u die oplossing gemeng? _____ _ 
Hoeveel vloeistof het u gebruik? ____________ ml/koppies 
Aantal lepels sout _______ _ 
Aantal lepels suiker: ______ _ 
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Dame, kan u asseblief vir my wys watter grootte lepel u gebruik het om die oplossing aan A 
te maak? 
A B c 
Anderbehandeling 
Het u enigiets anders vir baba gegee om die diaree te behandel? J I N 
Indien ja, beskryf: 
Dame, kan ek vir u 'n paar vrae vra oar u self en waar u woon? 
Vir hoeveel jaar was dame al by die skool? 
Ongeskoold 
Skool {St I Graad geslaag): _________ _ 
Het dame na skool verder studie? 
Indien ja 
Waar en vir hoe lank? 
Tertiere opleiding voltooi 
Opleidingskollege (aantal jare): ________ _ 
Technikon {aantal jare): __________ _ 
Universiteit {aantal jare): __________ _ 
Ander: ________________ _ 
In watter tipe huis woon dame? 
Alleenstaande huis 
Hutlrondawel (traditionele huisstruktuur) 
Woonstel in woonstelblok 
Skakel/dorpshuis 
Huisl woonstel Ikamer in agterplaas 
Plakkershuis in agterplaas 
Plakkershuis nie in agterplaas 
Kamer in koshuis of woonkwartier voorsien deur werkgewer 


















Het u en u familie toegang tot die volgende fasiliteite: 
Chemiese toilet 
Gat in grond 


















Kan dame asseblief vir my aandui of u die volgende items besit in u huis ongeag 
of dit werk of nie: 
Elektrisiteit 
Stoof (elektries, gas, steenkool, 
hout, paraffien [primus]) 






Ja, maar werk nie. 
(verduidelik) 
3 ____ _ 
3 ____ _ 
3 ____ _ 
Waarwoonu? ___________________ __ 
Hoe lank woon u in hierdie area: ___________ "'--__ 
Hoe lank woon u in hierdie huis: _____________ _ 
Woon baba sy/haar van geboorte af hier? J/N 
Indien nee 
Met wie I waar het baba tevore gebly: ________ _ 
Vir hoe lank? _________________ _ 
Het baba gedurende die afgelope jaar erens elders gewoon vir J I N 
enige tyd 
Indien ja, met wie (> 1 maand): ___________ _ 
Virhoelank? _________________ _ 
Waar: ___________________ _ 
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Appendix 3.5 Methods used to identify enteropathogens - provided by 
Andrew Whitehead and Karen Mcabe of the Institute of Child 
Health, Red Cross Children's Hospital, 2003 
Salmonella / Shigella / Campylobacter culture (AW): 
Stool samples were emulsified in normal saline (if necessary) and inoculated onto SS 
(Salmonella/Shigella) agar plates (McC [McConkey] agar plates) and into buffered 
peptone water. 
Campylobacters were isolated by placing a drop of emulsified stool on a 6 urn filter on a 
tryptose blood agar (TBA) plate for 15 minutes. The filter was then removed and the 
TBA plate incubated at 35°C in appropriate atmospheric conditions (in an anaerobic jar 
with a BR 38 sachet). The rBA plates were examined every 48 hours for 6 days. 
Colonies suspected of being Campylobacter species on the basis of Gram stain 
appearance and colony morphology were further identified as described below. 
SS agar plates and McConkey agar plates were incubated overnight at 35°C aerobically 
and examined at 24 and 48 hours' incubation. Non-lactose- fermenting colonies were 
further identified as described below. 
Buffered peptone water was incubated overnight at 42°C and subcultured onto MSRV 
(modified semi-solid Rappaport-Vassiliadis) agar after 24 hours. MSRV agar was then 
incubated at 35°C aerobically for 24 hours. Colonies that showed a "halo" on the agar 
were identified further. 
The identity of non-lactose-fermenting colonies on the SS or McC agar plates were 
confirmed by means of standard biochemical reactions. Similarly, suspicious colonies 
on the MSRV agar were also identified: 
• Fermentation of glucose, inositol and arabinose 
• Indole production from tryptophane 
• Presence of ornithine and lysine decarboxylase 
• Production of urease 
• Production of H2S 
• Growth on Simmon's citrate medium 
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• Presence of B galactosidase (ONPG) 
• Motility 
• Oxidase production 
On the basis of these biochemical reactions, potential Salmonella and Shigella isolates 
were confirmed as such by means of agglutination reactions. Potential Shigella isolates 
were first agglutinated with specific S. f/exneri antiserum (Mast Diagnostics). If this was 
negative, the isolate was typed using the Wellcolex Colour Shigella kit (Remel). 
Potential Salmonella isolates were typed using the Wellcolex Colour Salmonella kit 
(Remel). 
Campylobacter isolates were identified by means of the following tests: 
• Oxidase production 
• Hippurate hydrolysis 
• Indoxyl acetate hydrolysis 
• Growth on McConkey agar 
• H2S production 
• Susceptibility to nalidixic acid and cephalothin. 
Microscopy for Cryptosporidium (AW): 
Stool was emulsified in Sheather's Sugar Solution (500 g sucrose, 320 ml water, 6,5 g 
phenol) and examined under 400x magnification using a phase contrast filter. C. 
paNum oocysts were identified as refractile, round objects floating within the sugar 
solution, just below the cover-slip. 
Latex agglutination for rotavirus (AW): 
The presence of rotavirus was determined by using the Murex Rotavirus Latex kit 
(Murex) according to the manufacturers instructions. Briefly, stool was added to the 
extraction buffer, vortexed and then centrifuged for 10 minutes. Test latex was added to 
one drop of supernatant, control latex to another drop of supernatant and mixed for up 
to 2 minutes. The presence of agglutination in the test latex (with no agglutination in the 
control latex) was taken as indicating the presence of rotavirus in the sample. 
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E. coli culture, isolation and identification (KM): 
Stool samples (four E. coli colonies/sample were sub-cultured) were cultured overnjght 
on McConkey agar. Biochemical identification of the four E. coli isolates was done by 
sugar fermentation reactions using the Analytical Profile Index of Enterobacteriaceae 
(API 20E) system (Biomerieux). Serogrouping of E. coli isolates were done by slide 
agglutination tests using antisera specific for E. coli (Murex Biotech Ltd.). Isolates were 
stored on MicrobankTM vials (Pro-Lab Di~gnostics) at -70°C . Identification of the 
adherence patterns on the isolates was done by an in vitro adherence assay using 
HeLa cells. L T toxin (heat labile) production was detected by Reverse Passive Latex 
Agglutination using the VET-RPLA "SEIKEN" (Vibrio cholera and E. coli enterotoxins ) 
kit (Denka Seiken Co., Ltd.). VT1 and VT2 (verotoxin 1 and verotoxin2 ) production was 
detected by Reverse Passive Latex Agglutination using the VTEC-Screen "SEIKEN" 
(E. coli verotoxins ) kit (Denka Seiken Co., Ltd.). STh (heat stable toxin of human origin) 
coding genes were detected by a DNA hybridisation assay using djgoxigenin-11-ddUTP 
(2',3'-dideoxyuridine-5'-triphosphate coupled to digoxigenin via an 11-atom spacer arm) 
labelled oligonucleotide probe and a chemiluminescent detection with CSPD (Roche 
Diagostics) (a commercial reagent which contains chemiluminescent alkaline 
phosphatase substrates), STp (heat-stable toxin of porcine origin) coding genes were 
detected by DNA hybridisation assay using a digoxigenin-11-ddUTP labelled 
oligonucleotide probe and a chemiluminescent detection with CSPD (Roche 
Diagnostics) . 
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APPENDICES: CHAPTER FOUR 
Appendix 4.1a PubMed search strategy for determinants of seasonal 
fluctuations in sodium and potassium levels in children 
less than 2 years old with diarrhoea: period 1966 to April 
2005 
# 1 Search Hyponatremia 
#4 Search Hypernatremia 
#7 Search "Hyponatremia"[MESH] 
#8 Search "Hypernatremia"[MESH] 
#9 Search Hypokalemia 
# 10 Search Hyperkalemia 
#11 Search "Hyperkalemia"[MESH] 
#12 Search "Hypokalemia"[MESH 
#13 Search #1 OR #4 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 
#16 Search (hyponatremia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos * [Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic * [MeSH:noexp] OR 
diagnosis,differential [MeSH:noexp] OR diagnosis [Subheading:noexp])]) 
#17 Search (hypokalemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos * [Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR 
diagnosis,differential[MeSH:noexp] OR diagnosis [Subheading:noexp ]) 
#18 Search (hyperkalemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos * [Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR 
diagnosis,differential[MeSH:noexp] OR diagnosis [Subheading:noexp ]) 
#19 Search (hyperkalemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos*[Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic * [MeSH:noexp] OR 
diagnosis,differential [MeSH:noexp] OR diagnosis [Subheading:noexp ]) 
#20 Search #16 OR #17 OR #18 OR #19 
#2 Search "Sensitivity and Specificity"[MESH] 
#22 Search "Observer Variation"[MESH] 
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Appendix 4.1 a (continued) PubMed search strategy for determinants of 
seasonal fluctuations in sodium and potassium levels in 
children less than 2 years old with diarrhoea: period 
1966 to April 2005 
#23 Search # 15 OR #21 OR #22 
#24 Search "Diarrhea, Infantile"[MESH] Field: All Fields, Limits: Humans 
#26 Search #20 AND #24 
#27 Search # 13 AND #24 
#31 Search #21 OR #22 
#32 Search #31 OR # 13 
#33 Search #24 AND #32 Field: All Fields, Limits: Humans 
#34 Search #26 OR #33 Limits: Humans 
Appendix 4.1 b PubMed search strategy for determinants of seasonal 
fluctuations in sodium and potassium levels in children 
less than 2years old: period 1966 to December 2005 
#1 Search (hypokalaemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos*[Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic * [MeSH:noexp] OR 
diagnosis,differential[MeSH:noexp] OR diagnosis [Subheading:noexp ]) Field: 
All Fields, Limits: All Infant: birth-23 months, Humans 
#2 Search (hypernatraemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos*[Title/Abstract] OR 
diagnqsis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR 
diagnosis,differential [MeSH:noexp] OR diagnosis [Subheading:noexp ]) 
Limits: All Infant: birth-23 months, Humans 
#3 Search (hyponatraemia) AND (sensitiv*[Title/Abstract] OR sensitivity and 
specificity[MeSH Terms] OR diagnos*[Title/Abstract] OR 
diagnosis[MeSH:noexp] OR diagnostic * [MeSH:noexp] OR 
diagnosis,differential[MeSH:noexp] OR diagnosis [Subheading:noexp ]) 
Limits: All Infant: birth-23 months, Humans 
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Appendix 4.2 Contingency tables for data extracted from Hill et al. (1981) 
and Tjon A Ten (1999) to calculate measures of diagnostic 
accuracy 
$ign(n} 








Hill et al. (1981) 
Hyper-natraemic 














* All patients with coma/convulsion!drowsy removed (n=41) and data for 2 patients was missing. 
















* Assuming that 73 patients with data missing for sodium concentrations were normal. 
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Appendix 4.3 Information provided to medical officers at the beginning of 
their ward rotation (2 months) in the Rehydration Unit 
Gastro Electrolyte Study - Ward A9 
Why do the study? 
The main clinical objective is to assess the usefulness of clinical signs of hypokalaemia and 
hypernatraemia. The 'classical' clinical signs have not actually been tested to see how accurate 
they are (if at all). This knowledge would help clinicians manage patients better and enable 
better guidelines for electrolyte testing. 
What are admitting doctors asked to do? 
1. Complete the tick chart (including time and doctor's name) inserted into the A9 clerking 
notes. 
2. We may also ask you to complete a tick chart on a small sample of patients admitted by 
someone else (to see how much variation there is in eliciting different signs). If you will be 
unable to do so within 30 minutes of the admission examination, please let us know. 
3. Take blood for gases and electrolytes in the minority of children in whom it would not 
usually be done. (The researchers will obtain informed consent.) 
Why should the admitting doctors do this? 
• For the study findings to be generalisable to actual practice, the clinical signs need to be 
elicited by a range of clinicians who would normally see the children in actual practice. 
• We are asking admitting doctors to take the blood as a favour (Victoria Pillay is not a doctor 
or nurse). Tfyou are unwilling to do this in children who would not usually have blood taken 
(approx. 10-20% of admissions), please let us know and we will make an alternative 
arrangement. 
The investigators 
Victoria Pillay is enrolling patients and collecting data. Her co-investigator is George Swingler. 
Please do not hesitate to contact Victoria Pillay (ext 5120) or George Swingler (ext 5306) if you 
have any questions or reservations about the study. 
Explanatory notes 
• The tick chart records the doctors' findings of the clinical signs that we are testing, and 
takes two to three minutes to complete. We plan to enrol children between I I :00 and I9:00 
on each working day. 
• It is important that you DO NOT KNOW the sodium and potassium levels when eliciting 
the signs, otherwise this knowledge will unconsciously influence your findings. For this 
reason, a "Post It" slip will be placed over results in the notes. If you happen to know the 
electrolyte results, please tell Victoria and she'll make another plan. 
• The clinical signs are being tested, not the doctors. The doctor's name is needed to describe 
(anonymously) how many doctors took part and how many patients each saw. We shall not 
analyse individual doctors' perfonnance. 
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Appendix 4.4 Gastro Electrolyte Study: CLINICAL DETAILS 
Date: Time: ________ _ 
Examining doctor: ____________ _ 
Level of consciousness Tick 
Eyes opening Spontaneously 4 
To speech 3 
To pain 2 
No response 1 




Localises pain 5 
Flexion withdrawal 4 
Flexor posturing 3 
Extensor posturing 2 
No response 1 
Best verbal response Coos and babbles 5 
Irritable/cries 4 
Cries to pain 3 
Grunts 2 
No response 1 
R fl e exes: T est one Iceps an d one k nee, c h k th 'd ec 0 er Sl I 'f e only I unsure. 
Reduced Normal 
Biceps 0 1 
Knee 0 1 i 
Abdominal distension 
(in non-obese child, elevation of the abdominal wall above 






Appendix 4.5 Contingency tables used to calculate weighted Kappa 
scores for the each clinical assessment performed by 
medical officers independently and blind 
• Level of consciousness scale DrA DrB ----. 15 14 13 Total 
15 J J 8 0 19 
14 3 25 29 
13 1 0 2 
Total 15 34 50 
• Lies in a frog's legs position DrA DrB ----. Yes Maybe No Not done Total 
Yes 39 2 2 0 43 
Maybe 5 0 0 0 5 
No I 0 0 2 
Not Done 0 0 0 0 0 
Total 45 2 3 0 50 
• Marked head lag DrA DrB ----. Yes Maybe No Not done Total 
Yes 2 I 5 0 8 
Maybe 3 2 0 6 
No 1 5 26 0 32 
Not Done 0 0 0 4 4 
Total 4 9 33 4 50 
• Truncal Slump DrA DrB ----. Yes Maybe No Not done Total 
Yes 31 0 0 0 31 
Maybe 4 0 0 0 4 
No 2 0 1 0 3 
Not Done 0 0 0 12 12 
Total 37 0 12 50 
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Appendix 4.5 (continued) Contingency tables used to calculate weighted 
Kappa scores for the each clinical assessment performed 
by medical officers independently and blind 
• Resists procedure DrA DrB ---. Yes Maybe No Not done Total 
Yes 8 3 I 17 29 
Maybe 2 0 0 4 6 
No 0 0 0 0 0 
Not Done 12 2 0 15 
Total 22 5 2 21 50 
• Kicks away DrA DrB ---. Yes Maybe No Not done Total 
Yes 35 3 0 0 38 
Maybe 3 1 2 0 6 
No 3 0 I 0 4 
Not Done 2 0 0 0 2 
Total 43 4 3 0 50 
• Pushes Away DrA DrB ---. Yes Maybe No Not done Total 
Yes 32 3 5 0 40 
Maybe 3 2 I 0 6 
No 3 I 0 0 4 
Not Done 0 0 0 0 0 
Total 38 6 6 0 50 
• Lifts head from bed DrA DrB ---. Yes Maybe No Not done Total 
Yes 33 0 3 0 36 
Maybe 4 0 0 5 
No 3 2 3 0 8 
Not Done 0 0 I 0 I 
Total 40 2 8 0 50 
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Appendix 4.5 (continued) Contingency tables used to calculate weighted 
Kappa scores for the each clinical assessment performed 




DrB ----. Yes Maybe No Not done Total 
Yes 35 0 0 0 35 
Maybe 0 0 0 0 0 
No 2 0 1 0 3 
Not Done 0 0 0 12 12 




DrB ----. Yes Maybe No Not done Total 
Yes 11 6 2 0 19 
Maybe I I I 4 
No 6 0 0 7 
Not Done 0 I 0 19 20 




DrB ----. Yes Maybe No Not done Total 
Yes 13 0 1 0 14 
Maybe 4 3 2 0 9 
No 2 3 0 6 
Not Done 0 1 0 20 21 




DrB ----. Yes Maybe No Not done Total 
Yes 37 3 0 0 40 
Maybe 4 2 0 0 6 
No 3 I 0 0 4 
Not Done 0 0 0 0 0 
Total 44 6 0 0 50 
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Appendix 4.5 (continued) Contingency tables used to calculate weighted 
Kappa scores for the each clinical assessment performed 
by medical officers independently and blind 
• Abdominal distension DrA DrB ---.. Yes Maybe No Not done Total 
Yes 22 3 3 0 28 
Maybe 4 7 4 0 15 
No I 2 4 0 7 
Not Done 0 0 0 0 0 
Total 27 12 II 0 50 
• Wooden feel to the skin DrA DrB ---.. Yes Maybe No Not done Total 
Yes 42 I I 0 44 
Maybe 4 0 0 0 4 
No 2 0 0 0 2 
Not Done 0 0 0 0 0 
Total 48 0 50 
• Biceps, tendon reflexes DrA DrB ---.. Reduced Normal Brisk Not done Total 
Reduced 2 10 1 0 13 
Normal 4 28 3 I 36 
Brisk 1 0 0 0 I 
Not done 0 0 0 0 0 
Total 7 38 4 50 
• Knee, tendon reflexes DrA DrB ---.. Reduced Normal Brisk Not done Total 
Reduced 4 7 I 0 12 
Normal 5 23 4 1 33 
Brisk 0 4 1 0 5 
Not done 0 0 0 0 0 
Total 9 34 6 50 
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Appendix 4.6 Tables for the assessment (performed by medical officers) 
for each clinical sign that was used to calculate likelihood 
ratios for hyponatraemia 
Sign Levels Hyponatraemic Not hyponatraemic N 
Irritable Yes 76 174 
None 50 52 
Not reported 61 62 
187 288 475 
Seizures Yes 8 20 
No 177 266 
Not reported 2 2 
187 288 475 
Level of consciollsness <8 3 
(GLasgow Coma Score) 8.s:12 9 28 
>12 175 256 
Not reported 0 3 
187 288 475 
Resists procedure Present 141 207 
Uncertain 21 37 
Absent 12 12 
Not rep0l1ed 13 32 
187 288 475 
Kicks away Present 134 205 
Uncertain 23 39 
Absent 29 40 
Not reported I 4 
187 288 475 
Pushes away Present 138 195 
Uncertain 27 50 
Absent 21 39 
Not reported I 4 
187 288 475 
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Appendix 4.6 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for hyponatraemia 
Sign Levels Hyponatraemic Not hyponatraemic N 
Lifts head from bed Present 128 173 
Uncertain 16 33 
Absent 41 78 
Not reported 2 4 
187 288 475 
Sits unsupported Present 127 125 
Uncertain 3 10 
Absent 14 19 
Not reported 2 2 
146 156 302 
Rolls over Present 85 82 
Uncertain 16 13 
Absent 22 14 
Not reported 10 10 
133 119 252 
Stands Present 58 57 
Uncertain 13 7 
Absent 28 17 
Not reported 3 I 
102 82 184 
Wooden feel to the skin Absent 16 J 260 
Uncertain 10 15 
Present 16 J 0 
Not reported 0 3 
187 288 475 
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Appendix 4.6 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for hyponatraemia 
Sign Levels Hyponatraemic Not hyponatraemic N 
Biceps, tendon reflexes Reduced 35 57 
Normal 133 191 
Brisk 12 28 
Not reported 7 12 
187 288 475 
Knee, tendon reflexes Reduced 33 45 
Normal 128 173 
Brisk 22 57 
Not reported 4 13 
187 288 475 
Degree of dehydration >10% 34 45 
5% 98 151 
Potentially 45 98 
Good 16 35 
Not reported 3 3 
196 332 528 
PeripheraL peli"sion Poor 19 27 
Fair 92 97 
Good 80 200 
Not reported 0 13 
191 337 528 
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Appendix 4.7 Tables for the assessment (performed by medical 
officers) for each clinical sign that was used to calculate 




Level of consciousness 












































































































Appendix 4.7 (continued) Tables for the as.sessment (performed by 
medical officers) for each clinical that was used to 
calculate likelihood ratios for hypernatremia 
Sign Levels. aypernatraemic Not hypeTilatraemic 
Sits unsupported Present 4 248 
Uncertain 0 13 
Absent 3 30 
Not reported 0 4 
7 295 
Rolls over Present 2 165 
Uncertain 28 
Absent 35 
Not reported 19 
5 247 
Stands Present 2 113 
Uncertain 0 20 
Absent 2 43 
Not reported 0 4 
4 180 
Wooden/eel to tile skin Absent 25 396 
Uncertain 3 22 
Present 3 23 
Not reported 0 3 
31 444 
Biceps, tendon reflexes Reduced 7 85 
Normal 17 307 
Brisk 5 35 
Not reported 2 17 
31 444 
Knee, tendon reflexes Reduced 3 75 
Normal 16 285 
Brisk 9 70 










Appendix 4.7 (continued) Tables for the assessment (performed by 
medical officers) for each clinical that was used to 
calculate likelihood ratios for hypernatremia 
Sign Levels Hypernatraemic Not hypernatraemic 
Degree of dehydration 2:10% 10 69 
5% 22 227 
Potentially 4 139 
Good 50 
Not reported 0 6 
37 491 
Peripllerai perfusion Poor 7 39 
Fair II 178 
Good 19 261 






Appendix 4.8 Tables for the assessment (performed by medical 
officers) for each clinical sign that was used to calculate 




Level of consciousness 
















































































































Appendix 4.8 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 





Wooden/eel to the skin 
Biceps, tendon reflexes 




























































































Appendix 4.8 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for severe hypernatraemia 
.. Sign Levels ··Sev~r'ely Not severely 
hypeniatraemic hypernatraemic 
Degree of dehydration :::10% 5 74 
5% 12 237 
Potentially 0 143 
Good 0 51 
Not reported 0 6 
N 
17 511 528 
Peripheral perfusion Poor 5 41 
Fair 4 185 
Good 8 272 
Not reported 0 13 
17 511 528 
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Appendix 4.9 Tables for the assessment (performed by medical 
officers) for each clinical sign that was used to calculate 
likelihood ratios for hypokalaemia 
Sign Levels Qypokalaemic Nothypokalaemic N 
Level 0/ consciousness <8 0 4 
(Glasgow Coma Score) 8.::;12 18 19 
>12 210 217 
Not reported 3 0 
231 240 471 
Lies in/rog's legs 
position Absent 166 179 
Uncertain 34 26 
Present 33 27 
Not reported 3 3 
236 235 471 
Marked headlag Absent 115 127 
Uncertain 40 26 
Present 65 46 
Not reported 3 4 
223 203 426 
Truncal slump Absent 108 92 
Uncertain 29 15 
Present 28 17 
Not reported 5 5 
170 129 299 
Resists procedure Present 166 179 
Uncertain 35 23 
Absent 15 9 
Not reported 20 24 
236 235 471 
Kicks away Present 163 172 
Uncertain 32 30 
Absent 41 28 
Not reported 0 5 
236 235 471 
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Appendix 4.9 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for hypokalaemia 
Sign Levels Hypo){alaemic Not hypokalaemic N 
Pushes away Present 160 171 
Uncertain 44 32 
Absent 30 29 
Not reported 2 3 
236 235 471 
Lifts head from bed Present 150 148 
Uncertain 25 24 
Absent 59 59 
Not reported 2 4 
236 235 471 
Sits unsupported Present 143 107 
Uncertain 8 5 
Absent 18 14 
Not reported 3 
170 129 299 
Rolls over Present 94 71 
Uncertain 19 10 
Absent 20 17 
Not reported 13 7 
146 105 251 
Stands Present 62 52 
Uncertain 17 3 
Absent 33 13 
Not reported 3 
1I5 69 184 
Ileus Absent 211 221 
Uncertain 16 II 
Present 6 2 
Not reported 3 1 
236 235 471 
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Appendix 4.9 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for hypokalaemia 
Sign Levels Hypokalaemic Not hypokalaemic N 
Abdominal distension Absent 178 202 
Uncertain 29 14 
Present 28 19 
Not reported 0 
236 235 471 
Degree of dehydration =:10% 49 31 
5% 133 113 
Potentially 54 88 
Good 18 33 
Not reported 2 4 
256 269 525 
Peripheral perfusion Poor 25 21 
Fair 109 80 
Good 117 160 
Not reported 5 8 
256 269 525 
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Appendix 4.10 Tables for the assessment (performed by medical 
officers) for each clinical sign that was used to 
calculate likelihood ratios for severe hypokalaemia 
Sever.ely Not severely 
Sign Levels hypokalaemic hypokalaemic N 
Level 0/ consciousness <8 4 0 
(Glasgow Coma Score) 8.::::12 9 28 
>12 74 353 
Not reported 2 
89 382 471 
Lies in/rog's legs position Absent 56 289 
Uncertain 16 44 
Present 16 44 
Not reported 5 
89 382 471 
Marked headlag Absent 34 208 
Uncertain 14 52 
Present 37 74 
Not reported 6 
86 340 426 
Truncal slump Absent 36 164 
Uncertain 13 31 
Present 21 24 
Not reported 1 9 
71 228 299 
Resists procedure Present 49 296 
Uncertain 20 38 
Absent 9 15 
Not reported 11 33 
89 382 471 
Kicks away Present 49 286 
Uncertain 20 42 
Absent 20 49 
Not reported 0 5 
89 382 471 
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Appendix 4.10 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for severe hypokalaemia 
Not 
Sign Levels hypoka1aemic hypokalaemie N 
Pushes away Present 46 285 
Uncertain 26 50 
Absent 17 42 
Not reported 0 5 
89 382 471 
Lifts head from bed Present 44 254 
Uncertain 12 37 
Absent 32 86 
Not reported 1 5 
89 382 471 
Sits unsupported Present 55 195 
Uncertain 3 10 
Absent 13 19 
Not reported 3 
74 21S 299 
Rolls over Present 35 130 
Uncertain 8 21 
Absent 10 27 
N at reported 8 12 
61 190 2S1 
Stands Present 21 93 
Uncertain 8 12 
Absent 15 31 
Not reported 2 2 
46 138 184 
Ileus Absent 77 355 
Uncertain 9 18 
Present 2 6 
Not reported 1 3 
89 
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Appendix 4.10 (continued) Tables for the assessment (performed by 
medical officers) for each clinical sign that was used to 
calculate likelihood ratios for severe hypokalaemia 
Severely Not severely 
Sign Levels . hypokalaemic hypokalaeniic N 
Ahdominal dJ.'ilensJon Absent 64 316 
Uncertain 13 30 
Present II 36 
Not reported 1 0 
89 382 471 
Degree 0/ dehydralion 0% 25 55 
5% 48 198 
Potentially 14 128 
Good 4 47 
Not reported 2 4 
93 432 525 
Peripheral perfusion Poor 16 30 
Fair 48 141 
Good 26 251 
Not reported 3 10 
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APPENDICES: CHAPTER FIVE 
Appendix 5.1 PubMed search strategy on the therapeutic impact of 
routine electrolyte testing: period 1966 to June 2005 
#7 Search Diarrhoea 
#9 Search "Diarrhea, Infantile" [MeSH] 
#10 Search ("Sodiumlblood"[MeSH] OR "Sodium/therapeutic use"[MeSHD 
#11 Search ("Potassiumlblood"[MeSH] OR "Sodium/therapeutic use"[MeSHD 
# 12 Search "Hypernatremia" [MeSH] 
#13 Search "Hyponatremia"[MeSH] 
# 14 Search "Hypokalemia" [MeSH] 
#23 Search "therapeutic use"[Subheading] 
#24 Search #7 AND #9 
#25 Search #10 OR #11 
#26 Search #7 OR #9 
#27 Search #12 OR #13 OR #14 
#28 Search #25 AND #26 
#29 Search #26AND #27 
#30 Search #26 AND #27 
#33 Search "Electrolytes/diagnostic use"[MeSH] 
#34 Search "Electrolytes/therapeutic use" [MeSH] 
#35 Search #33 AND #34 
#36 Search #26 AND #35 
#37 Search #27 AND #23 
#38 Search #34 AND #26 
#39 Search "Potassium/blood"[MESH] 
#40 Search "Sodiumlblood"[MESH] 
#41 Search #39 OR #40 
#42 Search #41 AND #26 
#43 Search #42 AND #34 
#44 Search #26 AND #34 
#45 Search #30 AND #34 
#48 Search #28 OR #45 OR #43 Limits: Humans 
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Appendix 5.2 Extracted from the Rehydration Unit protocol for the 
management of sodium and potassium disturbances 
in children with diarrhoea 
Hypokalaemia 
If potassium < 3.0 mmolll 
OR 
potassium <4.0 mmolll AND base deficit >10 
i. KCI 100 mg/kg/dose 6hrly orally x 2 days (max 750 mg or 3 g daily) 
If potassium < 2.0 mmo/J1 
i. oral KCI as above 
ii. IV KCI: 2 ml KCI (15% solution) added to 200 ml1/2 DD. NEVER EXCEED 
THIS DOSE UNLESS DISCUSSED WITH REGISTRAR. 
iii. check potassium 4-hourly 
If potassium < 1. 5 mmolll 
i. As above 
ii. ECG monitor and inform registrar 
Hyponatraemia 
If sodium < 125 mmolll 
i. If IVI fluids: Normal saline 200 ml bag + 2 ml 15% KCI and 20 ml of 50% 
dextrose water, at usual rate for rehydration. 
If NG fluids: Continue with 1/2 DD and recheck sodium in 4-6 hours. If sodium 
has fallen further change to IV fluids. 
ii. Change back to 1/2 DD once the sodium is > 130 mmoi/i. 
Hypernatraemia 
If sodium > 150 mmolll 
i. Use 1/2 DD (NOT 5% dextrose water) for rehydration. Treat shock with volume 
expanders as usual. 
ii. Calculate fluid administration rates as usual according to clinical assessment 
of dehydration (remember that it is easy to underestimate dehydration in 
hypernatraemia). 
iii. Check serum sodium 4-hourly if Na >155 mmoi/i. The sodium should drop by 
1-2 mmol/h. Too rapid a fall leads to cerebral oedema and convulsions, while 
failure of the sodium to drop means that the patient needs more fluid. 
iv. Ensure hypovolaemia is corrected. Urine output should be ~2 ml/kg/h. 
v. Use soda bicarbonate only if pH <7.10. Half correct the acidosis. 
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Appendix 5.3 Booklet used to record clinical notes of patients admitted to 
the Rehydration Unit at Red Cross Children's Hospital 
.NAME: M~~LL_~ DISEASE: NO I YES 
FO..bPERNO: VACClti~ NOI YES 7112. 14112. 
D,O~B.: 
i'B'CONlRACT: NO I YES 
(USE STICKER IF AVAiLASt£) LI'/iMUNISATI0N~; COMPLETE I INCOMPLETE 
RECORD·.OF DIARRHOEAL DISEASE 
. 
ADMISSION . DISCliARGE 1 TRANSFER COMPLICATIONS RELATED TO DIARRHOEA ... 
NO . 1 















ACID -BASE ANOELECTROLYTE RESULTS 
















FIRST ADMISSION IRE·ADMISSION: DATE: ____ _ 
P.C. 1. DIARRHOEA _____ ,DAYS ___ COLOUR'--_____ CONSISTENCY 
BLOOD: YESINO MUCUS: 





3. FOODS: ___________________________________ __ 
4. OTHER PROBLEMS: ___________________ _ 
EXAMINATION 
1. HYDRA1'ION GOOD POTOEHYD 5% 10% >10% 




PERIPHERAL PERFUSION: . 
Pulse ____ ---'1 MIN 





N.B. NOW COMPLETE PROBLEM LIST ON FIRST PAGE 
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ASSESSMENT SHOCKED: YES/NO pEHYDRATION: % 
OTHER PROBLEMS: 
INITIAL FLUID THERAPY PLAN: 
PLASMA VOLUME ORAL 1/200 NPMAND NGANDORAL Na BIC. 
EXPANDER FOR AND IVI FLUIDS FLUIDS 
SHOCK REASSESS ONLY ________ ml 
FLUID SeHEOULE 
DATE BOITLE FLUID ADDITIVES VOLUME HOURS RATE riME TIME SIG. 
NO TO RUN DROPS STARTED COMPLETED 
IN IMIN -
205 
DRIP ROOM CONTINUING ASSESSMENT DRX 274 
DATE/DAY: 










TOTAL / 24 HRS 
ORAL FEEI:)S 
MANAGEME~I 
a) CURRENT PROBLEM 
b) ASSESSMENT OF 
PATIENT 
c) PLAN / TREATMENT 
SIGNATURE: 
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Appendix 5.4 Gastro Electrolyte Study: FOLDER INFORMATION 
Name: ___________ _ 
Folder No: _________ _ 
O.O.B: RIS: 
Date(s) folder examined: I I 
Date(s) data entered onto database: _---'--'-___ _ 
Na+ on admission: _________ _ 
K+ on admfssion: __________ _ 
normal 135 - 150 
normal 3.5 - 5.3 
Date blood taken: __ ---'---'-____ Time: ___ _ 
Date baby examined: Time: __ _ 
Time difference: __________ _ 
Potassium less than 3.5 mmolll on admission? 
If 'Yes' 
highest daily dose of oral KCI __________ _ 
daily dose above 1.5 g 
IV fluid containing more than 17 mmol/l of potassium 
(% DD = 17 K+) 
Potassium less than 2.5 mmolll on admission 
If 'Yes' 
Admission to ICU 
If 'Yes' 
Mention of the K+ level in the clinical notes before or 
at the time of the ICU admission decision? 
Sodium less than 135 mmolll on admission 
If 'Yes' 
IV fluid containing more than 61 mmol/l of sodium 
( Y2 DD = 61 Na +) 
Sodium more than 150 mmolll on admission 
If 'Yes' 
at least one repeat sodium measurement 
Sodium more than 158 mmol/l on admission 
If 'Yes' 














Mention of the Na+ level in the clinical notes before or at the time 





Discharge from A9 
Died in A9 
Transfer out to Ward/Hasp 
ICU 
Weight on admission: ________ _ 
Weight on discharge: ________ _ 
Length: __________ _ 
Date: _--'--'--__ _ 
Date: _---'--'--__ _ 
Date: _---'--'--__ _ 
Where: __ _ 
Date:_----'/----'-/ ___ _ 
Presence of co-morbidity: __________________ _ 
Presence of shock: YIN 
Good 5% >10% 
Normal Marasmic Maras/Kw8sh 
Peripheral perfusion: Good / fair / poor. 
HIV status: (Baby) - Positive = 1 
Test: __ _ 
Negative =2 
Test: __ _ 
Unknown = 3 
HIV status: (Mom) - Positive = 1 
Test: ___ _ 
Negative =2 
Test ___ _ 
Unknown = 3 
Tests for HIV: PCR=1; P4=2; Elisa=3; Rapid test=4; Not reported=5; Other=6. 
Medical emergency: YIN 
Time: _____ _ 
Time Difference: __ _ 
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